
<html lang="en"     class="pb-page"  data-request-id="b17be5d3-cd7a-4371-aaa0-2cf6cc11ab2e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-12;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.7b01709;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Identification of Highly Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors against Lopinavir and Darunavir Resistant Viruses from Allophenylnorstatine-Based Peptidomimetics with P2 Tetrahydrofuranylglycine" /></meta><meta name="dc.Creator" content="Koushi  Hidaka" /></meta><meta name="dc.Creator" content="Tooru  Kimura" /></meta><meta name="dc.Creator" content="Rajesh  Sankaranarayanan" /></meta><meta name="dc.Creator" content="Jun  Wang" /></meta><meta name="dc.Creator" content="Keith F.  McDaniel" /></meta><meta name="dc.Creator" content="Dale J.  Kempf" /></meta><meta name="dc.Creator" content="Masanori  Kameoka" /></meta><meta name="dc.Creator" content="Motoyasu  Adachi" /></meta><meta name="dc.Creator" content="Ryota  Kuroki" /></meta><meta name="dc.Creator" content="Jeffrey-Tri  Nguyen" /></meta><meta name="dc.Creator" content="Yoshio  Hayashi" /></meta><meta name="dc.Creator" content="Yoshiaki  Kiso" /></meta><meta name="dc.Description" content="The emergence of drug-resistant HIV from a widespread antiviral chemotherapy targeting HIV protease in the past decades is unavoidable and provides a challenge to develop alternative inhibitors. We..." /></meta><meta name="Description" content="The emergence of drug-resistant HIV from a widespread antiviral chemotherapy targeting HIV protease in the past decades is unavoidable and provides a challenge to develop alternative inhibitors. We..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 31, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01709" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01709" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01709" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01709" /></link>
        
    
    

<title>Identification of Highly Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors against Lopinavir and Darunavir Resistant Viruses from Allophenylnorstatine-Based Peptidomimetics with P2 Tetrahydrofuranylglycine | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01709" /></meta><meta property="og:title" content="Identification of Highly Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors against Lopinavir and Darunavir Resistant Viruses from Allophenylnorstatine-Based Peptidomimetics with P2 Tetrahydrofuranylglycine" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0017.jpeg" /></meta><meta property="og:description" content="The emergence of drug-resistant HIV from a widespread antiviral chemotherapy targeting HIV protease in the past decades is unavoidable and provides a challenge to develop alternative inhibitors. We synthesized a series of allophenylnorstatine-based peptidomimetics with various P3, P2, and P2́ moieties. The derivatives with P2 tetrahydrofuranylglycine (Thfg) were found to be potent against wild type HIV-1 protease and the virus, leading to a highly potent compound 21f (KNI-1657) against lopinavir/ritonavir- or darunavir-resistant strains. Co-crystal structures of 21f and the wild-type protease revealed numerous key hydrogen bonding interactions with Thfg. These results suggest that the strategy to design allophenylnorstatine-based peptidomimetics combined with Thfg residue would be promising for generating candidates to overcome multidrug resistance." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01709"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01709">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01709&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01709&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01709&amp;href=/doi/10.1021/acs.jmedchem.7b01709" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 5138-5153</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00002" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01829" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of Highly Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors against Lopinavir and Darunavir Resistant Viruses from Allophenylnorstatine-Based Peptidomimetics with P2 Tetrahydrofuranylglycine</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Koushi Hidaka</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Koushi Hidaka</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Medicinal Chemistry, Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Kobe 650-8586, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Koushi++Hidaka">Koushi Hidaka</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8956-6996" title="Orcid link">http://orcid.org/0000-0002-8956-6996</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tooru Kimura</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tooru Kimura</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Kyoto Pharmaceutical University, Kyoto 607-8412, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tooru++Kimura">Tooru Kimura</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rajesh Sankaranarayanan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rajesh Sankaranarayanan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Kyoto Pharmaceutical University, Kyoto 607-8412, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rajesh++Sankaranarayanan">Rajesh Sankaranarayanan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jun Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jun Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Kyoto Pharmaceutical University, Kyoto 607-8412, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jun++Wang">Jun Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Keith F. McDaniel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Keith F. McDaniel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Pharmaceutical Research and Development, AbbVie, North Chicago, Illinois 60064, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Keith+F.++McDaniel">Keith F. McDaniel</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5704-3288" title="Orcid link">http://orcid.org/0000-0001-5704-3288</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dale J. Kempf</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dale J. Kempf</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Pharmaceutical Research and Development, AbbVie, North Chicago, Illinois 60064, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dale+J.++Kempf">Dale J. Kempf</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Masanori Kameoka</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Masanori Kameoka</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of International Health, Kobe University Graduate School of Health Sciences, Kobe 654-0142, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Masanori++Kameoka">Masanori Kameoka</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Motoyasu Adachi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Motoyasu Adachi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Quantum Beam Science Drectorate, National Institutes for Quantum and Radiological Science and Technology, Tokai, Ibaraki 319-1106, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Motoyasu++Adachi">Motoyasu Adachi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ryota Kuroki</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ryota Kuroki</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Quantum Beam Science Center, Japan Atomic Energy Agency, Tokai, Ibaraki 319-1195, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ryota++Kuroki">Ryota Kuroki</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jeffrey-Tri Nguyen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jeffrey-Tri Nguyen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Kyoto Pharmaceutical University, Kyoto 607-8412, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey-Tri++Nguyen">Jeffrey-Tri Nguyen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yoshio Hayashi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yoshio Hayashi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yoshio++Hayashi">Yoshio Hayashi</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7010-6914" title="Orcid link">http://orcid.org/0000-0002-7010-6914</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Yoshiaki Kiso</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yoshiaki Kiso</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Peptide Sciences, Nagahama Institute of Bio-Science and Technology, Nagahama 526-0829, Japan</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +81-749-64-8113. Fax: +81-749-76-8140. E-mail: <a href="/cdn-cgi/l/email-protection#354c6a5e5c465a755b5452545d545854185c18575c5a1b54561b5f45"><span class="__cf_email__" data-cfemail="f68fa99d9f8599b6989791979e979b97db9fdb949f99d89795d89c86">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yoshiaki++Kiso">Yoshiaki Kiso</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7877-8221" title="Orcid link">http://orcid.org/0000-0002-7877-8221</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01709&amp;href=/doi/10.1021%2Facs.jmedchem.7b01709" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 5138–5153</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 31, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 November 2017</li><li><span class="item_label"><b>Published</b> online</span>31 May 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 June 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01709" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01709</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5138%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DKoushi%2BHidaka%252C%2BTooru%2BKimura%252C%2BRajesh%2BSankaranarayanan%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D12%26contentID%3Dacs.jmedchem.7b01709%26title%3DIdentification%2Bof%2BHighly%2BPotent%2BHuman%2BImmunodeficiency%2BVirus%2BType-1%2BProtease%2BInhibitors%2Bagainst%2BLopinavir%2Band%2BDarunavir%2BResistant%2BViruses%2Bfrom%2BAllophenylnorstatine-Based%2BPeptidomimetics%2Bwith%2BP2%2BTetrahydrofuranylglycine%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5153%26publicationDate%3DJune%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01709"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1190</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">7</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01709" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of Highly Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors against Lopinavir and Darunavir Resistant Viruses from Allophenylnorstatine-Based Peptidomimetics with P2 Tetrahydrofuranylglycine&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Koushi&quot;,&quot;last_name&quot;:&quot;Hidaka&quot;},{&quot;first_name&quot;:&quot;Tooru&quot;,&quot;last_name&quot;:&quot;Kimura&quot;},{&quot;first_name&quot;:&quot;Rajesh&quot;,&quot;last_name&quot;:&quot;Sankaranarayanan&quot;},{&quot;first_name&quot;:&quot;Jun&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Keith&quot;,&quot;last_name&quot;:&quot;F. McDaniel&quot;},{&quot;first_name&quot;:&quot;Dale&quot;,&quot;last_name&quot;:&quot;J. Kempf&quot;},{&quot;first_name&quot;:&quot;Masanori&quot;,&quot;last_name&quot;:&quot;Kameoka&quot;},{&quot;first_name&quot;:&quot;Motoyasu&quot;,&quot;last_name&quot;:&quot;Adachi&quot;},{&quot;first_name&quot;:&quot;Ryota&quot;,&quot;last_name&quot;:&quot;Kuroki&quot;},{&quot;first_name&quot;:&quot;Jeffrey-Tri&quot;,&quot;last_name&quot;:&quot;Nguyen&quot;},{&quot;first_name&quot;:&quot;Yoshio&quot;,&quot;last_name&quot;:&quot;Hayashi&quot;},{&quot;first_name&quot;:&quot;Yoshiaki&quot;,&quot;last_name&quot;:&quot;Kiso&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;31&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;5138-5153&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01709&quot;},&quot;abstract&quot;:&quot;The emergence of drug-resistant HIV from a widespread antiviral chemotherapy targeting HIV protease in the past decades is unavoidable and provides a challenge to develop alternative inhibitors. We synthesized a series of allophenylnorstatine-based peptidomimetics with various P3, P2, and P2́ moieties. The derivatives with P2 tetrahydrofuranylglycine (Thfg) were found to be potent against wild type HIV-1 protease and the virus, leading to a highly potent compound 21f (KNI-1657) against lopinavir/ritonavir- or darunavir-resistant strains. Co-crystal structures of 21f and the wild-type protease revealed numerous key hydrogen bonding interactions with Thfg. These results suggest that the strategy to design allophenylnorstatine-based peptidomimetics combined with Thfg residue would be promising for generating candidates to overcome multidrug resistance.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01709&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01709" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01709&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01709" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01709&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01709" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01709&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01709&amp;href=/doi/10.1021/acs.jmedchem.7b01709" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01709" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01709" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01709%26sid%3Dliteratum%253Aachs%26pmid%3D29852069%26genre%3Darticle%26aulast%3DHidaka%26date%3D2018%26atitle%3DIdentification%2Bof%2BHighly%2BPotent%2BHuman%2BImmunodeficiency%2BVirus%2BType-1%2BProtease%2BInhibitors%2Bagainst%2BLopinavir%2Band%2BDarunavir%2BResistant%2BViruses%2Bfrom%2BAllophenylnorstatine-Based%2BPeptidomimetics%2Bwith%2BP2%2BTetrahydrofuranylglycine%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D12%26spage%3D5138%26epage%3D5153%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292035" title="Viruses">Viruses</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/jmcmar.2018.61.issue-12/20180628/jmcmar.2018.61.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01709&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The emergence of drug-resistant HIV from a widespread antiviral chemotherapy targeting HIV protease in the past decades is unavoidable and provides a challenge to develop alternative inhibitors. We synthesized a series of allophenylnorstatine-based peptidomimetics with various P<sub>3</sub>, P<sub>2</sub>, and P<sub>2</sub>́ moieties. The derivatives with P<sub>2</sub> tetrahydrofuranylglycine (Thfg) were found to be potent against wild type HIV-1 protease and the virus, leading to a highly potent compound <b>21f</b> (KNI-1657) against lopinavir/ritonavir- or darunavir-resistant strains. Co-crystal structures of <b>21f</b> and the wild-type protease revealed numerous key hydrogen bonding interactions with Thfg. These results suggest that the strategy to design allophenylnorstatine-based peptidomimetics combined with Thfg residue would be promising for generating candidates to overcome multidrug resistance.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66153" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66153" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the past decades, antiretroviral therapy for human immunodeficiency virus type-1 (HIV-1) infection using nucleoside and non-nucleoside reverse transcriptase inhibitors, and protease inhibitors has advanced to become convenient for patients because of the once-daily dosing regimen and reduced numbers of orally administered tablets and capsules.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Recent approvals of entry and integrase inhibitors provide new options for patients struggling with drug resistance.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> HIV/AIDS has been, accordingly, recognized as a controllable chronic illness.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Despite the therapeutic success, drug resistance and side effects still remain a great concern in long-term treatment. Resistance to HIV protease inhibitors is one of the problems because of the market for generic drugs.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The situation is complicated by the existence of other HIV-1 subtypes and circular recombinant forms because of the altered susceptibility to drugs.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> Therefore, the development of alternative HIV protease inhibitors is still a challenge for researchers.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">Progress on recently approved HIV protease inhibitors led to drugs that possess a high genetic barrier against the virus. Lopinavir, as an example, requires more than six mutations to lose ten times its antiviral activity in vitro.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Another example, darunavir, is now the first option for therapeutic regimens and would take more than one hundred days to induce drug resistance.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Nevertheless, a research group of Abbott Laboratories has generated a lopinavir/ritonavir resistant HIV strain, A17.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The mutant clone displayed approximately 50-fold resistance to lopinavir. Although the mutation sites were identified in the protease coding region, a detailed study on the decreasing activity was not reported. Koh et al. reported high resistance to darunavir using mixed clones from four patients with therapeutic failure.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> A combination of the four mutations surprisingly attenuated the activity approximately 100-fold. Overcoming these resistances is the target of developing next-generation inhibitors.</div><div class="NLM_p">Allophenylnorstatine [Apns: (2<i>S</i>,3<i>S</i>)-3-amino-2-hydroxy-4-phenylbutyric acid] is an unnatural α-hydroxy-β-amino acid residue that contains a hydroxymethylcarbonyl (HMC) group as a transition-state isostere to act as a P<sub>1</sub> residue in peptidic HIV protease inhibitors.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13−15)</a> The ideal binding interactions of HMC isostere with two catalytic Asp residues of HIV-1 protease have been disclosed by neutron crystallography<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> in addition to former X-ray crystallography<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and NMR analyses.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Previously developed Apns-based compounds <b>1</b> and <b>2</b>, known as KNI-272 and KNI-764, respectively, are highly potent against the protease and the virus, and both were tested orally in clinical studies (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> Modifications of these inhibitors were extensively studied for improving antiviral activity against drug resistant strains, water-solubility, and pharmacokinetic profile.<a onclick="showRef(event, 'ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24">(21−24)</a> Their effective potency against resistances was unfortunately limited. To overcome the multidrug-resistant mutations, we planned a series of Apns-based tripeptidic compounds with a combination of residues and terminal caps that were selected from previous experiments exhibiting high protease inhibitory potency. Especially, unnatural P2 residue tetrahydrofuranylglycine (Thfg), originally designed by Ghosh et al.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and further exploited in urethanes in amprenavir<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and darunavir,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> is newly applied to the Apns-based derivatives, leading to compounds with highly potent anti-HIV activity, even against lopinavir/r- or darunavir-resistant strains.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Allophenylnorstatine-containing HIV protease inhibitors <b>1</b> and <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01709&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Ligand Selections for Combinational Modifications</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54211" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54211" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The general structure of the HIV protease inhibitor synthesized in this study is depicted in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>. Our combinational modifications were intended to be structurally focused on yielding high potency against the protease. First, Apns was chosen as the P<sub>1</sub> residue from a previous comparison with phenylnorstatine.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (<i>R</i>)-5,5-Dimethylthiazolidine-4-carboxylic acid (Dmt) was also selected as the P<sub>1</sub>́ residue from the reported proline-based modifications.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Three residues were selected to optimize the P2 residue. Asn was known as the most effective for protease inhibition among many natural and non-natural amino acid residues. Val was also selected with a little less potency than Asn. In addition to the above branched residues, Thfg, which is a hybrid structure of Asn and Val, was applied. The P<sub>3</sub> cap was searched among our results from previous structure–activity relationship studies.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Three types of phenoxyacetyl moieties, including 5-isoquinolinyloxyacetyl in compound <b>1</b> and the oxygen-mimicking chromonylcarbonyl and bezofurancarbonyl groups, were chosen. The seven P<sub>2</sub>́ amide residues were selected to include β-methallylamide from a previous study on highly potent dipeptidic inhibitors such as KNI-1689.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Incorporation of Thfg at the P<sub>2</sub> residue and the corresponding binding subsites.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01709&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14744" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14744" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The preparation of Thfg was performed as reported<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). (<i>R</i>)-3-Hydroxytetrahydrofuran (<b>3</b>) was converted to the substituted malonate <b>4</b>, and then decarboxylated with cuprous oxide to generate tetrahydrofuranylacetic acid <b>5</b>. The acid was coupled to (<i>S</i>)-Evans auxiliary and then subjected to stereoselective and electrophilic azidation using trisyl azide to afford (2<i>S</i>,3′<i>R</i>)-azidotetrahydrofuranylacetate <b>7</b>. The intermediate was subjected to reduction using SnCl<sub>2</sub> in ethanol and in situ Boc protection to give a mixture of <b>8a</b> and <b>8b</b> in 45 and 30% yields, respectively. Both were hydrolyzed to give (2<i>S</i>,3′<i>R</i>)-Boc-Thfg-OH (<b>9</b>). In the case of (2<i>S</i>,3′<i>S</i>)-isomer, (<i>S</i>)-3-hydroxytetrahydrofuran was used as the starting material and transformed in a manner similar to the (<i>R</i>)-form, and the intermediate azide <b>11</b> with Evans auxiliary attached was hydrolyzed using LiOH to yield (2<i>S</i>,3′<i>S</i>)-2-azidotetrahydrofuranylacetic acid <b>12</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01709&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, −10 °C, 2 h; (b) NaH, CH<sub>2</sub>(CO<sub>2</sub>Et)<sub>2</sub>, DMF, reflux, 20 h; (c) 1 M NaOH aq., 40 °C, 72 h then H<sub>3</sub>O<sup>+</sup>; (d) Cu<sub>2</sub>O, CH<sub>3</sub>CN, 80 °C, 12 h; (e) Me<sub>3</sub>COCl, Et<sub>3</sub>N, THF, −78 °C then <i>N</i>-lithio-(<i>S</i>)-(−)-4-benzyloxazolidine, 2 h; (f) KN(TMS)<sub>2</sub>, THF, −78 °C, 30 min then trisyl azide, −78 °C, 2 min then AcOH, 35 °C, 1 h; (g) SnCl<sub>2</sub>, EtOH, 0 °C, 3.5 h; (h) (Boc)<sub>2</sub>O, NaHCO<sub>3</sub> aq., dioxane, rt, 19 h; (i) LiOH, THF–H<sub>2</sub>O, rt, 2.5 h.</p></p></figure><div class="NLM_p">P<sub>3</sub> phenoxyacetic acid analogues were synthesized from the phenol derivatives as described before.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a><a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> illustrates the synthesis of Thfg-containing inhibitors. Compounds <b>15a</b> and <b>15b</b> were obtained from a previously reported intermediate, Boc-protected dipeptide carboxamides <b>13</b>.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The deprotection of the Boc group using HCl-dioxane gave the amine component to react with <b>9</b> using EDC–HOBt coupling reagents, and the subsequent deprotection and BOP coupling with quinolinecarboxylic acid derivatives afforded the desired compounds. The (2<i>S</i>,3′<i>S</i>)-Thfg isomer was incorporated as an azido form to give the intermediate <b>16</b>. The reduction to amine and BOP coupling with the P<sub>3</sub> carboxylic acids gave compounds <b>17a</b> and <b>17b</b> in good yields. The intermediate <b>14</b> was deprotected and used to combine 5-isoquinolinyloxyacetic acid to give compound <b>18</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01709&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 4 M-HCl/dioxane, anisole, rt, 15–60 min; (b) <b>9</b>, EDC·HCl, HOBt, Et<sub>3</sub>N, DMF, rt, 14 h; (c) 2-quinolinecarboxylic acid or 2-quinoxalinecarboxylic acid, BOP, Et<sub>3</sub>N, DMF, rt, 14–19 h, then RP-HPLC purification; (d) <b>12</b>, EDC·HCl, HOBt, Et<sub>3</sub>N, DMF, rt, 13 h, then RP-HPLC purification; (e) 5% Pd(OH)<sub>2</sub>, EtOH-THF, rt, 10 h; (f) 7-isoquinolinyloxyacetic acid, BOP, HOBt, Et<sub>3</sub>N, DMF, rt, 14 h, then RP-HPLC purification.</p></p></figure><div class="NLM_p">Preparation of a series of P<sub>3</sub> modifications was started from P<sub>2</sub>′-dimethylbenzyl intermediate <b>19</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). The Boc group was removed to couple with (2<i>S</i>,3′<i>R</i>)-Boc-Thfg-OH, and then removal of the Boc group and condensations with six types of P<sub>3</sub> carboxylic acids afforded compounds <b>21a</b>–<b>f</b>. Similarly, compounds <b>24a</b>–<b>f</b> were synthesized from P<sub>2</sub>′-intermediates except for the last BOP coupling procedure with P<sub>3</sub> 3-(dimethylamino)phenoxyacetic acid as shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a> describes the P<sub>2</sub> derivative synthesis using Boc-Asn-OH and Boc-Val-OH to couple with the amine generated from <b>19</b>. The subsequent deprotection and BOP coupling with benzofurancarboxylic acid derivatives gave the compounds <b>27a</b>–<b>d</b>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01709&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 4 N HCl/dioxane, anisole, rt, 15–30 min; (b) <b>9</b>, EDC·HCl, HOBt, Et<sub>3</sub>N, DMF, rt, 21 h; (d) carboxylic acid derivatives, BOP, Et<sub>3</sub>N, DMF, rt, 12–40 h, then RP-HPLC purification.</p></p></figure><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0008.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01709&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 4 N HCl/dioxane, anisole, rt, 15–60 min for <b>a</b>, <b>b</b>, <b>c</b>, <b>f</b> or 2–5 min for <b>d</b>, <b>e</b>; (b) <b>9</b>, EDC·HCl, HOBt, Et<sub>3</sub>N, DMF, rt, 13–21 h; (d) (3-dimethylamino)phenoxyacetic acid, BOP, Et<sub>3</sub>N, DMF, rt, 13–23 h, then RP-HPLC purification.</p></p></figure><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0009.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01709&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 4 N HCl/dioxane, anisole, rt, 30 min; (b) Boc-Val-OH or Boc-Asn-OH, EDC·HCl, HOBt, Et<sub>3</sub>N, DMF, rt, 14–15 h; (d) benzofuran-2-carboxylic acid or 7-methoxybenzofuran-2-carboxylic acid, BOP, Et<sub>3</sub>N, DMF, rt, 14–15 h, and prep. HPLC.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80068" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80068" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To test the matching of Thfg residue with Apns-based peptidomimetics, we first combined a P<sub>3</sub>–P<sub>2</sub> structure based on Merck’s compounds,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> quinolinecarbonyl-Thfg, with Apns-Dmt-(2-methyl)benzylamide of <b>2</b>. Compound <b>15a</b> with P<sub>2</sub> (2<i>S</i>,3′<i>R</i>)-Thfg exhibited highly potent HIV-1 protease inhibitory activity, 96% inhibition at 1 nM inhibitor concentration (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). As expected from the results in Merck’s report, compound <b>17a</b> with P<sub>2</sub> (2<i>S</i>,3′<i>S</i>)-Thfg was less potent than compound <b>15a</b>. The EC<sub>50</sub> value of compound <b>15a</b> was less than 3 nM. The anti-HIV activity of <b>17a</b> was weak (26 nM), in agreement with its protease inhibition. The activities of these Thfg-containing derivatives were relatively potent compared with the parent compounds <b>1</b> and <b>2</b> (176 and 60 nM, respectively). Replacement of P<sub>3</sub> quinolinecarbonyl with quinoxalinecarbonyl resulted in a slight increase in protease inhibition. An improvement was also observed in the anti-HIV activity under 50% human serum. Additional aromatic nitrogen may increase the basicity affecting the cellular membrane permeability. These successful results on the combination with Thfg urged us to optimize the P<sub>3</sub> position.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. HIV Protease Inhibitory and Anti-HIV Activity of P<sub>2</sub>-Thfg Derivatives<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0010.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">Anti-HIV-1<sub>pNL4–3</sub>, EC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Compound</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Configuration of Thfg</th><th class="colsep0 rowsep0" align="center" char=".">HIV-1 PR % inhibition at 1 nM</th><th class="colsep0 rowsep0" align="center" char=".">0% HS</th><th class="colsep0 rowsep0" align="center" char=".">50% HS</th><th class="colsep0 rowsep0" align="center" char=".">SBE</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15a</b> (KNI-1640)</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">(2<i>S</i>,3′<i>R</i>)</td><td class="colsep0 rowsep0" align="char" char=".">96</td><td class="colsep0 rowsep0" align="char" char="."><3</td><td class="colsep0 rowsep0" align="char" char=".">411</td><td class="colsep0 rowsep0" align="char" char=".">>137</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15b</b> (KNI-1639)</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">(2<i>S</i>,3′<i>R</i>)</td><td class="colsep0 rowsep0" align="char" char=".">97</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">84</td><td class="colsep0 rowsep0" align="char" char=".">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17a</b> (KNI-1603)</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">(2<i>S</i>,3′<i>S</i>)</td><td class="colsep0 rowsep0" align="char" char=".">69</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">602</td><td class="colsep0 rowsep0" align="char" char=".">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17b</b> (KNI-1609)</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">(2<i>S</i>,3′<i>S</i>)</td><td class="colsep0 rowsep0" align="char" char=".">86</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">131</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">176<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">2881<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">60</td><td class="colsep0 rowsep0" align="char" char=".">114<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">HS, human serum; SBE, serum binding effect, EC<sub>50</sub> with 50% HS/EC<sub>50</sub> 0% HS. % inhibition values were obtained by single determination. EC<sub>50</sub> values were averaged from multiple determinations (<i>n</i> = 3).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">IIIB strain.</p></div></div></div><div class="NLM_p">Selection of the 5-isoquinolinyloxyacetyl moiety was derived from inhibitor <b>1</b>. The resultant compound <b>18</b> exhibited sufficient HIV-1 protease inhibition and anti-HIV activity with EC<sub>50</sub> of 21 nM (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). However, the activity under 50% human serum was dramatically attenuated to 4.35 μM. We shifted to use the P<sub>2</sub>́ structure with an additional <i>o</i>-methyl group, that is 2,6-dimethylbenzylamide, which is the most favorable P<sub>2</sub>́ for enzyme inhibition among the previously reported dipeptidic inhibitors.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Compound <b>21a</b> exhibited 98% enzyme inhibition and 60 nM anti-HIV activity. Interestingly, the addition of serum slightly affected the activity with a serum binding effect of 2.4. Replacement with 3-(phenylamino)phenoxyacetyl (<b>21b</b>) increased the anti-HIV activity up to 5 nM. A minor variant with the dimethylamino moiety in compound <b>21c</b> improved anti-HIV inhibition (<3 nM). The activity in the presence of human serum scored 15 nM, which is the most potent among the series. Other P<sub>3</sub> modifications with chromonylcarbonyl, benzofurancarbonyl, and 7-methoxybenzofurancarbonyl were also successful in obtaining highly potent HIV protease inhibitors (<b>21d</b>–<b>21f</b>). The derivative <b>21d</b> with chromonylcarbonyl was equipotent to isoquinolinyloxyacetyl in inhibitory activity. Compounds <b>21e</b> and <b>21f</b> were slightly more effective than <b>21d</b> for anti-HIV activity with or without human serum.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibitory Activity of P<sub>3</sub> Derivatives with P<sub>2</sub>-Thfg<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0011.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0012.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">HS, human serum; SBE, serum binding effect. % inhibition values were obtained by single determination. EC<sub>50</sub> values were averaged from multiple replicates (<i>n</i> = 3).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></p></div></div><div></div></div><div class="NLM_p">The strong anti-HIV activity of compound <b>21c</b> with low serum binding effect encouraged us to perform combinatorial modification of the P<sub>2</sub>́ structure with a fixed P<sub>3</sub> moiety, that is, 3-(dimethylamino)phenoxyacetyl. Inhibitory activity of the derivatives with selected P<sub>2</sub>́ structures is summarized in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. HIV protease inhibitory activity ranged from 93% to 97% at 1 nM inhibitor concentration. Antiviral activity of compound <b>24a</b> was potent with EC<sub>50</sub> of 5 nM. The addition of human serum had a moderate effect with a 6-fold decrease. Modification with aminoindanol (<b>24b</b>), which was reported to be effective for malarial plasmepsin inhibition,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> was also successful for anti-HIV activity. In the presence of serum, the activity largely decreased approximately 20 times. In our previous paper, we presented relatively small P<sub>2</sub>́ structures that are effective in protease inhibition. Cyclopentylamide derivative <b>24c</b> exhibited 10 nM for viral inhibition and a moderate attenuation by serum addition. P<sub>2</sub>́ allyl analogues <b>24d</b> and <b>24e</b> were slightly better than the cyclopentylamide derivative for enzyme inhibition. Compound <b>24e</b> with an additional methyl moiety was more potent than <b>24d</b> for enzyme inhibition, which may be derived from interactions with hydrophobic side chains of Ala28, Ile84, and Ile50′ in the S<sub>2</sub>′ pocket as previously reported.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The anti-HIV activity had a positive relationship with enzyme inhibitory potency. However, activity reductions in human serum were different between the analogues, 24-fold and 7-fold, respectively. As a result, the β-methallylamide derivative <b>24e</b> was superior to the allyl derivative <b>24d</b>. The extension of the hydroxymethyl group from the allylamide structure was also effective for enzyme inhibition. As predicted from the previous results of dipeptide-type inhibitors, the anti-HIV activity was relatively weak. The effect of the human serum was small (3.6-fold).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibitory Activity of P<sub>2</sub>′ Derivatives with P<sub>2</sub>-Thfg<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0013.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0014.gif" alt="" id="gr100" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">HS, human serum; SBE, serum binding effect. % inhibition values were obtained by single determination. EC<sub>50</sub> values were averaged from multiple determinations (<i>n</i> = 3).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></p></div></div><div></div></div><div class="NLM_p">We selected the top-five inhibitors with high antiviral potency from the above-mentioned tests, and they were subjected to evaluation against the lopinavir/ritonavir-resistant HIV strain, A17, as shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. Lopinavir and <b>2</b> exhibited moderate potency with EC<sub>50</sub> values of 60 and 30 nM, respectively. Their potencies precipitously decreased against A17 up to the μM level. However, the activity of Thfg analogues was still in the nM range, one order more potent compared to lopinavir and compound <b>2</b>. The most potent inhibitor against A17 was compound <b>21f</b> with an EC<sub>50</sub> value of 25 nM (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The values of fold resistance were not much different from lopinavir and dipeptidic <b>2</b>. Although the strong potency of <b>21f</b> against wild-type (<3 nM) may also be largely attenuated, and the activity seemed to be sustained against the resistant virus.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure for <b>21f</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01709&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Activity against Lopinavir/Ritonavir-Resistant HIV, A17<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">Anti-HIV-1, EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Compound</th><th class="colsep0 rowsep0" align="center" char=".">WT<sub>pNL4–3</sub></th><th class="colsep0 rowsep0" align="center" char=".">A17</th><th class="colsep0 rowsep0" align="center" char=".">FR</th><th class="colsep0 rowsep0" align="center" char=".">TD<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lopinavir</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">1160</td><td class="colsep0 rowsep0" align="char" char=".">39</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">60</td><td class="colsep0 rowsep0" align="char" char=".">2730</td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="char" char=".">23000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15b</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21b</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">226</td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="char" char=".">39000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21c</b></td><td class="colsep0 rowsep0" align="char" char="."><3</td><td class="colsep0 rowsep0" align="char" char=".">165</td><td class="colsep0 rowsep0" align="char" char=".">>55</td><td class="colsep0 rowsep0" align="char" char=".">60000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21e</b></td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">678</td><td class="colsep0 rowsep0" align="char" char=".">57</td><td class="colsep0 rowsep0" align="char" char=".">38000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21f</b></td><td class="colsep0 rowsep0" align="char" char="."><3</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">>8</td><td class="colsep0 rowsep0" align="char" char=".">11000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">WT, wild-type; A17, lopinavir/ritonavir resistant HIV with mutations in the protease region, L10F/V32I/M46I/I47V/Q58E/I84V; FR, fold-resistance, the ratio of EC<sub>50</sub>(resistant mutant)/EC<sub>50</sub>(wild-type). EC<sub>50</sub> values were averaged from multiple replicates (<i>n</i> = 3). TD<sub>50</sub> values were averaged from multiple determinations (<i>n</i> = 3).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></p></div></div></div><div class="NLM_p">P<sub>2</sub> preference was explored on the P<sub>3</sub> benzofurancarbonyl derivatives, which exhibited promising anti-HIV activity. <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a> summarizes a comparison of Asn, Val, and Thfg at the P<sub>2</sub> position. The Asn analogues <b>27a</b> and <b>27c</b> were equipotent with Thfg analogues in HIV protease inhibitory activity with 96 and 97% inhibition at a 1 nM concentration (<b>27a</b> and <b>21e</b>, <b>27c</b>, <b>21f</b>). The Val derivatives <b>27b</b> and <b>27d</b> were slightly less potent than that of the Thfg and Asn derivatives. As expected, the potency of analogues was reversed in the antiviral assay: the Asn derivatives were less potent and the Val analogues were equipotent compared with the Thfg analogues. The hydrophilic and hydrophobic balance of the Asn analogue, which is caused by an increase of one amide group, may not be suitable for membrane permeability. The results against A17 disclosed another discrepancy between the P<sub>2</sub> structures. The potency of the Val analogues against A17 was drastically weakened with 60- to 100-fold resistance values. In contrast, the potency of Asn derivatives was sustained with 1.4- and 1.6-fold values. A dramatic decrease in potency was observed in compound <b>21e</b>, similar to that of the Val analogues <b>27b</b> and <b>27d</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). The result suggests that <b>21f</b>, with the structural similarity of the five-membered ring of Thfg compared to the bulkiness of branched isopropyl group, would also exhibit diminished potency. These results suggest that the flexible hydrogen bonding ability of the Asn carbamoylmethyl side chain could maintain the interactions in the mutated S<sub>2</sub> pocket. Other than the sustained activity of the Asn derivatives, the Thfg analogue <b>21f</b> was superior against A17 because of the intrinsic high potency against wild-type HIV.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Inhibitory Activity of P<sub>2</sub> Asn or Val Derivatives<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0015.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0016.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">WT, wild-type; FR, fold-resistance, the ratio of EC<sub>50</sub>(resistant mutant)/EC<sub>50</sub>(wild-type). % inhibition values were obtained by single determination. EC<sub>50</sub> values were averaged from multiple replicates (<i>n</i> = 3).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">pNL4–3 strain.</p></div></div><div></div></div><div class="NLM_p">To further examine the potency of <b>21f</b>, we prepared two-types of darunavir-resistant viral assays based on a lentivirus vector infection with 293T cells.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The mutation sites in the protease region were derived from an original report by Koh et al.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> First, we tested darunavir, which showed a strong inhibition against wild-type with an EC<sub>50</sub> value of 0.9 nM (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). The potency was attenuated to the virus containing V32I/L33F/I54M/V82I mutations approximately 15-fold. Another mutation of V32I/L33F/I54M/I84V precipitously dropped the susceptibility of darunavir by 137-fold. These observed activity reductions were similar to the reported results. Compound <b>21f</b> also exhibited strong potency against wild-type virus (1.71 nM) with three times less potency than that of darunavir. Interestingly, the activity of <b>21f</b> was enhanced approximately five times against the virus containing V32I/L33F/I54M/V82I with an EC<sub>50</sub> of 0.30 nM. However, the mutations, including I84V, presented a slight influence on the activity, with an EC<sub>50</sub> of 1.21 nM and a 0.7-fold decrease compared with the wild-type virus. These results indicate that compound <b>21f</b> did not show cross-resistance to darunavir.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Inhibitory Activity against Highly DRV-Resistant Viruses<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">Anti-HIV-1, EC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Compound</th><th class="colsep0 rowsep0" align="center" char="±">WT</th><th class="colsep0 rowsep0" align="center" char="±">V32I/L33F/I54M/V82I (FR<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a>)</th><th class="colsep0 rowsep0" align="center" char="±">V32I/L33F/I54M/I84V (FR<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DRV</td><td class="colsep0 rowsep0" align="char" char="±">0.82 ± 0.21</td><td class="colsep0 rowsep0" align="char" char="±">12.66 ± 0.88 (15)</td><td class="colsep0 rowsep0" align="char" char="±">112.08 ± 27.72 (137)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21f</b></td><td class="colsep0 rowsep0" align="char" char="±">1.71 ± 0.39</td><td class="colsep0 rowsep0" align="char" char="±">0.30 ± 0.07 (0.2)</td><td class="colsep0 rowsep0" align="char" char="±">1.21 ± 0.37 (0.7)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">WT: pCMVdR8.91. EC<sub>50</sub> values of SQV, RTV, IDV, NFV, APV, LPV, ATV, and TPV were 1.87, 10.39, 7.17, 17.52, 7.91, 1.60, 0.80, and 82.84, respectively.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">FR: fold-resistance, the ratio of EC<sub>50</sub>(resistant mutant)/EC<sub>50</sub>(wild-type).</p></div></div></div><div class="NLM_p">To determine the prominent potency of compound <b>21f</b>, X-ray crystallographic analysis of the complex with the wild-type protease (WTm5) was performed (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The result with a resolution of 0.85 Å showed an interaction between the HMC and the catalytic two Asp residues similar to the previous analysis using X-ray and neutron crystallography.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> Direct hydrogen bonding interactions were formed between the oxygen of the THF ring and amide NH group of Asp30′, as well as the NH of the Thfg residue and carbonyl group of Gly48′ (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>a). We identified the three bridging water molecules. One existed between the two carbonyl groups of the inhibitor and the NH groups of the Ile50 and Ile50′ residues in the flap region, which was known as water 301. The second water molecule interacted with the NH of the benzylamide moiety, the carbonyl of Gly27, and the amide NH of Asp29 in the entrance of the S<sub>2</sub>′ and S<sub>3</sub>′ pockets. Another water molecule was placed between the two carbonyl groups of the P<sub>3</sub> cap and Gly27′, and the carboxylate side chain of Asp29. There were ten hydrogen bonding interactions overall, including indirect bridging water molecules. The hydrogen bonding interactions were also observed in the active sites of the A17m5 protease, which has six mutations of V32I, I47V, and I84V to form S2 and S<sub>2</sub>′ pockets, retaining the binding orientation of <b>21f</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>b). The strong hydrogen bonding interactions would explain the sustained activities against drug-resistant viruses. However, the I47V and I84V mutations in these pockets resulted in a removal of the four methyl groups (green surfaces in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>b) in each pocket, generating unoccupied space. The loss of hydrophobic contacts may cause the decrease in the EC<sub>50</sub> value against A17 strain. Other mutations and the protein backbone structure in A17m5 protease seemed to not influence the binding mode of <b>21f</b> (see <a class="ref internalNav" href="#notes-2" aria-label="Supplementary Figure S1">Supplementary Figure S1</a>). The affinity experiments using A17m5 protease are ongoing to discuss the contribution of the unchanged conformation.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray crystal structures of <b>21f</b> bound to wild-type (PDB ID, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5YOK">5YOK</a>) and lopinavir-resistant (PDB ID, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5YOJ">5YOJ</a>) proteases. (a) Hydrogen bond interactions in the active sites of wild-type HIV-1 protease. (b) Superimposition of cocrystals complexed with WTm5 (green) and A17m5 (red). Side chains of the mutated residues in the S2/S2′ pockets were presented with molecular surfaces. Figures were generated using <i>PyMOL</i> (Schrödinger LLC, OR, SA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01709&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31734" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31734" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Highly potent Apns-containing inhibitors with P2 tetrahydrofuranylglycine (Thfg) were synthesized and evaluated against lopinavir/ritonavir- or darunavir-resistant HIV strains to identify compound <b>21f</b> (KNI-1657) with a strong inhibitory activity among the derivatives. Interestingly, compound <b>21f</b> did not show cross-resistance to darunavir. X-ray cocrystal analysis revealed ten hydrogen bonding interactions, suggesting the stability of the pocket to changes from multiple mutations. These results provide useful knowledge for designing next generation HIV protease inhibitors that are highly potent against drug resistant HIV strains.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47657" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47657" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Reagents and solvents used were purchased from Wako Pure Chemical Ind., Ltd. (Osaka, Japan), Nacalai Tesque (Kyoto, Japan), Aldrich Chemical Co. Inc. (Milwaukee, WI), and Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan) used without further purification. Column chromatography was performed on silica gel 60 (70–230 mesh, Merck 107734). The purities of the desired compounds were confirmed by HPLC with simple integration >95%. The purity of compound <b>27a</b> was determined to be 90.2%. Analytical HPLC was performed using a C18 reversed-phase column (4.6 × 150 mm; YMC Pack ODS AM302) with binary solvent systems: (A) linear gradient of CH<sub>3</sub>CN 40–100% in 0.1% aqueous TFA in 15 min, (B) linear gradient of CH<sub>3</sub>CN 20–80% in 0.1% aqueous TFA in 30 min at a flow rate of 0.9 mL/min, detected at 230 nm. Preparative HPLC was carried out on a C18 reversed-phase column (20 × 250 mm; YMC Pack ODS SH343–5) with a binary solvent system: a linear gradient of CH<sub>3</sub>CN in 0.1% aqueous TFA with a flow rate of 5.0 mL/min and detection at 230 nm. <sup>1</sup>H NMR spectra were recorded on a JNM-AL 300 (JEOL, Ltd.), UNITY INOVA 400NB (Varian, Inc.), or DPX400 (Bruker, Ltd.) spectrometer with TMS as an internal standard. Mass spectra with electrospray ionization using 50% aqueous methanol as mobile phase were recorded on a micrOTOF-Q II spectrometer (Bruker, Ltd.).</div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> (<i>S</i>)-2-<i>tert</i>-Butoxycarbonylamino-2-((<i>R</i>)-tetrahydrofuran-3-yl)acetic Acid (<b>9</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm): 12.56 (br s, 1H), 7.23 (d, <i>J</i> = 7.9 Hz, 1H), 3.78 (t, <i>J</i> = 8.8 Hz, 1H), 3.74–3.69 (m, 2H), 3.61 (dd, <i>J</i> = 15.8, 7.3 Hz, 1H), 3.39 (dd, <i>J</i> = 8.4, 7.0 Hz, 1H), 2.45–2.44 (m, 1H), 1.91–1.85 (m, 1H), 1.70–1.63 (m, 1H), 1.38 (s, 9H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>11</sub>H<sub>19</sub>NO<sub>5</sub>Na [M + Na]<sup>+</sup> 268.1155; found 268.1140.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> (<i>S</i>)-2-Azido-2-((<i>S</i>)-tetrahydrofuran-3-yl)acetic Acid (<b>12</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ (ppm): 3.99–3.92 (m, 2H), 3.91 (d, <i>J</i> = 7.5 Hz, 1H), 3.80 (dd, <i>J</i> = 16.0, 7.5 Hz, 1H), 3.72 (dd, <i>J</i> = 9.2, 6.6 Hz, 1H), 2.74 (dt, <i>J</i> = 14.9, 7.5 Hz, 1H), 2.18–2.07 (m, 1H), 1.98–1.86 (m, 1H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>6</sub>H<sub>8</sub>N<sub>3</sub>O<sub>3</sub> [M – H]<sup>−</sup> 170.0571; found 170.0567.</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> (<i>R</i>)-<i>N</i>-(2-Methylbenzyl)-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(<i>tert</i>-butoxycarbonyl)amino-2-((<i>R</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>14</b>)</h3><div class="NLM_p last">Compound <b>14</b> was prepared from Boc-Apns-Dmt-NH(2-methylbenzyl) <b>13</b><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> in a similar manner to that described for compound <b>20</b>; yield 65%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.38 (br s, 1H), 7.91 (d, <i>J</i> = 8.6 Hz, 1H), 7.32–7.30 (m, 1H), 7.28 (d, <i>J</i> = 7.3 Hz, 3H), 7.20–7.07 (m, 6H), 6.93 (d, <i>J</i> = 9.2 Hz, 1H), 5.26 (d, <i>J</i> = 7.0 Hz, 1H), 5.01 (d, <i>J</i> = 9.0 Hz, 1H), 4.93 (d, <i>J</i> = 9.2 Hz, 1H), 4.50 (s, 1H), 4.43 (d, <i>J</i> = 6.2 Hz, 1H), 4.40–4.34 (m, 2H), 4.27–4.2 (br s, 1H), 4.17 (dd, <i>J</i> = 14.8, 4.6 Hz, 1H), 3.76 (t, <i>J</i> = 9.2 Hz, 1H), 3.65–3.59 (m, 1H), 3.56 (t, <i>J</i> = 8.1 Hz, 1H), 3.46 (dd, <i>J</i> =15.4, 7.5 Hz, 1H), 3.27 (t, <i>J</i> = 7.0 Hz, 1H), 2.73 (br d, <i>J</i> = 11.7 Hz, 1H), 2.63 (br d, <i>J</i> = 13.6 Hz, 1H), 2.27 (s, 3H), 2.28–2.25 (m, 1H), 1.50 (s, 3H), 1.44 (m, 2H), 1.37 (s, 9H), 1.36 (s, 3H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>35</sub>H<sub>49</sub>N<sub>4</sub>O<sub>7</sub>S [M + H]<sup>+</sup> 669.3316; found 669.3288.</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> (<i>R</i>)-<i>N</i>-(2-Methylbenzyl)-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(quinoline-2-carbonyl)amino-2-((<i>R</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>15a</b>, KNI-1640)</h3><div class="NLM_p last">A mixture of intermediate <b>14</b> (84.9 mg, 0.13 mmol), anisole (27.6 μL, 0.25 mmol), and 4 M HCl in dioxane (1.27 mL) was stirred for 60 min at rt. After removal of the solvent in vacuo, the residue was precipitated from ether to give the hydrochloride salt. To a solution of the salt in DMF (2 mL) were added triethylamine (35.4 μL, 0.25 mmol), quinoline-2-carboxylic acid (24.2 mg, 0.14 mmol), and BOP (67.2 mg, 0.15 mmol) in an ice bath, and the mixture was stirred overnight at room temperature. After removal of the solvent in vacuo, the residue was added into EtOAc, washed sequentially with 5% NaHCO<sub>3</sub> and brine, dried over MgSO<sub>4</sub>, and concentrated in vacuo to give a product as a solid, 78 mg. Purification of the product by preparative HPLC gave compound <b>15a</b> as a white powder; yield 85%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.78 (d, <i>J</i> = 9.3 Hz, 1H), 8.59 (d, <i>J</i> = 8.2 Hz, 1H), 8.44 (d, <i>J</i> = 8.4 Hz, 1H), 8.40 (d, <i>J</i> = 6.0 Hz, 1H), 8.18–8.15 (m, 2H), 8.10 (dd, <i>J</i> = 8.4, 1.1 Hz, 1H), 7.88 (dt, <i>J</i> = 7.6, 1.5 Hz, 1H), 7.74 (dt, <i>J</i> = 7.4, 1.1 Hz, 1H), 7.31–7.29 (m, 1H), 7.27 (d, <i>J</i> = 7.1 Hz, 2H), 7.17–7.06 (m, 6H), 6.96 (t, <i>J</i> = 7.5 Hz, 1H), 5.34 (d, <i>J</i> = 7.1 Hz, 1H), 5.06 (d, <i>J</i> = 9.2 Hz, 1H), 4.98 (d, <i>J</i> = 9.0 Hz, 1H), 4.53 (t, <i>J</i> = 8.8 Hz, 1H), 4.51 (s, 1H), 4.46–4.38 (m, 2H), 4.3–4.23 (m, 1H), 4.18 (dd, <i>J</i> = 15.0, 4.8 Hz, 1H), 3.71 (dt, <i>J</i> = 7.9, 5.1 Hz, 1H), 3.64 (dd, <i>J</i> = 8.8, 7.3 Hz, 1H), 3.54 (dd, <i>J</i> = 15.8, 7.7, Hz, 1H), 3.45 (dd, <i>J</i> = 8.8, 6.4 Hz, 1H), 2.75 (dd, <i>J</i> = 13.6, 2.2 Hz, 1H), 2.67–2.61 (m, 1H), 2.26 (s, 3H), 1.66–1.59 (m, 2H), 1.51 (s, 3H), 1.36 (s, 3H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>40</sub>H<sub>46</sub>N<sub>5</sub>O<sub>6</sub>S [M + H]<sup>+</sup> 724.3163; found 724.3161.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> (<i>R</i>)-<i>N</i>-(2-Methylbenzyl)-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(quinoxaline-2-carbonyl)amino-2-((<i>R</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>15b</b>, KNI-1639)</h3><div class="NLM_p last">Compound <b>15b</b> was prepared from compound <b>14</b> using quinoxaline-2-carboxylic acid in a manner similar to that described for compound <b>15a</b>; yield 61%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 9.48 (s, 1H), 8.77 (d, <i>J</i> = 9.1 Hz, 1H), 8.45–8.35 (m, 2H), 8.27–8.20 (m, 2H), 8.04–7.97 (m, 2H), 7.33–7.25 (m, 3H), 7.13–7.05 (m, 6H), 6.98–6.92 (m, 1H), 5.34 (d, <i>J</i> = 7.2 Hz, 1H), 5.06 (d, <i>J</i> = 8.9 Hz, 1H), 4.98 (d, <i>J</i> = 9.2 Hz, 1H), 4.56–4.49 (m, 2H), 4.47–4.38 (m, 2H), 4.31–4.25 (m, 1H), 4.18 (dd, <i>J</i> = 15.0, 4.77 Hz, 1H), 3.75–3.69 (m, 1H), 3.65 (dd, <i>J</i> = 8.7, 7.2 Hz, 1H), 3.54 (q, <i>J</i> = 7.6 Hz, 1H), 3.46–3.42 (m, 1H), 2.79–2.73 (m, 1H), 2.69–2.61 (m, 2H), 2.26 (s, 3H), 1.65–1.58 (m, 2H), 1.51 (s, 3H), 1.36 (s, 3H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>39</sub>H<sub>45</sub>N<sub>6</sub>O<sub>6</sub>S [M + H]<sup>+</sup> 725.3116; found 725.3091. Anal. Calcd for C<sub>39</sub>H<sub>44</sub>N<sub>6</sub>O<sub>6</sub>S·1CF<sub>3</sub>COOH·0.4H<sub>2</sub>O: C, 58.2; H, 5.46; N, 9.93. Found: C, 58.26; H, 5.56; N, 9.81.</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (<i>R</i>)-<i>N</i>-(2-Methylbenzyl)-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-azido-2-((<i>S</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>16</b>)</h3><div class="NLM_p last">Compound <b>16</b> was prepared from <b>13</b> in a similar manner to that described for compound <b>20</b>; yield quantitative. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.50 (d, <i>J</i> = 8.6 Hz, 1H), 8.41 (t, <i>J</i> = 5.4 Hz, 1H), 7.33–7.24 (m, 3H), 7.23–7.17 (m, 2H), 7.17–7.10 (m, 4H), 5.41 (d, <i>J</i> = 7.1 Hz, 1H), 5.05–4.93 (m, 2H), 4.51 (s, 1H), 4.45–4.37 (m, 2H), 4.27–4.16 (m, 2H), 3.73–3.70 (m, 1 H), 3.69–3.65 (m, 1H), 3.62–3.57 (m, 2H), 3.44–3.40 (m, 1H), 2.77–2.71 (m, 1H), 2.66–2.59 (m, 1H), 2.27 (s, 3H), 1.95–1.87 (m, 1H), 1.73 (s, 9H), 1.69–1.55 (m, 2H), 1.50 (s, 3H), 1.36 (s, 3H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>30</sub>H<sub>39</sub>N<sub>6</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 595.2697; found 595.2672.</div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (<i>R</i>)-<i>N</i>-(2-Methylbenzyl)-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(quinoline-2-carbonyl)amino-2-((<i>S</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>17a</b>, KNI-1603)</h3><div class="NLM_p last">A mixture of compound <b>16</b> (680 mg, 1.14 mmol) and 5% Pd(OH)<sub>2</sub> (50 mg) in ethanol–THF (1:1, 40 mL) was stirred under hydrogen gas for 10 h at rt. After removal of the solvent in vacuo, the residue was purified by silica gel column chromatography to give the amino intermediate. To a solution of the intermediate in DMF were added triethylamine, quinoline-2-carboxylic acid, and BOP in an ice bath, and the mixture was stirred overnight at room temperature. After removal of the solvent in vacuo, the residue was added into EtOAc, washed sequentially with 5% NaHCO<sub>3</sub> and brine, dried over MgSO<sub>4</sub>, and concentrated in vacuo to give a product as a solid. Purification of the product by preparative HPLC gave compound <b>17a</b> as a white powder; yield 83%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.80 (d, <i>J</i> = 9.2 Hz, 1H), 8.60 (d, <i>J</i> = 8.6 Hz, 1H), 8.43–8.36 (m, 2H), 8.18–8.15 (m, 2H), 8.10 (dd, <i>J</i> = 8.1, 0.7 Hz, 1H), 7.88 (dt, <i>J</i> = 7.9, 1.1 Hz, 1H), 7.74 (t, <i>J</i> = 7.1 Hz, 1H), 7.31–7.29 (m, 1H), 7.25 (d, <i>J</i> = 7.3 Hz, 2H), 7.15–7.08 (m, 4H), 7.06 (d, <i>J</i> = 7.5 Hz, 2H), 6.94 (t, <i>J</i> = 7.3 Hz, 1H), 5.39 (d, <i>J</i> = 7.6 Hz, 1H), 5.05 (d, <i>J</i> = 9.0 Hz, 1H), 4.98 (d, <i>J</i> = 9.2 Hz, 1H), 4.54 (d, <i>J</i> = 8.8 Hz, 1H), 4.51 (s, 1H), 4.46–4.38 (m, 2H), 4.29–4.23 (m, 1H), 4.17 (dd, J = 15.0, 4.8 Hz, 1H), 3.70 (dt, <i>J</i> = 8.1, 4.9 Hz, 1H), 3.57 (dd, <i>J</i> = 15.4, 7.5 Hz, 1H), 3.50 (t, <i>J</i> = 7.5 Hz, 1H), 3.43–3.42 (m, 1H), 2.76–2.61 (m, 3H), 2.26 (s, 3H), 1.90–1.83 (m, 1H), 1.67–1.59 (m, 1H), 1.51 (s, 3H), 1.36 (s, 3H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>40</sub>H<sub>46</sub>N<sub>5</sub>O<sub>6</sub>S [M + H]<sup>+</sup> 724.3163; found 724.3147; Anal. Calcd for C<sub>40</sub>H<sub>45</sub>N<sub>5</sub>O<sub>6</sub>S·0.1H<sub>2</sub>O: C, 66.20; H, 6.28; N, 9.65. Found: C, 66.22; H, 6.19; N, 9.47.</div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (<i>R</i>)-<i>N</i>-(2-Methylbenzyl)-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(quinoxaline-2-carbonyl)amino-2-((<i>S</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>17b</b>, KNI-1609)</h3><div class="NLM_p last">Compound <b>17b</b> was prepared from compound <b>16</b> in a manner similar to that described for compound <b>17a</b>; yield 86%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 9.48 (s, 1H), 8.80 (d, <i>J</i> = 9.0 Hz, 1H), 8.40–8.38 (m, 2H), 8.26–8.2 (m, 2H), 7.31–7.29 (m, 1H), 7.25 (d, <i>J</i> = 7.0 Hz, 2H), 7.12–7.07 (m, 3H), 7.05 (d, <i>J</i> = 7.7 Hz, 2H), 6.94 (t, <i>J</i> = 7.3 Hz, 1H), 5.4 (d, <i>J</i> = 7.3 Hz, 1H), 5.05 (d, <i>J</i> = 9.0 Hz, 1H), 4.98 (d, <i>J</i> = 9.3 Hz, 1H), 4.52 (t, <i>J</i> = 9.0 Hz, 1H), 4.51 (s, 1H), 4.45–4.38 (m, 2H), 4.28–4.23 (m, 1H), 4.18 (dd, <i>J</i> = 14.8, 5.0 Hz, 1H), 3.70 (dt, <i>J</i> = 8.1, 5.0 Hz, 1H), 3.57 (dd, <i>J</i> = 15.6, 7.5 Hz, 1H), 3.52–3.32 (m, 2H, overlapped with water), 2.77–2.63 (m, 3H), 2.25 (s, 3H), 1.91–1.86 (m, 1H), 1.67–1.58 (m, 1H), 1.50 (s, 3H), 1.35 (s, 3H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>39</sub>H<sub>45</sub>N<sub>6</sub>O<sub>6</sub>S [M + H]<sup>+</sup> 725.3116; found 725.3099. Anal. Calcd for C<sub>39</sub>H<sub>44</sub>N<sub>6</sub>O<sub>6</sub>S: C, 64.62; H, 6.12; N, 11.59. Found: C, 64.33; H, 6.14; N, 11.30.</div></div><div id="sec6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (<i>R</i>)-<i>N</i>-(2-Methylbenzyl)-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(isoquinolin-5-yloxyacetyl)amino-2-((<i>R</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>18</b>, KNI-1641)</h3><div class="NLM_p last">Compound <b>18</b> was prepared from compound <b>14</b> in a manner similar to that described for compound <b>15a</b>; yield 66%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 9.29 (s, 1H), 8.54 (d, <i>J</i> = 5.9 Hz, 1H), 8.38 (t, <i>J</i> = 6.0 Hz, 1H), 8.20 (d, <i>J</i> = 8.8 Hz, 2H), 8.02 (dt, <i>J</i> = 5.9, 0.9 Hz, 1H), 7.70 (d, <i>J</i> = 8.2 Hz, 1H), 7.57 (t, <i>J</i> = 8.1 Hz, 1H), 7.31–7.29 (m, 1H), 7.26 (d, <i>J</i> = 7.7 Hz, 2H), 7.17 (t, <i>J</i> = 7.5 Hz, 3H), 7.15–7.09 (m, 4H), 5.4 (d, <i>J</i> = 7.1 Hz, 1H), 5.03 (d, <i>J</i> = 9.0 Hz, 1H), 4.96 (d, <i>J</i> = 9.2 Hz, 1H), 4.80 (d, <i>J</i> = 14.7 Hz, 1H), 4.72 (d, <i>J</i> = 14.7 Hz, 1H), 4.49 (s, 1H), 4.43–4.37 (m, 2H), 4.32 (t, <i>J</i> = 8.4 Hz, 1H), 4.26–4.21 (m, 1H), 4.17 (dd, <i>J</i> = 14.8, 4.6 Hz, 1H), 3.66 (dt, <i>J</i> = 8.1, 4.8 Hz, 1H), 3.57–3.48 (m, 2H), 3.40–3.30 (m, 1H, overlapped with water), 2.77 (dd, <i>J</i> = 14.1, 2.8 Hz, 1H), 2.69–2.63 (m, 2H), 2.26 (s, 3H), 1.68–1.61 (m, 1H), 1.59–1.52 (m, 1H), 1.50 (s, 3H), 1.34 (s, 3H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>41</sub>H<sub>48</sub>N<sub>5</sub>O<sub>7</sub>S [M + H]<sup>+</sup> 754.3269; found 754.3244. Anal. Calcd for C<sub>41</sub>H<sub>47</sub>N<sub>5</sub>O<sub>7</sub>S·1.5H<sub>2</sub>O: C, 63.06; H, 6.45; N, 8.97. Found: C, 63.02; H, 6.21; N, 8.85.</div></div><div id="sec6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (<i>R</i>)-<i>N</i>-(2,6-Dimethylbenzyl)-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(<i>tert</i>-butoxycarbonyl)amino-2-((<i>R</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>20</b>)</h3><div class="NLM_p last">A mixture of Boc-Apns-Dmt-NH(2,6-dimethylbenzyl) <b>19</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (789 mg, 1.42 mmol), anisole (307 μL, 2.84 mmol), and 4 M HCl in dioxane (4.6 mL) was stirred for 30 min at rt. After removal of the solvent in vacuo, the residue was precipitated from ether to give a white solid. To a solution of the hydrochloride salt in DMF (15 mL) were added triethylamine (198 μL, 1.29 mmol), HOBt·H<sub>2</sub>O (198 mg, 1.29 mmol), Boc-(2<i>S</i>,3<i>R</i>)-Tfg–OH <b>9</b> (316 mg, 1.29 mmol), and EDC·HCl (247 mg, 1.29 mmol) in an ice bath, and the mixture was stirred overnight at room temperature. After removal of the solvent in vacuo, the residue was added into EtOAc, washed sequentially with 10% citric acid, 5% NaHCO<sub>3</sub>, and brine, dried over MgSO<sub>4</sub>, and concentrated in vacuo to give the titled compound as an amorphous solid; quantitative yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.15–8.07 (m, 1H), 7.97 (d, <i>J</i> = 8.6 Hz, 1H), 7.35 (d, <i>J</i> = 7.2 Hz, 2H), 7.25–7.19 (m, 2H), 7.17–7.13 (m, 1H), 7.10–7.05 (m, 1H), 7.03–6.99 (m, 2H), 6.92 (d, <i>J</i> = 9.2 Hz, 1H), 5.15 (d, <i>J</i> = 7.5 Hz, 1H), 5.03 (d, <i>J</i> = 9.1 Hz, 1H), 4.90 (d, <i>J</i> = 8.9 Hz, 1H), 4.54 (s, 1H), 4.47 (dd, <i>J</i> = 13.9, 6.1 Hz, 1H), 4.37 (dd, <i>J</i> = 7.3, 2.0 Hz, 1H), 3.78 (t, <i>J</i> = 9.2 Hz, 1H), 4.24–4.13 (m, 2H), 3.62 (td, <i>J</i> = 8.0, 4.8 Hz, 1H), 3.55 (t, <i>J</i> = 7.9 Hz, 1H), 3.46 (q, <i>J</i> = 7.7 Hz, 1H), 3.28–3.24 (m, 1H), 2.73–2.61 (m, 2H), 2.31 (s, 6H), 2.24 (dd, <i>J</i> = 16.3, 7.9 Hz, 1H), 1.46 (s, 3H), 1.41–1.24 (m, 14H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>36</sub>H<sub>51</sub>N<sub>4</sub>O<sub>7</sub>S [M + H]<sup>+</sup> 683.3473; found 683.3440.</div></div><div id="sec6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (<i>R</i>)-<i>N</i>-(2,6-Dimethylbenzyl)-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(isoquinolin-5-yloxyacetyl)amino-2-((<i>R</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>21a</b>, KNI-1648)</h3><div class="NLM_p last">Compound <b>21a</b> was prepared from compound <b>20</b> in a manner similar to that described for compound <b>15a</b>; yield 76%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 9.56 (s, 1H), 8.62 (d, <i>J</i> = 6.0 Hz, 1H), 8.29 (br s, 1H), 8.28 (d, <i>J</i> = 6.8 Hz, 1H), 8.24 (d, <i>J</i> = 8.8 Hz, 1H), 8.12 (dd, <i>J</i> = 5.9, 3.7 Hz, 1H), 7.88 (d, <i>J</i> = 8.2 Hz, 1H), 7.73 (t, <i>J</i> = 8.0 Hz, 1H), 7.34 (d, <i>J</i> = 7.1 Hz, 2H), 7.29 (d, <i>J</i> = 7.7 Hz, 1H), 7.21 (t, <i>J</i> = 7.3 Hz, 2H), 7.15–7.05 (m, 2H), 7.01 (d, <i>J</i> = 7.3 Hz, 2H), 5.07 (d, <i>J</i> = 8.8 Hz, 1H), 4.92 (d, <i>J</i> = 8.8 Hz, 1H), 4.85 (d, <i>J</i> = 14.7 Hz, 1H), 4.78 (d, <i>J</i> = 14.7 Hz, 1H), 4.53 (s, 1H), 4.47–4.42 (m, 2H), 4.35 (t, <i>J</i> = 8.4 Hz, 1H), 4.22–4.17 (m, 1H), 4.17 (dd, <i>J</i> = 13.7, 4.2 Hz, 1H), 3.67 (dt, <i>J</i> = 8.4, 5.0 Hz, 1H), 3.58–3.32 (m, 3H, overlapped with water), 2.75–2.60 (m, 3H), 2.30 (s, 6H), 1.70–1.64 (m, 1H), 1.62–1.55 (m, 1H), 1.45 (s, 3H), 1.35 (s, 3H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>42</sub>H<sub>50</sub>N<sub>5</sub>O<sub>7</sub>S [M + H]<sup>+</sup> 768.3425; found 768.3383. Anal. Calcd for C<sub>42</sub>H<sub>49</sub>N<sub>5</sub>O<sub>7</sub>S·0.75H<sub>2</sub>O: C, 64.55; H, 6.51; N, 8.96. Found: C, 64.57; H, 6.56; N, 8.94.</div></div><div id="sec6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (<i>R</i>)-<i>N</i>-(2,6-Dimethylbenzyl)-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(3-(phenylamino)phenoxyacetyl)amino-2-((<i>R</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>21b</b>, KNI-1650)</h3><div class="NLM_p last">Compound <b>21b</b> was prepared from compound <b>20</b> in a manner similar to that described for compound <b>15a</b>; yield 57%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.24 (d, <i>J</i> = 8.6 Hz, 1H), 8.20 (br s, 1H), 8.11 (dd, <i>J</i> = 5.6, 3.7 Hz, 1H), 7.94 (d, <i>J</i> = 9.0 Hz, 1H), 7.33 (d, <i>J</i> = 7.3 Hz, 1H), 7.24 (d, <i>J</i> = 8.1 Hz, 1H), 7.23–7.22 (m, 3H), 7.20 (d, <i>J</i> = 7.7 Hz, 1H), 7.01–7.05 (m, 3H), 7.01 (d, <i>J</i> = 7.5 Hz, 2H), 6.84 (t, <i>J</i> = 7.0 Hz, 1H), 6.67 (dd, <i>J</i> = 8.1, 1.8 Hz, 1H), 6.63 (t, <i>J</i> = 2.2 Hz, 1H), 6.36 (dd, <i>J</i> = 8.2, 2.4 Hz, 1H), 5.05 (d, <i>J</i> = 9.0 Hz, 1H), 4.91 (d, <i>J</i> = 9.0 Hz, 1H), 4.53 (s, 1H), 4.50 (d, <i>J</i> = 14.8 Hz, 1H), 4.46–4.40 (m, 1H), 4.41 (d, <i>J</i> = 15.0 Hz, 1H), 4.40 (d, <i>J</i> = 2.6 Hz, 1H), 4.27 (t, <i>J</i> = 8.6 Hz, 1H), 4.21–4.15 (m, 1H), 4.17 (dd, <i>J</i> = 13.9, 3.3 Hz, 1H), 3.60 (dd, <i>J</i> = 13.4, 8.4 Hz, 1H), 3.50–3.42 (m, 2H, overlapped with water), 3.25–3.21 (m, 1H), 2.71–2.61 (m, 2H), 2.41–2.36 (m, 1H), 2.30 (s, 6H), 1.51–1.45 (m, 1H), 1.45 (s, 3H), 1.40–1.29 (m, 1H), 1.35 (s, 3H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>45</sub>H<sub>54</sub>N<sub>5</sub>O<sub>7</sub>S [M + H]<sup>+</sup> 808.3738; found 808.3704. Anal. Calcd for C<sub>45</sub>H<sub>53</sub>N<sub>5</sub>O<sub>7</sub>S·0.1CF<sub>3</sub>COOH: C, 66.25; H, 6.53; N, 8.55. Found: C, 66.21; H, 6.66; N, 8.41.</div></div><div id="sec6_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (<i>R</i>)-<i>N</i>-(2,6-Dimethylbenzyl)-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(3-(dimethylamino)phenoxyacetyl)amino-2-((<i>R</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>21c</b>, KNI-1652)</h3><div class="NLM_p last">Compound <b>21c</b> was prepared from compound <b>20</b> in a manner similar to that described for compound <b>15a</b>; yield 45%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.26 (d, <i>J</i> = 8.0 Hz, 1H), 8.13–8.09 (m, 1H), 7.92 (d, <i>J</i> = 9.2 Hz, 1H), 7.33 (d, <i>J</i> = 7.0 Hz, 2H), 7.21 (t, <i>J</i> = 7.3 Hz, 2H), 7.12–7.06 (m, 3H), 7.01 (d, <i>J</i> = 7.5 Hz, 2H), 6.37 (d, <i>J</i> = 7.6 Hz, 1H), 6.27 (s, 1H), 6.22 (d, <i>J</i> = 8.0 Hz, 1H), 5.06 (d, <i>J</i> = 8.7 Hz, 1H), 4.92 (d, <i>J</i> = 9.0 Hz, 1H), 4.54 (s, 1H), 4.50 (d, <i>J</i> = 15.2 Hz, 1H), 4.43 (m, 1H), 4.41 (d, <i>J</i> = 15.2 Hz, 1H), 4.408 (d, <i>J</i> = 2.0 Hz, 1H), 4.03 (t, <i>J</i> = 8.8 Hz, 1H), 4.21–4.17 (m, 2H), 3.64–3.59 (m, 1H), 3.52–3.46 (m, 2H), 3.28–3.22 (m, 1H), 2.87 (s, 6H), 2.74–2.58 (m, 2H), 2.30 (s, 6H), 2.02–1.95 (m, 1H), 1.55–1.49 (m, 2H), 1.46 (s, 3H), 1.35 (s, 3H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>41</sub>H<sub>54</sub>N<sub>5</sub>O<sub>7</sub>S [M + H]<sup>+</sup> 760.3738; found 760.3723. Anal. Calcd for C<sub>41</sub>H<sub>53</sub>N<sub>5</sub>O<sub>7</sub>S·0.2CF<sub>3</sub>COOH: C, 63.52; H, 6.85; N, 8.95. Found: C, 63.46; H, 6.94; N, 9.01.</div></div><div id="sec6_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (<i>R</i>)-<i>N</i>-(2,6-Dimethylbenzyl)-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(3-(chromon-2-carbonyl)amino-2-((<i>R</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>21d</b>, KNI-1654)</h3><div class="NLM_p last">Compound <b>21d</b> was prepared from compound <b>20</b> in a manner similar to that described for compound <b>15a</b>; yield 42%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.88 (d, <i>J</i> = 8.6 Hz, 1H), 8.33 (d, <i>J</i> = 8.2 Hz, 1H), 8.10 (br. s, 1H), 8.06 (dd, <i>J</i> = 7.9, 1.7 Hz, 1H), 7.90 (dt, <i>J</i> = 7.9, 1.8 Hz, 1H), 7.78 (d, <i>J</i> = 7.9 Hz, 1H), 7.55 (dt, <i>J</i> = 7.6, 0.9 Hz, 1H), 7.33 (d, <i>J</i> = 7.1 Hz, 2H), 7.15 (d, <i>J</i> = 7.5 Hz, 2H), 7.07–7.03 (m, 2H), 7.00 (d, <i>J</i> = 7.3 Hz, 2H), 6.84 (s, 1H), 5.3 (d, <i>J</i> = 7.1 Hz, 1H), 5.06 (d, <i>J</i> = 9.0 Hz, 1H), 4.94 (d, <i>J</i> = 9.0 Hz, 1H), 4.53 (s, 1H), 4.47–4.43 (m, 2H), 4.40 (t, <i>J</i> = 9.0 Hz, 1H), 4.23–4.2 (m, 1H), 4.17 (dd, <i>J</i> = 13.9, 3.3 Hz, 1H), 3.75 (dt, <i>J</i> = 8.1, 5.1 Hz, 1H), 3.69 (dd, <i>J</i> = 8.4, 7.0 Hz, 1H), 3.59 (dt, <i>J</i> = 15.1, 7.5 Hz, 1H), 3.40 (dd, <i>J</i> = 8.8, 6.4 Hz, 1H), 2.75 (dt, <i>J</i> = 13.7, 2.4 Hz, 1H), 2.69–2.59 (m, 2H), 2.30 (s, 6H), 1.72–1.69 (m, 1H), 1.68–1.62 (m, 1H), 1.45 (s, 3H), 1.34 (s, 3H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>41</sub>H<sub>47</sub>N<sub>4</sub>O<sub>8</sub>S [M + H]<sup>+</sup> 755.3109; found 755.3094. Anal. Calcd for C<sub>41</sub>H<sub>46</sub>N<sub>4</sub>O<sub>8</sub>S·0.75H<sub>2</sub>O: C, 64.09; H, 6.23; N, 7.29. Found: C, 64.06; H, 6.13; N, 7.27.</div></div><div id="sec6_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (<i>R</i>)-<i>N</i>-(2,6-Dimethylbenzyl)-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(3-(benzofuran-2-carbonyl)amino-2-((<i>R</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>21e</b>, KNI-1666)</h3><div class="NLM_p last">Compound <b>21e</b> was prepared from compound <b>20</b> in a manner similar to that described for compound <b>15a</b>; yield 39%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.55 (d, <i>J</i> = 8.8 Hz, 1H), 8.26 (d, <i>J</i> = 8.4 Hz, 1H), 8.15–8.08 (m, 1H), 7.79 (d, <i>J</i> = 7.0 Hz, 1H), 7.70 (d, <i>J</i> = 8.1 Hz, 1H), 7.62 (s, 1H), 7.49 (t, <i>J</i> = 8.2 Hz, 1H), 7.38–7.34 (m, 3H), 7.15 (d, <i>J</i> = 7.3 Hz, 2H), 7.06 (dd, <i>J</i> = 14.8, 6.8 Hz, 2H), 7 (d, <i>J</i> = 7.5 Hz, 2H), 5.05 (d, <i>J</i> = 9.0 Hz, 1H), 4.93 (d, <i>J</i> = 9.3 Hz, 1H), 4.53 (s, 1H), 4.47–4.36 (m, 3H), 4.25–4.14 (m, 2H), 3.72–3.63 (m, 2H), 3.52 (dd, <i>J</i> = 15.2, 10.4 Hz, 1H), 3.46–3.31 (m, 1H, overlapped with water), 2.74–2.59 (m, 2H), 2.49–2.45 (m, 1H), 2.30 (s, 6H), 1.54–1.47 (m, 2H), 1.45 (s, 3H), 1.35 (s, 3H), 1.31–1.20 (m, 1H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>40</sub>H<sub>47</sub>N<sub>4</sub>O<sub>7</sub>S [M + H]<sup>+</sup> 727.3160; found 727.3143. Anal. Calcd for C<sub>40</sub>H<sub>46</sub>N<sub>4</sub>O<sub>7</sub>S·0.6H<sub>2</sub>O: C, 65.13; H, 6.45; N, 7.59. Found: C, 65.03; H, 6.43; N, 7.75.</div></div><div id="sec6_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (<i>R</i>)-<i>N</i>-(2,6-Dimethylbenzyl)-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(3-(7-methoxybenzofuran-2-carbonyl)amino-2-((<i>R</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>21f</b>, KNI-1657)</h3><div class="NLM_p last">Compound <b>21f</b> was prepared from compound <b>20</b> in a manner similar to that described for compound <b>15a</b>; yield 57%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.39 (d, <i>J</i> = 9.5 Hz, 1H), 8.22 (d, <i>J</i> = 8.4 Hz, 1H), 8.06 (br s, 1H), 7.54 (d, <i>J</i> = 2.0 Hz, 1H), 7.28 (t, <i>J</i> = 7.9 Hz, 3H), 7.22 (t, <i>J</i> = 7.9 Hz, 1H), 7.1 (t, <i>J</i> = 7.5 Hz, 2H), 7.05–6.95 (m, 5H), 5.00 (d, <i>J</i> = 9.0 Hz, 1H), 4.89 (d, <i>J</i> = 8.6 Hz, 1H), 4.49 (s, 1H), 4.43–4.32 (m, 3H), 4.18–4.1 (m, 2H), 3.93 (s, 3H), 3.67–3.64 (m, 2H), 3.51–3.48 (m, 2H, overlapped with water), 2.70–2.56 (m, 3H), 2.25 (s, 6H), 1.48–1.44 (m, 2H), 1.40 (s, 3H), 1.30 (s, 3H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 170.12, 169.92, 167.72, 157.57, 148.49, 145.26, 143.62, 139.21, 137.29, 134.45, 129.44, 128.62, 127.89, 127.79, 127.26, 125.77, 124.59, 114.45, 110.64, 108.76, 72.51, 72.28, 71.64, 70.88, 69.82, 67.19, 63.08, 60.25, 55.72, 55.26, 53.96, 53.12, 51.14, 47.68, 41.34, 37.23, 33.11, 30.32, 28.38, 24.57, 19.41. TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>41</sub>H<sub>49</sub>N<sub>4</sub>O<sub>8</sub>S [M + H]<sup>+</sup> 757.3266; found 757.3248. Anal. Calcd for C<sub>40</sub>H<sub>51</sub>N<sub>5</sub>O<sub>6</sub>S·0.6H<sub>2</sub>O: C, 64.14; H, 6.46; N, 7.30. Found: C, 64.07; H, 6.43; N, 7.38.</div></div><div id="sec6_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (<i>R</i>)-<i>N</i>-[(<i>S</i>)-Indan-1-yl]-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(<i>tert</i>-butoxycarbonyl)amino-2-((<i>R</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>23a</b>)</h3><div class="NLM_p last">Compound <b>23a</b> was prepared from <b>22a</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> in a manner similar to that described for compound <b>20</b>; yield 82%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.36 (d, <i>J</i> = 8.1 Hz, 1H), 7.93 (d, <i>J</i> = 8.6 Hz, 1H), 7.28–7.25 (m, 3H), 7.23–7.21 (m, 2H), 7.17 (d, <i>J</i> = 7.3 Hz, 2H), 7.14–7.12 (m, 2H), 6.92 (d, <i>J</i> = 8.8 Hz, 1H), 5.31 (dd, <i>J</i> = 15.4, 7.7 Hz, 1H), 5.19 (d, <i>J</i> = 7.3 Hz, 1H), 5.01 (d, <i>J</i> = 9.2 Hz, 1H), 4.95 (d, <i>J</i> = 9.2 Hz, 1H), 4.46 (s, 1H), 4.39 (dd, <i>J</i> = 7.3, 2.2 Hz, 1H), 4.25 (br. s., 1H), 3.76 (t, <i>J</i> = 9.2 Hz, 1H), 3.62 (dt, <i>J</i> = 5.8 Hz, 1H), 3.55 (t, <i>J</i> = 7.7 Hz, 1H), 3.46 (dd, <i>J</i> = 15.4, 7.7 Hz, 1H), 3.31–3.24 (m, 1H), 2.94 (ddd, <i>J</i> = 15.9, 8.6, 3.2 Hz, 1H), 2.84–2.78 (m, 2H), 2.72–2.68 (m, 2H), 2.42–2.34 (m, 1H), 2.27–2.22 (m, 1H), 1.91–1.80 (m, 1H), 1.51 (s, 3H), 1.46 (s, 3H), 1.37 (s, 9H), 1.36–1.27 (m, 2H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>36</sub>H<sub>49</sub>N<sub>4</sub>O<sub>7</sub>S [M + H]<sup>+</sup> 681.3316; found 681.3275.</div></div><div id="sec6_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (<i>R</i>)-<i>N</i>-[(1<i>S</i>,2<i>R</i>)-2-Hydroxyindan-1-yl]-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(<i>tert</i>-butoxycarbonyl)amino-2-((<i>R</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>23b</b>)</h3><div class="NLM_p last">Compound <b>23b</b> was prepared from <b>22b</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> in a manner similar to that described for compound <b>20</b>; quantitative yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.10 (d, <i>J</i> = 8.80 Hz, 1H), 7.97 (d, <i>J</i> = 8.6 Hz, 1H), 7.35 (d, <i>J</i> = 7.2 Hz, 2H), 7.27 (d, <i>J</i> = 7.3 Hz, 1H), 7.25–7.05 (m, 7H), 6.92 (d, <i>J</i> = 9.1 Hz, 1H), 5.28 (dd, <i>J</i> = 8.8, 5.1 Hz, 1H), 5.22–5.14 (m, 1H), 5.10–4.99 (m, 2H), 4.95 (d, <i>J</i> = 9.1 Hz, 1H), 4.75 (s, 1H), 4.48–4.38 (m, 2H), 4.27–4.19 (m, 1H), 3.77 (t, <i>J</i> = 9.2 Hz, 1H), 3.64–3.58 (m, 1H), 3.54 (t, <i>J</i> = 7.8 Hz, 1H), 3.47–3.42 (m, 1H), 3.28–3.22 (m, 1H), 3.08–3.02 (m, 1H), 2.86–2.75 (m, 2H), 2.68–2.62 (m, 2H), 2.22 (dt, <i>J</i> = 16.1, 8.0 Hz, 1H), 1.56 (s, 3H), 1.48 (s, 3H), 1.37 (s, 9H), 1.31–1.21 (m, 2H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>36</sub>H<sub>49</sub>N<sub>4</sub>O<sub>8</sub>S [M + H]<sup>+</sup> 697.3266; found 697.3209.</div></div><div id="sec6_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (<i>R</i>)-<i>N</i>-Cyclopentyl-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(<i>tert</i>-butoxycarbonyl)amino-2-((<i>R</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>23c</b>)</h3><div class="NLM_p last">Compound <b>23c</b> was prepared from <b>22c</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> in a manner similar to that described for compound <b>20</b>; yield 92%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 7.92 (d, <i>J</i> = 7.1 Hz, 2H), 7.31 (d, <i>J</i> = 7.3 Hz, 2H), 7.20 (d, <i>J</i> = 7.6 Hz, 2H), 7.15–7.13 (m, 1H), 6.91 (d, <i>J</i> = 9.2 Hz, 1H), 5.14 (d, <i>J</i> = 7.3 Hz, 1H), 4.98 (d, <i>J</i> = 9.0 Hz, 1H), 4.92 (d, <i>J</i> = 9.0 Hz, 1H), 4.42 (s, 1H), 4.38 (dd, <i>J</i> = 7.5, 2.3 Hz, 1H), 4.26–4.20 (br. s., 1H), 4.05–3.97 (m, 1H), 3.76 (t, <i>J</i> = 9.2 Hz, 1H), 3.61 (dt, <i>J</i> = 7.9, 4.8 Hz, 1H), 3.54 (t, <i>J</i> = 7.7 Hz, 1H), 3.42 (dd, <i>J</i> = 15.4, 7.5 Hz, 1H), 3.29–3.23 (m, 1H), 2.69–2.65 (m, 1H), 2.62–2.58 (m, 1H), 2.26–2.18 (m, 1H), 1.80–1.72 (m, 2H), 1.65–1.60 (s, 2H), 1.49–1.37 (s, 19H), 1.34–1.25 (m, 2H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>32</sub>H<sub>49</sub>N<sub>4</sub>O<sub>7</sub>S [M + H]<sup>+</sup> 633.3316; found 633.3289.</div></div><div id="sec6_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (<i>R</i>)-<i>N</i>-Allyl-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(<i>tert</i>-butoxycarbonyl)amino-2-((<i>R</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>23d</b>)</h3><div class="NLM_p last">Compound <b>23d</b> was prepared from <b>22d</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> in a manner similar to that described for compound <b>20</b>; yield 94%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.16 (t, <i>J</i> = 5.8 Hz, 1H), 7.89 (d, <i>J</i> = 8.6 Hz, 1), 7.29 (d, <i>J</i> = 7.2 Hz, 2H), 7.15–7.11 (m, 1H), 7.22–7.17 (m, 2 H), 6.94 (d, <i>J</i> = 8.8 Hz, 1H), 5.28–5.17 (m, 2H), 5.83–5.73 (m, 1H), 5.03 (dq, <i>J</i> = 10.3, 1.67 Hz, 1H), 4.42 (s, 1H) 5.04–4.92 (m, 3H), 4.36 (dd, <i>J</i> = 7.2, 3.42 Hz, 1H), 4.24 (t, <i>J</i> = 9.4 Hz, 1H), 3.65–3.53 (m, 2H) 3.78–3.69 (m, 3H), 3.28–3.23 (m, 1H) 3.49–3.42 (m, 1H), 2.73–2.63 (m, 2H), 2.24 (dd, <i>J</i> = 15.9, 7.6 Hz, 1H), 1.51 (s, 3H), 1.41–1.33 (m, 12H), 1.30–1.24 (m, 2H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>30</sub>H<sub>45</sub>N<sub>4</sub>O<sub>7</sub>S [M + H]<sup>+</sup> 605.3003; found 605.2969.</div></div><div id="sec6_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (<i>R</i>)-<i>N</i>-(2-Methylallyl)-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(<i>tert</i>-butoxycarbonyl)amino-2-((<i>R</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>23e</b>)</h3><div class="NLM_p last">Compound <b>23e</b> was prepared from <b>22e</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> in a manner similar to that described for compound <b>20</b>; yield 99%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.17 (t, <i>J</i> = 5.8 Hz, 1H), 7.89 (d, <i>J</i> = 8.4 Hz, 1H), 7.29 (d, <i>J</i> = 7.2 Hz, 2H), 7.19 (t, <i>J</i> = 7.3 Hz, 2H), 7.16–7.12 (m, 1H), 6.94 (d, <i>J</i> = 9.1 Hz, 1H), 5.25 (d, <i>J</i> = 7.5 Hz, 1H), 5.02–4.96 (m, 1H), 4.96–4.88 (m, 2H), 4.74 (s, 1H), 4.45 (s, 1H), 4.36 (dd, <i>J</i> = 7.3, 3.2 Hz, 1H), 4.23 (t, <i>J</i> = 9.4 Hz, 1H), 3.77–3.72 (m, 2H), 3.64–3.53 (m, 3H), 3.46 (q, <i>J</i> = 7.7 Hz, 1H), 3.28–3.23 (m, 1H), 2.73–2.62 (m, 2H), 2.24 (dd, <i>J</i> = 16.3, 7.7 Hz, 1H), 1.51 (s, 3H) 1.66 (s, 3H), 1.41–1.23 (m, 14H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>31</sub>H<sub>47</sub>N<sub>4</sub>O<sub>7</sub>S [M + H]<sup>+</sup> 619.3160; found 619.3148.</div></div><div id="sec6_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>R</i>)-<i>N</i>-(<i>cis</i>-4-Hydroxy-2-buten-1-yl)-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(<i>tert</i>-butoxycarbonyl)amino-2-((<i>R</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>23f</b>)</h3><div class="NLM_p last">Compound <b>23f</b> was prepared from <b>22f</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> in a manner similar to that described for compound <b>20</b>; yield 85%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.14 (br. s., 1H), 7.91 (d, <i>J</i> = 8.4 Hz, 1H), 7.30 (d, <i>J</i> = 7.3 Hz, 2H), 7.24–7.08 (m, 5H), 6.93 (d, <i>J</i> = 9.1 Hz, 1H), 5.57–5.50 (m, 1H), 5.37–5.29 (m, 1H), 5.23 (d, <i>J</i> = 7.3 Hz, 1H), 4.99–4.89 (m, 2H), 4.66 (t, <i>J</i> = 5.3 Hz, 1H), 4.40–4.32 (m, 2H), 4.23 (br. s., 1H), 4.03 (t, <i>J</i> = 5.8 Hz, 2H), 3.80–3.70 (m, 3H), 3.65–3.52 (m, 2H), 3.49–3.43 (m, 1H), 3.29–3.23 (m, 1H), 2.73–2.65 (m, 2H), 2.28–2.19 (m, 1H), 1.53–1.47 (m, 3H), 1.42–1.26 (m, 14H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>31</sub>H<sub>47</sub>N<sub>4</sub>O<sub>8</sub>S [M + H]<sup>+</sup> 635.3109; found 635.3078.</div></div><div id="sec6_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>R</i>)-<i>N</i>-[(<i>S</i>)-Indan-1-yl]-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(3-(dimethylamino)phenoxyacetyl)amino-2-((<i>R</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>24a</b>, KNI-1665)</h3><div class="NLM_p last">Compound <b>24a</b> was prepared from compound <b>23a</b> in a manner similar to that described for compound <b>15a</b>; yield 40%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.36 (d, <i>J</i> = 8.1 Hz, 1H), 8.22 (d, <i>J</i> = 8.6 Hz, 1H), 7.92 (d, <i>J</i> = 8.8 Hz, 1H), 7.26 (d, <i>J</i> = 7.1 Hz, 2H), 7.23–7.15 (m, 6H), 7.13–7.08 (m, 2H), 6.43 (d, <i>J</i> = 7.0 Hz, 1H), 6.35 (br s, 1H), 6.29 (d, <i>J</i> = 7.5 Hz, 1H), 5.30 (dd, <i>J</i> = 15.6, 7.9 Hz, 1H), 5.03 (d, <i>J</i> = 9.2 Hz, 1H), 4.97 (d, <i>J</i> = 9.2 Hz, 1H), 4.51 (d, <i>J</i> = 14.8 Hz, 1H), 4.46 (s, 1H), 4.43 (d, <i>J</i> = 14.8 Hz, 1H), 4.42 (d, <i>J</i> = 3.1 Hz, 1H), 4.28 (t, <i>J</i> = 8.6 Hz, 1H), 4.25–4.19 (m, 1H), 3.73–3.45 (m, 4H, overlapped with water), 3.25 (dd, <i>J</i> = 8.6, 7.0 Hz, 1H), 2.96–2.91 (m, 1H), 2.89 (s, 6H), 2.83–2.58 (m, 3H), 2.42–2.35 (m, 2H), 1.86–1.81 (m, 1H), 1.56–1.47 (m, 2H), 1.50 (s, 3H), 1.45 (s, 3H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>41</sub>H<sub>52</sub>N<sub>5</sub>O<sub>7</sub>S [M + H]<sup>+</sup> 758.3582; found 758.3556. Anal. Calcd for C<sub>41</sub>H<sub>51</sub>N<sub>5</sub>O<sub>7</sub>S·1CF<sub>3</sub>COOH: C, 59.23; H, 6.01; N, 8.03. Found: C, 59.38; H, 6.16; N, 8.33.</div></div><div id="sec6_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>R</i>)-<i>N</i>-[(1<i>S</i>,2<i>R</i>)-2-Hydroxyindan-1-yl]-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(3-(dimethylamino)phenoxyacetyl)amino-2-((<i>R</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>24b</b>, KNI-1749)</h3><div class="NLM_p last">Compound <b>24b</b> was prepared from compound <b>23b</b> in a manner similar to that described for compound <b>15a</b>; yield 31%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.26 (d, <i>J</i> = 7.9 Hz, 1H), 8.11 (d, <i>J</i> = 9.0 Hz, 1H), 7.92 (d, <i>J</i> = 9.0 Hz, 1H), 7.33 (d, <i>J</i> = 7.3 Hz, 2H), 7.26 (d, <i>J</i> = 7.0 Hz, 1H), 7.22–7.14 (m, 4H), 7.11–7.05 (m, 3H), 6.37 (d, <i>J</i> = 8.8 Hz, 1H), 6.28 (br s, 1H), 6.23 (d, <i>J</i> = 7.9 Hz, 1H), 5.27 (dd, <i>J</i> = 9.0, 5.5 Hz, 1H), 5.04 (d, <i>J</i> = 9.2 Hz, 1H), 4.95 (d, <i>J</i> = 9.0 Hz, 1H), 4.74 (s, 1H), 4.49 (d, <i>J</i> = 15.0 Hz, 1H), 4.46 (d, <i>J</i> = 2.8 Hz, 1H), 4.42 (d, <i>J</i> = 14.7 Hz, 1H), 4.41 (m, 1H), 4.27 (t, <i>J</i> = 8.8 Hz, 1H), 4.20–4.19 (m, 1H), 3.61 (dd, <i>J</i> = 13.0, 7.7 Hz, 1H), 3.50–3.29 (m, 2H, overlapped with water), 3.24–3.20 (m, 1H), 3.04 (dd, <i>J</i> = 15.8, 4.6 Hz, 1H), 2.87 (s, 6H), 2.83–2.79 (m, 3H), 2.70–2.63 (m, 1H), 2.43–2.33 (m,1H), 1.55 (s, 3H), 1.54–1.49 (m, 2H), 1.48 (s, 3H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>41</sub>H<sub>52</sub>N<sub>5</sub>O<sub>8</sub>S [M + H]<sup>+</sup> 774.3531; found 774.3512.</div></div><div id="sec6_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>R</i>)-<i>N</i>-Cyclopentyl-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(3-(dimethylamino)phenoxyacetyl)amino-2-((<i>R</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>24c</b>, KNI-1729)</h3><div class="NLM_p last">Compound <b>24c</b> was prepared from compound <b>23c</b> in a manner similar to that described for compound <b>15a</b>; yield 66%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.22 (d, <i>J</i> = 8.4 Hz, 1H), 7.94–7.91 (m, 2H), 7.30 (d, <i>J</i> = 7.0 Hz, 2H), 7.20 (t, <i>J</i> = 7.5 Hz, 2H), 7.15–7.08 (m, 2H), 6.43 (br. d, <i>J</i> = 7.3 Hz, 1H), 6.34 (br s, 1H), 6.28 (d, <i>J</i> = 7.9 Hz, 1H), 5.00 (d, <i>J</i> = 9.0 Hz, 1H), 4.94 (d, <i>J</i> = 9.2 Hz, 1H), 4.31 (d, <i>J</i> = 15 Hz, 1H), 4.43 (d, <i>J</i> = 13.2 Hz, 1H), 4.428 (s, 1H), 4.41 (m, 1H), 4.29 (t, <i>J</i> = 8.8 Hz, 1H), 4.23–4.19 (br. s, 1H), 4.00 (dt, <i>J</i> = 12.1, 5.1 Hz, 1H), 3.62 (dt, <i>J</i> = 8.1, 5.3 Hz, 1H), 3.52–3.46 (m, 2H, overlapped with water), 3.24 (dd <i>J</i> = 8.8, 7.0 Hz, 1H), 2.89 (s, 6H), 2.70 (dd, <i>J</i> = 13.7, 2.4 Hz, 1H), 2.63 (dd, <i>J</i> = 13.9, 2.9 Hz, 1H), 2.44–2.37 (m,1H), 1.78–1.74 (m, 2H), 1.64–1.59 (m, 2H), 1.56–1.38 (m, 6H), 1.49 (s, 3H), 1.36 (s, 3H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>37</sub>H<sub>52</sub>N<sub>5</sub>O<sub>7</sub>S [M + H]<sup>+</sup> 710.3582; found 710.3553.</div></div><div id="sec6_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (<i>R</i>)-<i>N</i>-Allyl-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(3-(dimethylamino)phenoxyacetyl)amino-2-((<i>R</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>24d</b>, KNI-1742)</h3><div class="NLM_p last">Compound <b>24d</b> was prepared from compound <b>23d</b> in a manner similar to that described for compound <b>15a</b>; yield 56%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.22–8.09 (m, 2H), 7.93 (d, <i>J</i> = 8.9 Hz, 1H), 7.32–7.23 (m, 2H), 7.22–7.16 (m, 2H), 7.15–7.06 (m, 2H), 6.39 (d, <i>J</i> = 8.3 Hz, 1H), 6.30 (br. s., 1H), 6.25 (d, <i>J</i> = 8.1 Hz, 1H), 5.82–5.72 (m, 1H), 5.25–5.19 (m, 1H), 5.06–4.92 (m, 3H), 4.53–4.48 (m, 1H), 4.46–4.35 (m, 3H), 4.29–4.19 (m, 2H), 3.78–3.58 (m, 4H), 3.52–3.47 (m, 2H), 3.27–3.23 (m, 1H), 2.88 (s, 6 H), 2.76–2.70 (m, 1H), 2.68–2.63 (m, 1H), 2.43–2.37 (m, 1H), 1.58–1.44 (m, 5H), 1.36 (s, 3H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>35</sub>H<sub>48</sub>N<sub>5</sub>O<sub>7</sub>S [M + H]<sup>+</sup> 682.3269; found 682.3234.</div></div><div id="sec6_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (<i>R</i>)-<i>N</i>-(2-Methylallyl)-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(3-(dimethylamino)phenoxyacetyl)amino-2-((<i>R</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>24e</b>, KNI-1728)</h3><div class="NLM_p last">Compound <b>24e</b> was prepared from compound <b>23e</b> in a manner similar to that described for compound <b>15a</b>; yield 37%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.18–8.16 (m, 2H), 7.95 (d, <i>J</i> = 8.8 Hz, 1H), 7.27 (d, <i>J</i> = 7.1 Hz, 2H), 7.19 (t, <i>J</i> = 7.3 Hz, 2H), 7.15–7.08 (m, 2H), 6.42 (d, <i>J</i> = 7.9 Hz, 1H), 6.3 (s, 1H), 6.27 (d, <i>J</i> = 8.1 Hz, 1H), 5.01 (d, <i>J</i> = 9.2 Hz, 1H), 4.94 (d, <i>J</i> = 9.3 Hz, 1H), 4.90 (s, 1H), 4.74 (s, 1H), 4.51 (d, <i>J</i> = 14.8 Hz, 1H), 4.44 (s, 1H), 4.43 (d, <i>J</i> = 14.7 Hz, 1H), 4.38 (d, <i>J</i> = 3.7 Hz, 1H), 4.27 (t, <i>J</i> = 8.8 Hz, 1H), 4.23–4.18 (m, 1H), 3.74 (dd, <i>J</i> = 15.4, 6.2 Hz, 1H), 3.64–3.57 (m, 2H), 3.24 (dd, <i>J</i> = 7, 8.6 Hz, 1H), 2.88 (s, 6H), 2.74–2.60 (m, 2H), 2.43–2.37 (m, 1H), 1.65 (s, 3H), 1.56–1.45 (m, 2H), 1.51 (s, 3H), 1.36 (s, 3H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>36</sub>H<sub>50</sub>N<sub>5</sub>O<sub>7</sub>S [M + H]<sup>+</sup> 696.3425; found 696.3409.</div></div><div id="sec6_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (<i>R</i>)-<i>N</i>-(<i>cis</i>-4-Hydroxy-2-buten-1-yl)-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(3-(dimethylamino)phenoxyacetyl)amino-2-((<i>R</i>)-tetrahydrofuran-3-yl)acetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>24f</b>, KNI-1653)</h3><div class="NLM_p last">Compound <b>24f</b> was prepared from compound <b>23f</b> in a manner similar to that described for compound <b>15a</b>; yield 24%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.22–8.08 (m, 2H), 7.93 (d, <i>J</i> = 8.93 Hz, 1H), 7.32–7.24 (m, 2H), 7.24–7.17 (m, 2H), 7.14–7.07 (m, 2H), 6.40 (d, <i>J</i> = 8.2 Hz, 1H), 6.30 (br. s., 1H), 6.25 (d, <i>J</i> = 7.7 Hz, 1H), 5.58–5.50 (m, 1H), 5.36–5.29 (m, 1H), 4.96 (q, <i>J</i> = 9.2 Hz, 2H), 4.50 (d, <i>J</i> = 14.9 Hz, 1H), 4.43 (d, <i>J</i> = 14.8 Hz, 1H), 4.40–4.34 (m, 2H), 4.29–4.18 (m, 2H), 4.05–4.00 (m, 2H), 3.81–3.69 (m, 4H), 3.62 (d, <i>J</i> = 4.9 Hz, 2H), 3.27–3.23 (m, 1H), 2.88 (s, 6 H), 2.76–2.71 (m, 1H), 2.68–2.60 (m, 2H), 2.40 (dd, <i>J</i> = 15.5, 7.7 Hz, 1H), 1.58–1.42 (m, 5H), 1.35 (s, 3H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>36</sub>H<sub>50</sub>N<sub>5</sub>O<sub>8</sub>S [M + H]<sup>+</sup> 712.3375; found 712.3343.</div></div><div id="sec6_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (<i>R</i>)-<i>N</i>-(2,6-Dimethylbenzyl)-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(<i>tert</i>-butoxycarbonyl)amino-3-carbamoylpropionyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>25</b>)</h3><div class="NLM_p last">Compound <b>25</b> was prepared from <b>19</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> using Boc-Asn-OH in a manner similar to that described for compound <b>20</b>; yield 94%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.09 (br. s., 1H), 7.89 (d, <i>J</i> = 8.4 Hz, 1H), 7.32 (d, <i>J</i> = 7.7 Hz, 2H), 7.26–7.06 (m, 4H), 7.03–7.00 (m, 2H), 6.87 (br. s., 2H), 6.80 (d, <i>J</i> = 8.3 Hz, 1H), 5.22 (d, <i>J</i> = 7.2 Hz, 1H), 4.95 (d, <i>J</i> = 8.9 Hz, 1H), 4.87 (d, <i>J</i> = 9.1 Hz, 1H), 4.50 (s, 1 H), 4.45 (dd, <i>J</i> = 13.9, 5.9 Hz, 1H), 4.36 (dd, <i>J</i> = 7.2, 2.8 Hz, 1H), 4.22–4.11 (m, 3H), 2.72–2.61 (m, 2H), 2.31 (s, 6H), 2.29–2.20 (m, 2H), 1.45 (s, 3H), 1.41–1.32 (m, 12H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>34</sub>H<sub>48</sub>N<sub>5</sub>O<sub>7</sub>S [M + H]<sup>+</sup> 670.3269; found 670.3244.</div></div><div id="sec6_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (<i>R</i>)-<i>N</i>-(2,6-Dimethylbenzyl)-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(<i>tert</i>-butoxycarbonyl)amino-3-methylbutanoyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>26</b>)</h3><div class="NLM_p last">Compound <b>26</b> was prepared from <b>19</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> using Boc-Val-OH in a manner similar to that described for compound <b>20</b>; yield 77%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.12 (dd, <i>J</i> = 5.7, 3.2 Hz, 1H), 7.89 (d, <i>J</i> = 8.4 Hz, 1H), 7.36 (d, <i>J</i> = 7.2 Hz, 2H), 7.23–7.18 (m, 2H), 7.16–7.05 (m, 2H), 7.04–6.99 (m, 2H), 6.65 (d, <i>J</i> = 9.7 Hz, 1H), 5.14–5.03 (m, 2H), 4.89 (d, <i>J</i> = 9.1 Hz, 1H), 4.54 (s, 1H), 4.48 (dd, <i>J</i> = 13.9, 6.2 Hz, 1H), 4.38 (dd, <i>J</i> = 7.4, 1.9 Hz, 1H), 4.23–4.13 (m, 2H), 3.70–3.65 (m, 1H), 2.71–2.60 (m, 2H), 2.31 (s, 6H), 1.78–1.68 (m, 1H), 1.46 (s, 3H), 1.41–1.32 (m, 12H), 0.67 (d, <i>J</i> = 6.7 Hz, 3H), 0.56 (d, <i>J</i> = 6.6 Hz, 3H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>35</sub>H<sub>51</sub>N<sub>4</sub>O<sub>6</sub>S [M + H]<sup>+</sup> 655.3524; found 655.3492.</div></div><div id="sec6_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (<i>R</i>)-<i>N</i>-(2,6-Dimethylbenzyl)-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(3-(benzofuran-2-carbonyl)amino-3-carbamoylpropionyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>27a</b>, KNI-1539)</h3><div class="NLM_p last">Compound <b>27a</b> was prepared from compound <b>25</b> in a manner similar to that described for compound <b>15a</b>; yield 33%; purity 90.2%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.60 (d, <i>J</i> = 8.2 Hz, 1H), 8.11 (dd, <i>J</i> = 5.8, 3.7 Hz, 1H), 8.05 (d, <i>J</i> = 8.4 Hz, 1H), 7.83–7.78 (m, 1H), 7.69 (dd, <i>J</i> = 8.4, 0.8 Hz, 1H), 7.58 (s, 1H), 7.51–7.46 (m, 1 H), 7.38–7.28 (m, 4H), 7.09–7.03 (m, 3H), 7.02–6.96 (m, 2H), 6.90 (br. s., 2H), 5.74 (br. s., 1H), 5.01 (d, <i>J</i> = 8.9 Hz, 1H), 4.89 (d, <i>J</i> = 9.1 Hz, 1H), 4.80–4.73 (m, 1H), 4.52 (s, 1H), 4.50–4.40 (m, 2H), 4.17 (dd, <i>J</i> = 13.9, 3.4 Hz, 2H), 2.70–2.62 (m, 2H), 2.56–2.53 (m, 2H), 2.30 (s, 6H), 1.45 (s, 3H), 1.34 (s, 3H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>38</sub>H<sub>44</sub>N<sub>5</sub>O<sub>7</sub>S [M + H]<sup>+</sup> 714.2956; found 714.2951.</div></div><div id="sec6_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (<i>R</i>)-<i>N</i>-(2,6-Dimethylbenzyl)-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(3-(benzofuran-2-carbonyl)amino-3-methylbutanoyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>27b</b>, KNI-1540)</h3><div class="NLM_p last">Compound <b>27b</b> was prepared from compound <b>25</b> in a manner similar to that described for compound <b>15a</b>; yield 46%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.26 (d, <i>J</i> = 8.2 Hz, 1H), 8.19 (d, <i>J</i> = 9.3 Hz, 1H), 8.12 (dd, <i>J</i> = 3.5, 6.0 Hz, 1H), 7.78 (td, <i>J</i> = 7.9, 1.3 Hz, 1H), 7.70 (dd, <i>J</i> = 8.4, 0.7 Hz, 1H), 7.62 (d, <i>J</i> = 0.9 Hz, 1H), 7.48 (dt, <i>J</i> = 7.3, 1.3 Hz, 1H), 7.37–7.32 (m, 3H), 7.16 (t, <i>J</i> = 7.5 Hz, 2H),7.09–7.05 (m, 2H), 7.01 (d, <i>J</i> = 7.7 Hz, 2H), 5.20 (br s, 1H), 5.09 (d, <i>J</i> = 8.8 Hz, 1H), 4.93 (d, <i>J</i> = 9.0 Hz, 1H), 4.54 (s, 1H), 4.47 (dd, <i>J</i> = 14.1, 6.2 Hz, 1H), 4.42 (br s, 1H), 4.28–4.14 (m, 3H), 2.74–2.60 (m, 2H), 2.3 (s, 6H), 2.02–1.97 (m, 1H), 1.45 (s, 3H), 1.36 (s, 3H), 0.82 (d, <i>J</i> = 6.6 Hz, 3H), 0.68 (d, <i>J</i> = 6.8 Hz, 3H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>39</sub>H<sub>47</sub>N<sub>4</sub>O<sub>6</sub>S [M + H]<sup>+</sup> 699.3211; found 699.3201.</div></div><div id="sec6_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (<i>R</i>)-<i>N</i>-(2,6-Dimethylbenzyl)-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(7-methoxybenzofuran-2-carbonyl)amino-3-carbamoylpropionyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>27c</b>, KNI-1565)</h3><div class="NLM_p last">Compound <b>27c</b> was prepared from compound <b>26</b> in a manner similar to that described for compound <b>15a</b>; yield 29%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.54 (d, <i>J</i> = 8.2 Hz, 1H), 8.10 (dd, <i>J</i> = 5.8, 3.6 Hz, 1H), 8.06 (d, <i>J</i> = 8.6 Hz, 1H), 7.57–7.53 (m, 1H), 7.36–7.24 (m, 5H), 7.12–7.04 (m, 4H), 7.01–6.97 (m, 2H), 6.90 (br. s., 1H), 5.75 (br. s., 1H), 5.00 (d, <i>J</i> = 8.9 Hz, 1H), 4.89 (d, <i>J</i> = 8.9 Hz, 1H), 4.75 (td, <i>J</i> = 7.8, 5.8 Hz, 1H), 4.52 (s, 1 H), 4.48–4.41 (m, 2H), 4.20–4.12 (m, 2H), 3.98 (s, 3H), 2.72–2.62 (m, 2H), 2.57–2.53 (m, 2H), 2.30 (s, 6H), 1.45 (s, 3H), 1.34 (s, 3H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>39</sub>H<sub>46</sub>N<sub>5</sub>O<sub>8</sub>S [M + H]<sup>+</sup> 744.3062; found 744.3040.</div></div><div id="sec6_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (<i>R</i>)-<i>N</i>-(2,6-Dimethylbenzyl)-3-[(2<i>S</i>,3<i>S</i>)-3-((<i>S</i>)-2-(7-methoxybenzofuran-2-carbonyl)amino-3-methylbutanoyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide (<b>27d</b>, KNI-1566)</h3><div class="NLM_p last">Compound <b>27d</b> was prepared from compound <b>26</b> in a manner similar to that described for compound <b>15a</b>; yield 40%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.28 (d, <i>J</i> = 8.4 Hz, 1H), 8.12 (dd, <i>J</i> = 6, 3.5 Hz, 1H), 8.07 (d, <i>J</i> = 9.3 Hz, 1H), 7.60 (s, 1H), 7.35 (d, <i>J</i> = 7.1 Hz, 2H), 7.31 (dd, <i>J</i> = 7.9, 1.1 Hz, 1H), 7.26 (t, <i>J</i> = 7.9 Hz, 1H), 7.16 (t, <i>J</i> = 7.7 Hz, 2H), 7.1–7.03 (m, 3H), 7.01 (d, <i>J</i> = 7.5 Hz, 2H), 5.19 (d, <i>J</i> = 7.1 Hz, 1H), 5.08 (d, <i>J</i> = 8.8 Hz, 1H), 4.93 (d, <i>J</i> = 9.2 Hz, 1H), 4.54 (s, 1H), 4.47 (dd, <i>J</i> = 14.1, 6.4 Hz, 1H), 4.42 (dd, <i>J</i> = 7.1, 2.7 Hz, 1H), 4.26 (t, <i>J</i> = 8.1 Hz, 1H), 4.24–4.20 (m, 1H), 4.17 (dd, <i>J</i> = 13.9, 3.3 Hz, 1H), 3.97 (s, 3H), 2.72 (dd, <i>J</i> = 13.9, 2.6 Hz, 1H), 2.64 (dd, <i>J</i> = 13.6, 2.6 Hz, 1H), 2.30 (s, 6H), 2.04–1.97 (m, 1H), 1.45 (s, 3H), 1.36 (s, 3H), 0.82 (d, <i>J</i> = 6.8 Hz, 3H), 0.69 (d, <i>J</i> = 6.8 Hz, 3H). TOF-MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>40</sub>H<sub>49</sub>N<sub>4</sub>O<sub>7</sub>S [M + H]<sup>+</sup> 729.3316; found 729.3297. Anal. Calcd for C<sub>40</sub>H<sub>48</sub>N<sub>4</sub>O<sub>7</sub>S·0.1H<sub>2</sub>O: C, 65.75; H, 6.65; N, 7.67. Found: C, 65.72; H, 6.71; N, 7.76.</div></div><div id="sec6_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> HIV Protease Inhibition</h3><div class="NLM_p last">Recombinant HIV-1 protease was purchased from Bachem AG, Bubendorf, Switzerland. In the inhibition assay, 25 μL of 200 mM 2-(<i>N</i>-morpholino)ethanesulfonic acid (MES)–NaOH buffer (pH 5.5), containing 2 mM dithiothreitol, 2 mM EDTA-2Na, and 1 M NaCl, was mixed with 5 μL of the inhibitor (10 nM) dissolved in DMSO and 10 μL of HIV-1 protease (40 ng/mL) in 50 mM AcOH (pH 5.0) containing 1 mM EDTA-2Na, 25 mM NaCl, 0.2% 2-mercaptoethanol, 0.2% Nonidet P-40, and 10% glycerol. The mixture was preincubated for 5 min at 37 °C, and the reaction was initiated by adding 10 μL of a 1.0 mM substrate solution (H-Lys-Ala-Arg-Val-Tyr-Phe(<i>p</i>-NO<sub>2</sub>)-Glu-Ala-Nle-NH<sub>2</sub>). After incubation for 3 h at 37 °C, the reaction was terminated by the addition of 1 N HCl, and the N-terminal cleavage fragment (H-Lys-Ala-Arg-Val-Tyr-OH) was separated by reversed-phase HPLC on a C18 column (3.0 × 75 mm; YMC Pack ODS AS-3E7) with a linear gradient of CH<sub>3</sub>CN in 0.1% aqueous TFA at a flow rate of 1.0 mL/min, and its quantity was determined by monitoring fluorescence intensity (Ex, 275 nm; Em, 305 nm).</div></div><div id="sec6_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Anti-HIV Activity</h3><div class="NLM_p">Anti-HIV activity of test compounds was determined based on inhibition of an HIV-induced cytopathic effect in MT-4 cells.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Wild-type HIV-1 (pNL4-3) or LPV-resistant strain A17<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> was inoculated to MT-4 cells in a 96-well plate. The resulting culture was treated with an equal volume of a 1% DMSO solution of each test compound with several concentrations and 10% fetal bovine serum, and was incubated for 5 days in a CO<sub>2</sub> incubator at 37 °C, in triplicate. After treatment with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), the optical density of the plate was measured, and percent cytopathic effect reduction was calculated, then EC<sub>50</sub> values were estimated by fitting the data to a median-effect equation. Cytotoxicity (TD<sub>50</sub>) was determined by incubation in the absence of the virus.</div><div class="NLM_p last">In addition, pNL4-3-based, wild-type, or DRV-resistant luciferase reporter lentiviral vector<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> was generated by transfecting 293T cells with pCMV-ΔR8.91 or the derivatives containing V32I/L33F/I54M/V82I or V32I/L33F/I54M/I84V mutations together with pLenti CMV Puro LUC (w168–1) (17477, Addgene, Cambridge, MA) and pHit/G<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> using FuGENE HD Transfection Regent (Promega, Madison, WI) in the presence or absence of HIV-1 protease inhibitor. Forty-eight hours later, 293T cells were infected with lentiviral vector. Twenty-four hours after infection, luciferase activity in infected cells was measured using a Steady-Glo Luciferase Assay System (Promega, Madison, WI) with an LB962 microplate luminometer (Berthold, Bad Wildbad, Germany). Drug susceptibility was evaluated as a reduction in luciferase activity in infected cells. The 50% inhibitory concentration (IC<sub>50</sub>) of protease inhibitors for suppressing the transduction of luciferase gene was calculated from the dose–response curve using a standard function of GraphPad Prism 5 software (GraphPad Software, San Diego, CA).</div></div><div id="sec6_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Preparation and X-ray Crystallographic Analysis of WTm5 and A17m5</h3><div class="NLM_p last">The chemically synthesized DNA encoded the gene for the initial methionine and the 99 amino acid including five mutations of Q7K, L33I, L63I C67A, and C95A (WTm5) and the gene derived from A17 type HIV-1 protease<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> with additional lopinavir/ritonavir-resistant mutations of L10F, V32I, M46I, I47V, Q58E, and I84V (A17m5) were used for expression in <i>E. coli</i>. Preparation of WTm5 and A17m5 for crystallization was performed as reported.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> WTm5 and A17m5/<b>21f</b> complexes were prepared with a 2-fold molar excess of inhibitors to protease at 5.0 and 2.0 mg/mL protein concentrations, respectively. The both complexes were crystallized using hanging drop vapor diffusion method by mixing in equal volumes (2 μL each) of protease solution and crystallization buffer containing 126 mM phosphate buffer at pH 5.0, 63 mM sodium citrate. For crystallization of A17m5/<b>21f</b> complex, PEG4000 was used as a precipitant for crystallization at the final concentration of 20% (w/v). The obtained crystals were flash-frozen under a N<sub>2</sub> gas cryo-stream (100 K), and subjected to X-ray at BL41XU beamline in SPring-8. Data for WTm5/<b>21f</b> and A17m5/<b>21f</b> crystals belong to the same space group of <i>P</i>2<sub>1</sub>2<sub>1</sub>2 with similar cell constants, and the crystals were processed to the resolution of 0.85 and 1.50 Å resolution, respectively, by using HKL2000.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The structures of WTm5/<b>21f</b> and A17m5/<b>21f</b> were refined to a crystallographic <i>R</i>-factor of 10.3% (free <i>R</i>-factor = 12.5%) using program SHELX-97,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and <i>R</i>-factor of 17.1% (free <i>R</i>-factor = 18.8%) using program Refmac5<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and PHENIX 1.9,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> respectively (see <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a> for X-ray diffraction data).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i51"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01709" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46438" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46438" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01709" class="ext-link">10.1021/acs.jmedchem.7b01709</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">HPLC analysis of target compounds; X-ray diffraction data collection and refinement statistics; Supplementary figure (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01709/suppl_file/jm7b01709_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01709/suppl_file/jm7b01709_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01709/suppl_file/jm7b01709_si_001.pdf">jm7b01709_si_001.pdf (262.35 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01709/suppl_file/jm7b01709_si_002.csv">jm7b01709_si_002.csv (3.06 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The atomic coordinates for the crystal structures of WTm5 and A17m5 proteases with compound <b>21f</b> can be assessed using PDB ID codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5YOK">5YOK</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5YOJ">5YOJ</a>, respectively.</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b01709" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25811" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25811" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yoshiaki Kiso</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Peptide Sciences, Nagahama Institute
of Bio-Science and Technology, Nagahama 526-0829, Japan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7877-8221" title="Orcid link">http://orcid.org/0000-0002-7877-8221</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c7be98acaeb4a887a9a6a0a6afa6aaa6eaaeeaa5aea8e9a6a4e9adb7"><span class="__cf_email__" data-cfemail="50290f3b39233f103e31373138313d317d397d32393f7e31337e3a20">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Koushi Hidaka</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Kobe 650-8586, Japan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8956-6996" title="Orcid link">http://orcid.org/0000-0002-8956-6996</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tooru Kimura</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Kyoto Pharmaceutical
University, Kyoto 607-8412, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rajesh Sankaranarayanan</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Kyoto Pharmaceutical
University, Kyoto 607-8412, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jun Wang</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Kyoto Pharmaceutical
University, Kyoto 607-8412, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keith F. McDaniel</span> - <span class="hlFld-Affiliation affiliation">Global
Pharmaceutical Research and Development, AbbVie, North
Chicago, Illinois 60064, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5704-3288" title="Orcid link">http://orcid.org/0000-0001-5704-3288</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dale J. Kempf</span> - <span class="hlFld-Affiliation affiliation">Global
Pharmaceutical Research and Development, AbbVie, North
Chicago, Illinois 60064, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Masanori Kameoka</span> - <span class="hlFld-Affiliation affiliation">Department
of International Health, Kobe University
Graduate School of Health Sciences, Kobe 654-0142, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Motoyasu Adachi</span> - <span class="hlFld-Affiliation affiliation">Quantum
Beam Science Drectorate, National Institutes
for Quantum and Radiological Science and Technology, Tokai, Ibaraki 319-1106, Japan</span></div></li><li><div class="authorItemInformation"><sup>Δ</sup><span class="hlFld-ContribAuthor strong">Ryota Kuroki</span> - <span class="hlFld-Affiliation affiliation">Quantum Beam
Science Center, Japan Atomic Energy Agency, Tokai, Ibaraki 319-1195, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey-Tri Nguyen</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Kyoto Pharmaceutical
University, Kyoto 607-8412, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yoshio Hayashi</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Tokyo University
of Pharmacy and Life Sciences, Tokyo 192-0392, Japan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7010-6914" title="Orcid link">http://orcid.org/0000-0002-7010-6914</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><sup>Δ</sup>Deceased on Aug 8, 2015.<br /></br></div></li></ul></div><div class="ack" id="ACK-d79e5766-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76211" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76211" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are sincerely grateful to Ms. Y. Matsui, Ms. S. Shibakawa, and Mr. T. Hamada for the determination of HIV-1 protease inhibitory activity, and to Ms. Tatyana Dekhtyar for the determination of anti-HIV activity. This research was supported in parts by the Frontier Research Program and the 21st Century COE Program from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The synchrotron radiation experiments were performed at the BL41-XU and BL38B1 of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal No. 2011A1124 and 2014B1313).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">HIV</td><td class="NLM_def"><p class="first last">human immunodeficiency virus</p></td></tr><tr><td class="NLM_term">AIDS</td><td class="NLM_def"><p class="first last">acquired immune deficiency syndrome</p></td></tr><tr><td class="NLM_term">Apns</td><td class="NLM_def"><p class="first last">allophenylnorstatine</p></td></tr><tr><td class="NLM_term">HMC</td><td class="NLM_def"><p class="first last">hydroxymethylcarbonyl</p></td></tr><tr><td class="NLM_term">Dmt</td><td class="NLM_def"><p class="first last">(<i>R</i>)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid</p></td></tr><tr><td class="NLM_term">Thfg</td><td class="NLM_def"><p class="first last">tetrahydrofuranylglycine</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationships</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyloxycarbonyl</p></td></tr><tr><td class="NLM_term">BOP</td><td class="NLM_def"><p class="first last">benzotriazol-1-yloxy-tris(dimethylamino)phosphonium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3,3-dimethylamino-propyl)carbodiimide</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i56">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02285" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02285" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 36 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span>US Department
of Health and Human Services panel on antiretroviral guidelines for
adults and adolescents. Guidelines for the use of antiretroviral agents
in HIV-1-infected adults and adolescents. <a href="https://aidsinfo.nih.gov/guidelines" class="extLink">https://aidsinfo.nih.gov/guidelines</a> (accessed on Dec 27, <span class="NLM_year">2016</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=US+Department%0Aof+Health+and+Human+Services+panel+on+antiretroviral+guidelines+for%0Aadults+and+adolescents.+Guidelines+for+the+use+of+antiretroviral+agents%0Ain+HIV-1-infected+adults+and+adolescents.+https%3A%2F%2Faidsinfo.nih.gov%2Fguidelines+%28accessed+on+Dec+27%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armour, D.</span></span> <span> </span><span class="NLM_article-title">The discovery of the CCR5 receptor antagonist, UK-427,857, a new agent for the treatment of HIV infection and AIDS</span>. <i>Prog. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">271</span>, <span class="refDoi"> DOI: 10.1016/S0079-6468(05)43007-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1016%2FS0079-6468%2805%2943007-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=15850827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADC%252BD2MXps1Citbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2005&pages=239-271&author=A.+Woodauthor=D.+Armour&title=The+discovery+of+the+CCR5+receptor+antagonist%2C+UK-427%2C857%2C+a+new+agent+for+the+treatment+of+HIV+infection+and+AIDS&doi=10.1016%2FS0079-6468%2805%2943007-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of the CCR5 receptor antagonist, UK-427,857, a new agent for the treatment of HIV infection and AIDS</span></div><div class="casAuthors">Wood, Anthony; Armour, Duncan</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">239-271</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The drug discovery program that led to the identification of UK-427,857, a prototype CCR5 antagonist with excellent potency against lab-adapted and primary HIV-1 isolates, as a clin. candidate for the treatment of HIV is described.  In particular, strategies for minimizing cardiac toxicity while maintaining ADME properties commensurate with low dose are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIJQwMygW-grVg90H21EOLACvtfcHk0lgw-REKtIfz3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXps1Citbg%253D&md5=8c4bb50b02b7e6d8cfa13d844e39017c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2805%2943007-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252805%252943007-6%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DA.%26aulast%3DArmour%26aufirst%3DD.%26atitle%3DThe%2520discovery%2520of%2520the%2520CCR5%2520receptor%2520antagonist%252C%2520UK-427%252C857%252C%2520a%2520new%2520agent%2520for%2520the%2520treatment%2520of%2520HIV%2520infection%2520and%2520AIDS%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D43%26spage%3D239%26epage%3D271%26doi%3D10.1016%2FS0079-6468%2805%2943007-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johns, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasuji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weatherhead, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taishi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temelkoff, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taoda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanimoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshinaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garvey, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, T.</span></span> <span> </span><span class="NLM_article-title">Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5901</span>– <span class="NLM_lpage">5916</span>, <span class="refDoi"> DOI: 10.1021/jm400645w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400645w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVWhurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5901-5916&author=B.+A.+Johnsauthor=T.+Kawasujiauthor=J.+G.+Weatherheadauthor=T.+Taishiauthor=D.+P.+Temelkoffauthor=H.+Yoshidaauthor=T.+Akiyamaauthor=Y.+Taodaauthor=H.+Muraiauthor=R.+Kiyamaauthor=M.+Fujiauthor=N.+Tanimotoauthor=J.+Jeffreyauthor=S.+A.+Fosterauthor=T.+Yoshinagaauthor=T.+Sekiauthor=M.+Kobayashiauthor=A.+Satoauthor=M.+N.+Johnsonauthor=E.+P.+Garveyauthor=T.+Fujiwara&title=Carbamoyl+pyridone+HIV-1+integrase+inhibitors+3.+A+diastereomeric+approach+to+chiral+nonracemic+tricyclic+ring+systems+and+the+discovery+of+dolutegravir+%28S%2FGSK1349572%29+and+%28S%2FGSK1265744%29&doi=10.1021%2Fjm400645w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Carbamoyl Pyridone HIV-1 Integrase Inhibitors 3. A Diastereomeric Approach to Chiral Nonracemic Tricyclic Ring Systems and the Discovery of Dolutegravir (S/GSK1349572) and (S/GSK1265744)</span></div><div class="casAuthors">Johns, Brian A.; Kawasuji, Takashi; Weatherhead, Jason G.; Taishi, Teruhiko; Temelkoff, David P.; Yoshida, Hiroshi; Akiyama, Toshiyuki; Taoda, Yoshiyuki; Murai, Hitoshi; Kiyama, Ryuichi; Fuji, Masahiro; Tanimoto, Norihiko; Jeffrey, Jerry; Foster, Scott A.; Yoshinaga, Tomokazu; Seki, Takahiro; Kobayashi, Masanori; Sato, Akihiko; Johnson, Matthew N.; Garvey, Edward P.; Fujiwara, Tamio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5901-5916</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report herein the discovery of the human immunodeficiency virus type-1 (HIV-1) integrase inhibitors dolutegravir (S/GSK1349572) (3, III) and S/GSK1265744 (4, IV).  These drugs stem from a series of carbamoyl pyridone analogs designed using a two-metal chelation model of the integrase catalytic active site.  Structure-activity studies evolved a tricyclic series of carbamoyl pyridines that demonstrated properties indicative of once-daily dosing and superior potency against resistant viral strains.  An inherent hemiaminal ring fusion stereocenter within the tricyclic carbamoyl pyridone scaffold led to a crit. substrate controlled diastereoselective synthetic strategy whereby chiral information from small readily available amino alcs. was employed to control relative and abs. stereochem. of the final drug candidates.  Modest to extremely high levels of stereochem. control were obsd. depending on ring size and position of the stereocenter.  This approach resulted in the discovery of 3 and 4, which are currently in clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1G_fuC1lAtLVg90H21EOLACvtfcHk0ljSgQwevmr02A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVWhurfK&md5=c44c9e62870c2177b07cdd08d22ea600</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm400645w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400645w%26sid%3Dliteratum%253Aachs%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DWeatherhead%26aufirst%3DJ.%2BG.%26aulast%3DTaishi%26aufirst%3DT.%26aulast%3DTemelkoff%26aufirst%3DD.%2BP.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DTaoda%26aufirst%3DY.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DTanimoto%26aufirst%3DN.%26aulast%3DJeffrey%26aufirst%3DJ.%26aulast%3DFoster%26aufirst%3DS.%2BA.%26aulast%3DYoshinaga%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DM.%2BN.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DCarbamoyl%2520pyridone%2520HIV-1%2520integrase%2520inhibitors%25203.%2520A%2520diastereomeric%2520approach%2520to%2520chiral%2520nonracemic%2520tricyclic%2520ring%2520systems%2520and%2520the%2520discovery%2520of%2520dolutegravir%2520%2528S%252FGSK1349572%2529%2520and%2520%2528S%252FGSK1265744%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5901%26epage%3D5916%26doi%3D10.1021%2Fjm400645w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deeks, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewin, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Havlir, D. V.</span></span> <span> </span><span class="NLM_article-title">The end of AIDS: HIV infection as a chronic disease</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>382</i></span>,  <span class="NLM_fpage">1525</span>– <span class="NLM_lpage">1533</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(13)61809-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1016%2FS0140-6736%2813%2961809-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2013&pages=1525-1533&author=S.+G.+Deeksauthor=S.+R.+Lewinauthor=D.+V.+Havlir&title=The+end+of+AIDS%3A+HIV+infection+as+a+chronic+disease&doi=10.1016%2FS0140-6736%2813%2961809-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2813%2961809-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252813%252961809-7%26sid%3Dliteratum%253Aachs%26aulast%3DDeeks%26aufirst%3DS.%2BG.%26aulast%3DLewin%26aufirst%3DS.%2BR.%26aulast%3DHavlir%26aufirst%3DD.%2BV.%26atitle%3DThe%2520end%2520of%2520AIDS%253A%2520HIV%2520infection%2520as%2520a%2520chronic%2520disease%26jtitle%3DLancet%26date%3D2013%26volume%3D382%26spage%3D1525%26epage%3D1533%26doi%3D10.1016%2FS0140-6736%2813%2961809-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hill, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozniak, A. L.</span></span> <span> </span><span class="NLM_article-title">How can we achieve universal access to low-cost treatment for HIV?</span>. <i>J. Virus Erad.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=27781100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A280%3ADC%252BC2srps1Kisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=193-197&author=A.+M.+Hillauthor=A.+L.+Pozniak&title=How+can+we+achieve+universal+access+to+low-cost+treatment+for+HIV%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">How can we achieve universal access to low-cost treatment for HIV?</span></div><div class="casAuthors">Hill Andrew M; Pozniak Anton L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of virus eradication</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">193-197</span>
        ISSN:<span class="NLM_cas:issn">2055-6640</span>.
    </div><div class="casAbstract">Mass production of low-cost antiretrovirals (ARVs) has already allowed over 17 million individuals to access treatment for HIV infection, mainly in low-income countries.  It is possible to manufacture combination ARVs for $110 per person-year, using tenofovir (TDF), lamivudine (3TC) and efavirenz (EFV).  New combinations of ARVs costing as little as $60 per person-year will be available in the near future.  Pre-exposure prophylaxis using TDF in combination with either 3TC or emtricitabine (FTC) could also be provided for less than $90 per person-year.  Voluntary licensing allows people in the poorest countries to access new ARVs at prices close to manufacturing costs.  Patents on several key ARVs will expire by 2018 and should allow worldwide access to high-quality, low-cost triple combination therapy, such as TDF/3TC/EFV.  Several protease inhibitors will also become available as generics by 2018.  However, ongoing patent restrictions will lead to sustained high prices for the most recently developed ARVs in most middle- and high-income countries.  These include the nucleotide tenofovir alafenamide, the integrase strand inhibitor dolutegravir and several single combination tablet regimens.  We suggest that as patents for ARVs expire, health authorities first need to rapidly import and introduce generic versions of drugs such as abacavir, 3TC, EFV and TDF.  Once these low prices have been established for these generics, cost-effectiveness of patented ARVs needs to be re-evaluated.  It may no longer be justified to pay high prices for these drugs.  A strategy of low-cost generic ARVs for most people, with higher-cost patented alternatives used as switch options, could allow for an increased number of people to receive ARVs in the context of fixed health budgets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ6gwms_bc8qLYtC3U5jeOifW6udTcc2ea0M-enE1mtfbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srps1Kisg%253D%253D&md5=cef75b0db592fa7cc85fac3d6b91d297</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DA.%2BM.%26aulast%3DPozniak%26aufirst%3DA.%2BL.%26atitle%3DHow%2520can%2520we%2520achieve%2520universal%2520access%2520to%2520low-cost%2520treatment%2520for%2520HIV%253F%26jtitle%3DJ.%2520Virus%2520Erad.%26date%3D2016%26volume%3D2%26spage%3D193%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clemente, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coman, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiaville, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janka, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeung, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nukoolkarn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govindasamy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agbandje-McKenna, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leelamanit, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodenow, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, B. M.</span></span> <span> </span><span class="NLM_article-title">Analysis of HIV-1 CRF_01 A/E protease inhibitor resistance: structural determinants for maintaining sensitivity and developing resistance to atazanavir</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">5468</span>– <span class="NLM_lpage">5477</span>, <span class="refDoi"> DOI: 10.1021/bi051886s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi051886s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=5468-5477&author=J.+C.+Clementeauthor=R.+M.+Comanauthor=M.+M.+Thiavilleauthor=L.+K.+Jankaauthor=J.+A.+Jeungauthor=S.+Nukoolkarnauthor=L.+Govindasamyauthor=M.+Agbandje-McKennaauthor=R.+McKennaauthor=W.+Leelamanitauthor=M.+M.+Goodenowauthor=B.+M.+Dunn&title=Analysis+of+HIV-1+CRF_01+A%2FE+protease+inhibitor+resistance%3A+structural+determinants+for+maintaining+sensitivity+and+developing+resistance+to+atazanavir&doi=10.1021%2Fbi051886s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fbi051886s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi051886s%26sid%3Dliteratum%253Aachs%26aulast%3DClemente%26aufirst%3DJ.%2BC.%26aulast%3DComan%26aufirst%3DR.%2BM.%26aulast%3DThiaville%26aufirst%3DM.%2BM.%26aulast%3DJanka%26aufirst%3DL.%2BK.%26aulast%3DJeung%26aufirst%3DJ.%2BA.%26aulast%3DNukoolkarn%26aufirst%3DS.%26aulast%3DGovindasamy%26aufirst%3DL.%26aulast%3DAgbandje-McKenna%26aufirst%3DM.%26aulast%3DMcKenna%26aufirst%3DR.%26aulast%3DLeelamanit%26aufirst%3DW.%26aulast%3DGoodenow%26aufirst%3DM.%2BM.%26aulast%3DDunn%26aufirst%3DB.%2BM.%26atitle%3DAnalysis%2520of%2520HIV-1%2520CRF_01%2520A%252FE%2520protease%2520inhibitor%2520resistance%253A%2520structural%2520determinants%2520for%2520maintaining%2520sensitivity%2520and%2520developing%2520resistance%2520to%2520atazanavir%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D5468%26epage%3D5477%26doi%3D10.1021%2Fbi051886s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coman, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilliland, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sochet, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodenow, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, B. M.</span></span> <span> </span><span class="NLM_article-title">The contribution of naturally occurring polymorphisms in altering the biochemical and structural characteristics of HIV-1 subtype C protease</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">731</span>– <span class="NLM_lpage">743</span>, <span class="refDoi"> DOI: 10.1021/bi7018332</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi7018332" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=731-743&author=R.+M.+Comanauthor=A.+H.+Robbinsauthor=M.+A.+Fernandezauthor=C.+T.+Gillilandauthor=A.+A.+Sochetauthor=M.+M.+Goodenowauthor=R.+McKennaauthor=B.+M.+Dunn&title=The+contribution+of+naturally+occurring+polymorphisms+in+altering+the+biochemical+and+structural+characteristics+of+HIV-1+subtype+C+protease&doi=10.1021%2Fbi7018332"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fbi7018332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi7018332%26sid%3Dliteratum%253Aachs%26aulast%3DComan%26aufirst%3DR.%2BM.%26aulast%3DRobbins%26aufirst%3DA.%2BH.%26aulast%3DFernandez%26aufirst%3DM.%2BA.%26aulast%3DGilliland%26aufirst%3DC.%2BT.%26aulast%3DSochet%26aufirst%3DA.%2BA.%26aulast%3DGoodenow%26aufirst%3DM.%2BM.%26aulast%3DMcKenna%26aufirst%3DR.%26aulast%3DDunn%26aufirst%3DB.%2BM.%26atitle%3DThe%2520contribution%2520of%2520naturally%2520occurring%2520polymorphisms%2520in%2520altering%2520the%2520biochemical%2520and%2520structural%2520characteristics%2520of%2520HIV-1%2520subtype%2520C%2520protease%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D731%26epage%3D743%26doi%3D10.1021%2Fbi7018332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osswald, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glauninger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agniswamy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span> <span> </span><span class="NLM_article-title">Probing lipophilic adamantyl group as the P1-ligand for HIV-1 protease inhibitors: design, synthesis, protein X-ray structural studies, and biological evaluation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6826</span>– <span class="NLM_lpage">6837</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00639</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00639" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFWgsL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6826-6837&author=A.+K.+Ghoshauthor=H.+L.+Osswaldauthor=K.+Glauningerauthor=J.+Agniswamyauthor=Y.-F.+Wangauthor=H.+Hayashiauthor=M.+Aokiauthor=I.+T.+Weberauthor=H.+Mitsuya&title=Probing+lipophilic+adamantyl+group+as+the+P1-ligand+for+HIV-1+protease+inhibitors%3A+design%2C+synthesis%2C+protein+X-ray+structural+studies%2C+and+biological+evaluation&doi=10.1021%2Facs.jmedchem.6b00639"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Probing Lipophilic Adamantyl Group as the P1-Ligand for HIV-1 Protease Inhibitors: Design, Synthesis, Protein X-ray Structural Studies, and Biological Evaluation</span></div><div class="casAuthors">Ghosh, Arun K.; Osswald, Heather L.; Glauninger, Kristof; Agniswamy, Johnson; Wang, Yuan-Fang; Hayashi, Hironori; Aoki, Manabu; Weber, Irene T.; Mitsuya, Hiroaki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6826-6837</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of potent HIV-1 protease inhibitors with a lipophilic adamantyl P1 ligand have been designed, synthesized, and evaluated.  We have developed an enantioselective synthesis of adamantane-derived hydroxyethylamine isosteres utilizing Sharpless asym. epoxidn. as the key step.  Various inhibitors incorporating P1-adamantylmethyl in combination with P2 ligands such as 3-(R)-THF, 3-(S)-THF, bis-THF, and THF-THP were examd.  The S1' pocket was also probed with Ph and phenylmethyl ligands.  Inhibitor 15d, with an iso-Bu P1' ligand and a bis-THF P2 ligand, proved to be the most potent of the series.  The cLogP value of inhibitor 15d is improved compared to inhibitor 2 with a phenylmethyl P1-ligand.  X-ray structural studies of 15d, 15h, and 15i with HIV-1 protease complexes revealed mol. insight into the inhibitor-protein interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn14NWamaSc7Vg90H21EOLACvtfcHk0ljHBtI0b-TOfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFWgsL7F&md5=133ec054d4a0d142c827cfd34fd3edaa</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00639%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DOsswald%26aufirst%3DH.%2BL.%26aulast%3DGlauninger%26aufirst%3DK.%26aulast%3DAgniswamy%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.-F.%26aulast%3DHayashi%26aufirst%3DH.%26aulast%3DAoki%26aufirst%3DM.%26aulast%3DWeber%26aufirst%3DI.%2BT.%26aulast%3DMitsuya%26aufirst%3DH.%26atitle%3DProbing%2520lipophilic%2520adamantyl%2520group%2520as%2520the%2520P1-ligand%2520for%2520HIV-1%2520protease%2520inhibitors%253A%2520design%252C%2520synthesis%252C%2520protein%2520X-ray%2520structural%2520studies%252C%2520and%2520biological%2520evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6826%26epage%3D6837%26doi%3D10.1021%2Facs.jmedchem.6b00639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kempf, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Real, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernstein, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Japour, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rode, R. A.</span></span> <span> </span><span class="NLM_article-title">Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">7462</span>– <span class="NLM_lpage">7469</span>, <span class="refDoi"> DOI: 10.1128/JVI.75.16.7462-7469.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1128%2FJVI.75.16.7462-7469.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=11462018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsFKkurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2001&pages=7462-7469&author=D.+J.+Kempfauthor=J.+D.+Isaacsonauthor=M.+S.+Kingauthor=S.+C.+Brunauthor=Y.+Xuauthor=K.+Realauthor=B.+M.+Bernsteinauthor=A.+J.+Japourauthor=E.+Sunauthor=R.+A.+Rode&title=Identification+of+genotypic+changes+in+human+immunodeficiency+virus+protease+that+correlate+with+reduced+susceptibility+to+the+protease+inhibitor+lopinavir+among+viral+isolates+from+protease+inhibitor-experienced+patients&doi=10.1128%2FJVI.75.16.7462-7469.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients</span></div><div class="casAuthors">Kempf, Dale J.; Isaacson, Jeffrey D.; King, Martin S.; Brun, Scott C.; Xu, Yi; Real, Kathryn; Bernstein, Barry M.; Japour, Anthony J.; Sun, Eugene; Rode, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7462-7469</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The assocn. of genotypic changes in human immunodeficiency virus (HIV) protease with reduced in vitro susceptibility to the new protease inhibitor lopinavir (previously ABT-378) was explored using a panel of viral isolates from subjects failing therapy with other protease inhibitors.  Two statistical tests showed that specific mutations at 11 amino acid positions in protease (L10F/I/R/V, K20M/R, L24I, M46I/L, F53L, I54L/T/V, L63P, A71I/L/T/V, V82A/F/T, I84V, and L90M) were assocd. with reduced susceptibility.  Mutations at positions 82, 54, 10, 63, 71, and 84 were most closely assocd. with relatively modest (4- and 10-fold) changes in phenotype, while the K20M/R and F53L mutations, in conjunction with multiple other mutations, were assocd. with >20- and >40-fold-reduced susceptibility, resp.  The median 50% inhibitory concns. (IC50) of lopinavir against isolates with 0 to 3, 4 or 5, 6 or 7, and 8 to 10 of the above 11 mutations were 0.8-, 2.7-, 13.5-, and 44.0-fold higher, resp., than the IC50 against wild-type HIV.  On av., the IC50 of lopinavir increased by 1.74-fold per mutation in isolates contg. three or more mutations.  Each of the 16 viruses that displayed a >20-fold change in susceptibility contained mutations at residues 10, 54, 63, and 82 and/or 84, along with a median of three mutations at residues 20, 24, 46, 53, 71, and 90.  The no. of protease mutations from the 11 identified in these analyses (the lopinavir mutation score) may be useful for the interpretation of HIV genotypic resistance testing with respect of lopinavir-ritonavir (Kaletra) regimens and may provide insight into the genetic barrier to resistance to lopinavir-ritonavir in both antiretroviral therapy-naive and protease inhibitor-experienced patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqymRxgMBzAbbVg90H21EOLACvtfcHk0lggWGBR3qPX9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsFKkurk%253D&md5=03c037022055c0f5868fd0f48f410539</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1128%2FJVI.75.16.7462-7469.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.75.16.7462-7469.2001%26sid%3Dliteratum%253Aachs%26aulast%3DKempf%26aufirst%3DD.%2BJ.%26aulast%3DIsaacson%26aufirst%3DJ.%2BD.%26aulast%3DKing%26aufirst%3DM.%2BS.%26aulast%3DBrun%26aufirst%3DS.%2BC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DReal%26aufirst%3DK.%26aulast%3DBernstein%26aufirst%3DB.%2BM.%26aulast%3DJapour%26aufirst%3DA.%2BJ.%26aulast%3DSun%26aufirst%3DE.%26aulast%3DRode%26aufirst%3DR.%2BA.%26atitle%3DIdentification%2520of%2520genotypic%2520changes%2520in%2520human%2520immunodeficiency%2520virus%2520protease%2520that%2520correlate%2520with%2520reduced%2520susceptibility%2520to%2520the%2520protease%2520inhibitor%2520lopinavir%2520among%2520viral%2520isolates%2520from%2520protease%2520inhibitor-experienced%2520patients%26jtitle%3DJ.%2520Virol.%26date%3D2001%26volume%3D75%26spage%3D7462%26epage%3D7469%26doi%3D10.1128%2FJVI.75.16.7462-7469.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Surleraux, D. L. N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verschueren, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pille, G. M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de
Kock, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonckers, T. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peeters, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Meyer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azijn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauwels, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bethune, M.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabu-Jeyabalan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiffer, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigerinck, P. B. T. P.</span></span> <span> </span><span class="NLM_article-title">Discovery and selection of TMC114, a next generation HIV-1 protease inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1813</span>– <span class="NLM_lpage">1822</span>, <span class="refDoi"> DOI: 10.1021/jm049560p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049560p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotVOlu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1813-1822&author=D.+L.+N.+G.+Surlerauxauthor=A.+Tahriauthor=W.+G.+Verschuerenauthor=G.+M.+E.+Pilleauthor=H.+A.+de%0AKockauthor=T.+H.+M.+Jonckersauthor=A.+Peetersauthor=S.+De+Meyerauthor=H.+Azijnauthor=R.+Pauwelsauthor=M.-P.+de+Bethuneauthor=N.+M.+Kingauthor=M.+Prabu-Jeyabalanauthor=C.+A.+Schifferauthor=P.+B.+T.+P.+Wigerinck&title=Discovery+and+selection+of+TMC114%2C+a+next+generation+HIV-1+protease+inhibitor&doi=10.1021%2Fjm049560p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Selection of TMC114, a Next Generation HIV-1 Protease Inhibitor</span></div><div class="casAuthors">Surleraux, Dominique L. N. G.; Tahri, Abdellah; Verschueren, Wim G.; Pille, Geert M. E.; de Kock, Herman A.; Jonckers, Tim H. M.; Peeters, Anik; De Meyer, Sandra; Azijn, Hilde; Pauwels, Rudi; de Bethune, Marie-Pierre; King, Nancy M.; Prabu-Jeyabalan, Moses; Schiffer, Celia A.; Wigerinck, Piet B. T. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1813-1822</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The screening of known HIV-1 protease inhibitors against a panel of multidrug-resistant viruses revealed the potent activity of TMC126 on drug-resistant mutants.  In comparison to amprenavir, the improved affinity of TMC126 is largely the result of one extra hydrogen bond to the backbone of the protein in the P2 pocket.  Modification of the substitution pattern on the phenylsulfonamide P2' substituent of TMC126 created an interesting SAR, with the close analog TMC114 being found to have a similar antiviral activity against the mutant and the wild-type viruses.  X-ray and thermodn. studies on both wild-type and mutant enzymes showed an extremely high enthalpy driven affinity of TMC114 for HIV-1 protease.  In vitro selection of mutants resistant to TMC114 starting from wild-type virus proved to be extremely difficult; this was not the case for other close analogs.  Therefore, the extra H-bond to the backbone in the P2 pocket cannot be the only explanation for the interesting antiviral profile of TMC114.  Absorption studies in animals indicated that TMC114 has pharmacokinetic properties comparable to currently approved HIV-1 protease inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdYfZu3Lc6mbVg90H21EOLACvtfcHk0lggWGBR3qPX9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotVOlu7Y%253D&md5=35809ccdec57ebb6afa7af1b80362f74</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm049560p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049560p%26sid%3Dliteratum%253Aachs%26aulast%3DSurleraux%26aufirst%3DD.%2BL.%2BN.%2BG.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DVerschueren%26aufirst%3DW.%2BG.%26aulast%3DPille%26aufirst%3DG.%2BM.%2BE.%26aulast%3Dde%2BKock%26aufirst%3DH.%2BA.%26aulast%3DJonckers%26aufirst%3DT.%2BH.%2BM.%26aulast%3DPeeters%26aufirst%3DA.%26aulast%3DDe%2BMeyer%26aufirst%3DS.%26aulast%3DAzijn%26aufirst%3DH.%26aulast%3DPauwels%26aufirst%3DR.%26aulast%3Dde%2BBethune%26aufirst%3DM.-P.%26aulast%3DKing%26aufirst%3DN.%2BM.%26aulast%3DPrabu-Jeyabalan%26aufirst%3DM.%26aulast%3DSchiffer%26aufirst%3DC.%2BA.%26aulast%3DWigerinck%26aufirst%3DP.%2BB.%2BT.%2BP.%26atitle%3DDiscovery%2520and%2520selection%2520of%2520TMC114%252C%2520a%2520next%2520generation%2520HIV-1%2520protease%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1813%26epage%3D1822%26doi%3D10.1021%2Fjm049560p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekhtyar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempf, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molla, A.</span></span> <span> </span><span class="NLM_article-title">Characterization of resistant HIV variants generated by in vitro passage with lopinavir/ritonavir</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">173</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.1016/S0166-3542(03)00107-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1016%2FS0166-3542%2803%2900107-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2003&pages=173-180&author=H.+Moauthor=L.+Luauthor=T.+Dekhtyarauthor=K.+D.+Stewartauthor=E.+Sunauthor=D.+J.+Kempfauthor=A.+Molla&title=Characterization+of+resistant+HIV+variants+generated+by+in+vitro+passage+with+lopinavir%2Fritonavir&doi=10.1016%2FS0166-3542%2803%2900107-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0166-3542%2803%2900107-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-3542%252803%252900107-4%26sid%3Dliteratum%253Aachs%26aulast%3DMo%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DDekhtyar%26aufirst%3DT.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DSun%26aufirst%3DE.%26aulast%3DKempf%26aufirst%3DD.%2BJ.%26aulast%3DMolla%26aufirst%3DA.%26atitle%3DCharacterization%2520of%2520resistant%2520HIV%2520variants%2520generated%2520by%2520in%2520vitro%2520passage%2520with%2520lopinavir%252Fritonavir%26jtitle%3DAntiviral%2520Res.%26date%3D2003%26volume%3D59%26spage%3D173%26epage%3D180%26doi%3D10.1016%2FS0166-3542%2803%2900107-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danish, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki-Ogata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shafer, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span> <span> </span><span class="NLM_article-title">Loss of protease dimerization inhibition activity of darunavir is associated with the acquisition of resistance to darunavir by HIV-1</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">10079</span>– <span class="NLM_lpage">10089</span>, <span class="refDoi"> DOI: 10.1128/JVI.05121-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1128%2FJVI.05121-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=21813613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlWiur3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2011&pages=10079-10089&author=Y.+Kohauthor=M.+Aokiauthor=M.+L.+Danishauthor=H.+Aoki-Ogataauthor=M.+Amanoauthor=D.+Dasauthor=R.+W.+Shaferauthor=A.+K.+Ghoshauthor=H.+Mitsuya&title=Loss+of+protease+dimerization+inhibition+activity+of+darunavir+is+associated+with+the+acquisition+of+resistance+to+darunavir+by+HIV-1&doi=10.1128%2FJVI.05121-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of protease dimerization inhibition activity of darunavir is associated with the acquisition of resistance to darunavir by HIV-1</span></div><div class="casAuthors">Koh, Yasuhiro; Aoki, Manabu; Danish, Matthew L.; Aoki-Ogata, Hiromi; Amano, Masayuki; Das, Debananda; Shafer, Robert W.; Ghosh, Arun K.; Mitsuya, Hiroaki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">10079-10089</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Dimerization of HIV protease is essential for the acquisition of protease's proteolytic activity.  We previously identified a group of HIV protease dimerization inhibitors, including darunavir (DRV).  In the present work, we examine whether loss of DRV's protease dimerization inhibition activity is assocd. with HIV development of DRV resistance.  Single amino acid substitutions, including I3A, L5A, R8A/Q, L24A, T26A, D29N, R87K, T96A, L97A, and F99A, disrupted protease dimerization, as examd. using an intermol. fluorescence resonance energy transfer (FRET)-based HIV expression assay.  All recombinant HIVNL4-3-based clones with such a protease dimerization-disrupting substitution failed to replicate.  A highly DRV-resistant in vitro-selected HIV variant and clin. HIV strains isolated from AIDS patients failing to respond to DRV-contg. antiviral regimens typically had the V32I, L33F, I54M, and I84V substitutions in common in protease.  None of up to 3 of the 4 substitutions affected DRV's protease dimerization inhibition, which was significantly compromised by the four combined substitutions.  Recombinant infectious clones contg. up to 3 of the 4 substitutions remained sensitive to DRV, while a clonal HIV variant with all 4 substitutions proved highly resistant to DRV with a 205-fold 50% effective concn. (EC50) difference compared to HIVNL4-3.  The present data suggest that the loss of DRV activity to inhibit protease dimerization represents a novel mechanism contributing to HIV resistance to DRV.  The finding that 4 substitutions in PR are required for significant loss of DRV's protease dimerization inhibition should at least partially explain the reason DRV has a high genetic barrier against HIV's acquisition of DRV resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogoboda3XZ0rVg90H21EOLACvtfcHk0lgwd1jf2RF7uA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlWiur3M&md5=1deea3ce630cf9a04cbbbe3ee253195d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1128%2FJVI.05121-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.05121-11%26sid%3Dliteratum%253Aachs%26aulast%3DKoh%26aufirst%3DY.%26aulast%3DAoki%26aufirst%3DM.%26aulast%3DDanish%26aufirst%3DM.%2BL.%26aulast%3DAoki-Ogata%26aufirst%3DH.%26aulast%3DAmano%26aufirst%3DM.%26aulast%3DDas%26aufirst%3DD.%26aulast%3DShafer%26aufirst%3DR.%2BW.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DMitsuya%26aufirst%3DH.%26atitle%3DLoss%2520of%2520protease%2520dimerization%2520inhibition%2520activity%2520of%2520darunavir%2520is%2520associated%2520with%2520the%2520acquisition%2520of%2520resistance%2520to%2520darunavir%2520by%2520HIV-1%26jtitle%3DJ.%2520Virol.%26date%3D2011%26volume%3D85%26spage%3D10079%26epage%3D10089%26doi%3D10.1128%2FJVI.05121-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisanuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shintani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakikawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akaji, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, Y.</span></span> <span> </span><span class="NLM_article-title">Rational design and synthesis of a novel class of active site-targeted HIV protease inhibitors containing a hydroxymethylcarbonyl isostere. Use of phenylnorstatine or allophenylnorstatine as a transition-state mimic</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">2465</span>– <span class="NLM_lpage">2467</span>, <span class="refDoi"> DOI: 10.1248/cpb.39.2465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1248%2Fcpb.39.2465" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1991&pages=2465-2467&author=T.+Mimotoauthor=J.+Imaiauthor=S.+Tanakaauthor=N.+Hattoriauthor=O.+Takahashiauthor=S.+Kisanukiauthor=Y.+Naganoauthor=M.+Shintaniauthor=H.+Hayashiauthor=K.+Sakikawaauthor=K.+Akajiauthor=Y.+Kiso&title=Rational+design+and+synthesis+of+a+novel+class+of+active+site-targeted+HIV+protease+inhibitors+containing+a+hydroxymethylcarbonyl+isostere.+Use+of+phenylnorstatine+or+allophenylnorstatine+as+a+transition-state+mimic&doi=10.1248%2Fcpb.39.2465"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1248%2Fcpb.39.2465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.39.2465%26sid%3Dliteratum%253Aachs%26aulast%3DMimoto%26aufirst%3DT.%26aulast%3DImai%26aufirst%3DJ.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DHattori%26aufirst%3DN.%26aulast%3DTakahashi%26aufirst%3DO.%26aulast%3DKisanuki%26aufirst%3DS.%26aulast%3DNagano%26aufirst%3DY.%26aulast%3DShintani%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DH.%26aulast%3DSakikawa%26aufirst%3DK.%26aulast%3DAkaji%26aufirst%3DK.%26aulast%3DKiso%26aufirst%3DY.%26atitle%3DRational%2520design%2520and%2520synthesis%2520of%2520a%2520novel%2520class%2520of%2520active%2520site-targeted%2520HIV%2520protease%2520inhibitors%2520containing%2520a%2520hydroxymethylcarbonyl%2520isostere.%2520Use%2520of%2520phenylnorstatine%2520or%2520allophenylnorstatine%2520as%2520a%2520transition-state%2520mimic%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1991%26volume%3D39%26spage%3D2465%26epage%3D2467%26doi%3D10.1248%2Fcpb.39.2465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisanuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akaji, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, Y.</span></span> <span> </span><span class="NLM_article-title">KNI-102, a novel tripeptide HIV protease inhibitor containing allophenylnorstatine as a transition-state mimic</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">3088</span>– <span class="NLM_lpage">3090</span>, <span class="refDoi"> DOI: 10.1248/cpb.39.3088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1248%2Fcpb.39.3088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1799953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADyaK38XhsVegsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1991&pages=3088-3090&author=T.+Mimotoauthor=J.+Imaiauthor=S.+Tanakaauthor=N.+Hattoriauthor=S.+Kisanukiauthor=K.+Akajiauthor=Y.+Kiso&title=KNI-102%2C+a+novel+tripeptide+HIV+protease+inhibitor+containing+allophenylnorstatine+as+a+transition-state+mimic&doi=10.1248%2Fcpb.39.3088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">KNI-102, a novel tripeptide HIV protease inhibitor containing allophenylnorstatine as a transition-state mimic</span></div><div class="casAuthors">Mimoto, Tsutomu; Imai, Junya; Tanaka, Shigeki; Hattori, Naoko; Kisanuki, Sumitsugu; Akaji, Kenichi; Kiso, Yoshiaki</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3088-90</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    </div><div class="casAbstract">HIV-1 protease inhibitors contg. allophenylnorstatine[Apns; (2S,3S)-3-amino-2-hydroxy-4-phenylbutyric acid]-Pro (syn diastereomer) as a transition-state mimic were established to be potent and highly selective.  Z-Asn-Apns-Pro-NHBut (KNI-102) is the only tripeptide exhibiting substantial anti-HIV activity and may be of min. size for potent, selective inhibition of HIV protease.  Ready availability due to its simple chem. structure and stability should make it valuable for studies of the development of metabolically stable anti-AIDS drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3IUEjcsc-gLVg90H21EOLACvtfcHk0lgwd1jf2RF7uA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsVegsbw%253D&md5=3e32a98a7b2bfe77f33897b23349f1df</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1248%2Fcpb.39.3088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.39.3088%26sid%3Dliteratum%253Aachs%26aulast%3DMimoto%26aufirst%3DT.%26aulast%3DImai%26aufirst%3DJ.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DHattori%26aufirst%3DN.%26aulast%3DKisanuki%26aufirst%3DS.%26aulast%3DAkaji%26aufirst%3DK.%26aulast%3DKiso%26aufirst%3DY.%26atitle%3DKNI-102%252C%2520a%2520novel%2520tripeptide%2520HIV%2520protease%2520inhibitor%2520containing%2520allophenylnorstatine%2520as%2520a%2520transition-state%2520mimic%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1991%26volume%3D39%26spage%3D3088%26epage%3D3090%26doi%3D10.1248%2Fcpb.39.3088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akaji, K.</span></span> <span> </span><span class="NLM_article-title">Small dipeptide-based HIV protease inhibitors containing the hydroxymethylcarbonyl isostere as an ideal transition-state mimic</span>. <i>Biopolymers</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1097-0282(1999)51:1<59::AID-BIP7>3.0.CO;2-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1002%2F%28SICI%291097-0282%281999%2951%3A1%3C59%3A%3AAID-BIP7%3E3.0.CO%3B2-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1999&pages=59-68&author=Y.+Kisoauthor=H.+Matsumotoauthor=S.+Mizumotoauthor=T.+Kimuraauthor=Y.+Fujiwaraauthor=K.+Akaji&title=Small+dipeptide-based+HIV+protease+inhibitors+containing+the+hydroxymethylcarbonyl+isostere+as+an+ideal+transition-state+mimic&doi=10.1002%2F%28SICI%291097-0282%281999%2951%3A1%3C59%3A%3AAID-BIP7%3E3.0.CO%3B2-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0282%281999%2951%3A1%3C59%3A%3AAID-BIP7%3E3.0.CO%3B2-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0282%25281999%252951%253A1%253C59%253A%253AAID-BIP7%253E3.0.CO%253B2-3%26sid%3Dliteratum%253Aachs%26aulast%3DKiso%26aufirst%3DY.%26aulast%3DMatsumoto%26aufirst%3DH.%26aulast%3DMizumoto%26aufirst%3DS.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DFujiwara%26aufirst%3DY.%26aulast%3DAkaji%26aufirst%3DK.%26atitle%3DSmall%2520dipeptide-based%2520HIV%2520protease%2520inhibitors%2520containing%2520the%2520hydroxymethylcarbonyl%2520isostere%2520as%2520an%2520ideal%2520transition-state%2520mimic%26jtitle%3DBiopolymers%26date%3D1999%26volume%3D51%26spage%3D59%26epage%3D68%26doi%3D10.1002%2F%28SICI%291097-0282%281999%2951%3A1%3C59%3A%3AAID-BIP7%3E3.0.CO%3B2-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohhara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honjo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okazaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hidaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroki, R.</span></span> <span> </span><span class="NLM_article-title">Structure of HIV-1 protease in complex with potent inhibitor KNI-272 determined by high resolution X-ray and neutron crystallography</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">4641</span>– <span class="NLM_lpage">4646</span>, <span class="refDoi"> DOI: 10.1073/pnas.0809400106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1073%2Fpnas.0809400106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=4641-4646&author=M.+Adachiauthor=T.+Ohharaauthor=K.+Kuriharaauthor=T.+Tamadaauthor=E.+Honjoauthor=N.+Okazakiauthor=S.+Araiauthor=Y.+Shoyamaauthor=K.+Kimuraauthor=H.+Matsumuraauthor=S.+Sugiyamaauthor=H.+Adachiauthor=K.+Takanoauthor=Y.+Moriauthor=K.+Hidakaauthor=T.+Kimuraauthor=Y.+Hayashiauthor=Y.+Kisoauthor=R.+Kuroki&title=Structure+of+HIV-1+protease+in+complex+with+potent+inhibitor+KNI-272+determined+by+high+resolution+X-ray+and+neutron+crystallography&doi=10.1073%2Fpnas.0809400106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0809400106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0809400106%26sid%3Dliteratum%253Aachs%26aulast%3DAdachi%26aufirst%3DM.%26aulast%3DOhhara%26aufirst%3DT.%26aulast%3DKurihara%26aufirst%3DK.%26aulast%3DTamada%26aufirst%3DT.%26aulast%3DHonjo%26aufirst%3DE.%26aulast%3DOkazaki%26aufirst%3DN.%26aulast%3DArai%26aufirst%3DS.%26aulast%3DShoyama%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DK.%26aulast%3DMatsumura%26aufirst%3DH.%26aulast%3DSugiyama%26aufirst%3DS.%26aulast%3DAdachi%26aufirst%3DH.%26aulast%3DTakano%26aufirst%3DK.%26aulast%3DMori%26aufirst%3DY.%26aulast%3DHidaka%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DKiso%26aufirst%3DY.%26aulast%3DKuroki%26aufirst%3DR.%26atitle%3DStructure%2520of%2520HIV-1%2520protease%2520in%2520complex%2520with%2520potent%2520inhibitor%2520KNI-272%2520determined%2520by%2520high%2520resolution%2520X-ray%2520and%2520neutron%2520crystallography%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D4641%26epage%3D4646%26doi%3D10.1073%2Fpnas.0809400106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulnik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Topol, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, J. W.</span></span> <span> </span><span class="NLM_article-title">Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophenylnorstatine</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.1016/S0969-2126(01)00192-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1016%2FS0969-2126%2801%2900192-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=8590019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADyaK2MXmvVyrs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1995&pages=581-590&author=E.+T.+Baldwinauthor=T.+N.+Bhatauthor=S.+Gulnikauthor=B.+Liuauthor=I.+A.+Topolauthor=Y.+Kisoauthor=T.+Mimotoauthor=H.+Mitsuyaauthor=J.+W.+Erickson&title=Structure+of+HIV-1+protease+with+KNI-272%2C+a+tight-binding+transition-state+analog+containing+allophenylnorstatine&doi=10.1016%2FS0969-2126%2801%2900192-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophenylnorstatine</span></div><div class="casAuthors">Baldwin, Eric T.; Bhat, T. Narayana; Gulnik, Sergel; Liu, Beishan; Topol, Igor A.; Kiso, Yoshiaki; Mimoto, Tsutomu; Mitsuya, Hiroaki; Erickson, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">581-90</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">HIV-1 protease (HIV PR), an aspartic protease, cleaves Phe-Pro bonds in the Gag and Gag-Pol viral polyproteins.  Substrate-based peptide mimics constitute a major class of inhibitors of HIV PR presently being developed for AIDS treatment.  One such compd., KNI-272, which incorporates allophenylnorstatine (Apns)-thioproline (Thp) in place of Phe-Pro, has potent antiviral activity and is undergoing clin. trials.  The structure of the enzyme-inhibitor complex should lead to an understanding of the structural basis for its tight binding properties and provide a framework for interpreting the emerging resistance to this drug.  The three-dimensional crystal structure of KNI-272 bound to HIV PR has been detd. to 2.0 Å resoln. and used to analyze structure-activity data and drug resistance for the Arg8→Gln and Ile84→Val mutations in HIV PR.  The conformationally constrained Apns-Thp linkage is favorably recognized in its low energy trans conformation, which results in a sym. mode of binding to the active-site aspartic acids and also explains the unusual preference of HIV PR for the S, or syn, hydroxyl group of the Apns residue.  The inhibitor recognizes the enzyme via hydrogen bonds to three bridging water mols., including one that is coordinated directly to the catalytic Asp125 residue.  The structure of the HIV PR/KNI-272 complex illustrates the importance of limiting the conformational degrees of freedom and of using protein-bound water mols. for binding potent inhibitors.  The binding mode of HIV PR inhibitors can be predicted from the stereochem. relation between adjacent hydroxyl-bearing and side chain bearing carbon atoms of the P1 substituent.  The structure also provides a framework for designing analogs targeted to drug-resistant mutant enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJR45zXxpXZbVg90H21EOLACvtfcHk0ljIe20AiVqTZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvVyrs74%253D&md5=4a8f8d322cdb9c1bef21ce589df93f92</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2801%2900192-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252801%252900192-7%26sid%3Dliteratum%253Aachs%26aulast%3DBaldwin%26aufirst%3DE.%2BT.%26aulast%3DBhat%26aufirst%3DT.%2BN.%26aulast%3DGulnik%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DTopol%26aufirst%3DI.%2BA.%26aulast%3DKiso%26aufirst%3DY.%26aulast%3DMimoto%26aufirst%3DT.%26aulast%3DMitsuya%26aufirst%3DH.%26aulast%3DErickson%26aufirst%3DJ.%2BW.%26atitle%3DStructure%2520of%2520HIV-1%2520protease%2520with%2520KNI-272%252C%2520a%2520tight-binding%2520transition-state%2520analog%2520containing%2520allophenylnorstatine%26jtitle%3DStructure%26date%3D1995%26volume%3D3%26spage%3D581%26epage%3D590%26doi%3D10.1016%2FS0969-2126%2801%2900192-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedberg, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wingfield, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufman, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torchia, D. A.</span></span> <span> </span><span class="NLM_article-title">Solution NMR evidence that the HIV-1 protease catalytic aspartyl groups have different ionization states in the complex formed with the asymmetric drug KNI-272</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">9945</span>– <span class="NLM_lpage">9950</span>, <span class="refDoi"> DOI: 10.1021/bi961268z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi961268z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADyaK28XksVCht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1996&pages=9945-9950&author=Y.-X.+Wangauthor=D.+I.+Freedbergauthor=T.+Yamazakiauthor=P.+T.+Wingfieldauthor=S.+J.+Stahlauthor=J.+D.+Kaufmanauthor=Y.+Kisoauthor=D.+A.+Torchia&title=Solution+NMR+evidence+that+the+HIV-1+protease+catalytic+aspartyl+groups+have+different+ionization+states+in+the+complex+formed+with+the+asymmetric+drug+KNI-272&doi=10.1021%2Fbi961268z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Solution NMR Evidence That the HIV-1 Protease Catalytic Aspartyl Groups Have Different Ionization States in the Complex Formed with the Asymmetric Drug KNI-272</span></div><div class="casAuthors">Wang, Yun-Xing; Freedberg, Daron I.; Yamazaki, Toshimasa; Wingfield, Paul T.; Stahl, Stephen J.; Kaufman, Joshua D.; Kiso, Yoshiaki; Torchia, Dennis A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">9945-9950</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In order to improve the design of HIV-1 protease inhibitors, it is essential to understand how they interact with active site residues, particularly the catalytic Asp25 and Asp125 residues.  KNI-272 is a promising, potent HIV-1 protease inhibitor (Ki ≈ 5 pM), currently undergoing phase 1 clin. trials.  Because KNI-272 is asym., the complex it forms with the homodimeric HIV-1 protease also lacks symmetry, and the two protease monomers can have distinct NMR spectra.  Monomer specific signal assignments were obtained for amino acid residues in the drug binding site as well as for six of the eight Asp residues in the protease/KNI-272 complex.  Using these assignments, the ionization states of the Asp carboxyl groups were detd. from measurements of (a) the pD dependence of the chem. shifts of the Asp carboxyl carbons and (b) the H/D isotope effect upon the Asp carboxyl carbon chem. shifts.  The results of these measurements indicate that the carboxyl of Asp25 is protonated while that of Asp125 is not protonated.  These findings provide not only the first exptl. evidence regarding the distinct protonation states of Asp25/125 in HIV-1 protease/drug complexes, but also shed light on interactions responsible for inhibitor binding that should form the basis for improved drug designs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr3SuB8Bk727Vg90H21EOLACvtfcHk0ljIe20AiVqTZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XksVCht7o%253D&md5=a99ca03ebff3a485f71b411f744b3f0d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fbi961268z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi961268z%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.-X.%26aulast%3DFreedberg%26aufirst%3DD.%2BI.%26aulast%3DYamazaki%26aufirst%3DT.%26aulast%3DWingfield%26aufirst%3DP.%2BT.%26aulast%3DStahl%26aufirst%3DS.%2BJ.%26aulast%3DKaufman%26aufirst%3DJ.%2BD.%26aulast%3DKiso%26aufirst%3DY.%26aulast%3DTorchia%26aufirst%3DD.%2BA.%26atitle%3DSolution%2520NMR%2520evidence%2520that%2520the%2520HIV-1%2520protease%2520catalytic%2520aspartyl%2520groups%2520have%2520different%2520ionization%2520states%2520in%2520the%2520complex%2520formed%2520with%2520the%2520asymmetric%2520drug%2520KNI-272%26jtitle%3DBiochemistry%26date%3D1996%26volume%3D35%26spage%3D9945%26epage%3D9950%26doi%3D10.1021%2Fbi961268z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaku, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisanuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukazawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terashima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nojima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enomoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakikawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shintani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, Y.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship of orally potent tripeptide-based HIV protease inhibitors containing hydroxymethylcarbonyl isostere</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1310</span>– <span class="NLM_lpage">1326</span>, <span class="refDoi"> DOI: 10.1248/cpb.48.1310</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1248%2Fcpb.48.1310" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2000&pages=1310-1326&author=T.+Mimotoauthor=N.+Hattoriauthor=H.+Takakuauthor=S.+Kisanukiauthor=T.+Fukazawaauthor=K.+Terashimaauthor=R.+Katoauthor=S.+Nojimaauthor=S.+Misawaauthor=T.+Uenoauthor=J.+Imaiauthor=H.+Enomotoauthor=S.+Tanakaauthor=H.+Sakikawaauthor=M.+Shintaniauthor=H.+Hayashiauthor=Y.+Kiso&title=Structure-activity+relationship+of+orally+potent+tripeptide-based+HIV+protease+inhibitors+containing+hydroxymethylcarbonyl+isostere&doi=10.1248%2Fcpb.48.1310"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1248%2Fcpb.48.1310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.48.1310%26sid%3Dliteratum%253Aachs%26aulast%3DMimoto%26aufirst%3DT.%26aulast%3DHattori%26aufirst%3DN.%26aulast%3DTakaku%26aufirst%3DH.%26aulast%3DKisanuki%26aufirst%3DS.%26aulast%3DFukazawa%26aufirst%3DT.%26aulast%3DTerashima%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DR.%26aulast%3DNojima%26aufirst%3DS.%26aulast%3DMisawa%26aufirst%3DS.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DImai%26aufirst%3DJ.%26aulast%3DEnomoto%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DSakikawa%26aufirst%3DH.%26aulast%3DShintani%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DH.%26aulast%3DKiso%26aufirst%3DY.%26atitle%3DStructure-activity%2520relationship%2520of%2520orally%2520potent%2520tripeptide-based%2520HIV%2520protease%2520inhibitors%2520containing%2520hydroxymethylcarbonyl%2520isostere%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2000%26volume%3D48%26spage%3D1310%26epage%3D1326%26doi%3D10.1248%2Fcpb.48.1310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaku, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nojima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terashima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukazawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shintani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, H.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship of small-sized HIV protease inhibitors containing allophenylnorstatine</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1789</span>– <span class="NLM_lpage">1802</span>, <span class="refDoi"> DOI: 10.1021/jm980637h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm980637h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1789-1802&author=T.+Mimotoauthor=R.+Katoauthor=H.+Takakuauthor=S.+Nojimaauthor=K.+Terashimaauthor=S.+Misawaauthor=T.+Fukazawaauthor=T.+Uenoauthor=H.+Satoauthor=M.+Shintaniauthor=Y.+Kisoauthor=H.+Hayashi&title=Structure-activity+relationship+of+small-sized+HIV+protease+inhibitors+containing+allophenylnorstatine&doi=10.1021%2Fjm980637h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm980637h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980637h%26sid%3Dliteratum%253Aachs%26aulast%3DMimoto%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DR.%26aulast%3DTakaku%26aufirst%3DH.%26aulast%3DNojima%26aufirst%3DS.%26aulast%3DTerashima%26aufirst%3DK.%26aulast%3DMisawa%26aufirst%3DS.%26aulast%3DFukazawa%26aufirst%3DT.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DShintani%26aufirst%3DM.%26aulast%3DKiso%26aufirst%3DY.%26aulast%3DHayashi%26aufirst%3DH.%26atitle%3DStructure-activity%2520relationship%2520of%2520small-sized%2520HIV%2520protease%2520inhibitors%2520containing%2520allophenylnorstatine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1789%26epage%3D1802%26doi%3D10.1021%2Fjm980637h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yusa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kavlick, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maroun, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shintani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falloon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masur, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span> <span> </span><span class="NLM_article-title">JE-2147: A dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">8675</span>– <span class="NLM_lpage">8680</span>, <span class="refDoi"> DOI: 10.1073/pnas.96.15.8675</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1073%2Fpnas.96.15.8675" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=8675-8680&author=K.+Yoshimuraauthor=R.+Katoauthor=K.+Yusaauthor=M.+F.+Kavlickauthor=V.+Marounauthor=A.+Nguyenauthor=T.+Mimotoauthor=T.+Uenoauthor=M.+Shintaniauthor=J.+Falloonauthor=H.+Masurauthor=H.+Hayashiauthor=J.+Ericksonauthor=H.+Mitsuya&title=JE-2147%3A+A+dipeptide+protease+inhibitor+%28PI%29+that+potently+inhibits+multi-PI-resistant+HIV-1&doi=10.1073%2Fpnas.96.15.8675"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.15.8675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.15.8675%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimura%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DR.%26aulast%3DYusa%26aufirst%3DK.%26aulast%3DKavlick%26aufirst%3DM.%2BF.%26aulast%3DMaroun%26aufirst%3DV.%26aulast%3DNguyen%26aufirst%3DA.%26aulast%3DMimoto%26aufirst%3DT.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DShintani%26aufirst%3DM.%26aulast%3DFalloon%26aufirst%3DJ.%26aulast%3DMasur%26aufirst%3DH.%26aulast%3DHayashi%26aufirst%3DH.%26aulast%3DErickson%26aufirst%3DJ.%26aulast%3DMitsuya%26aufirst%3DH.%26atitle%3DJE-2147%253A%2520A%2520dipeptide%2520protease%2520inhibitor%2520%2528PI%2529%2520that%2520potently%2520inhibits%2520multi-PI-resistant%2520HIV-1%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D8675%26epage%3D8680%26doi%3D10.1073%2Fpnas.96.15.8675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hidaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Rahman, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, J.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDaniel, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlbrenner, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempf, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, Y.</span></span> <span> </span><span class="NLM_article-title">Small-sized human immunodeficiency virus type-1 protease inhibitors containing allophenylnorstatine to explore the S<sub>2</sub>′ pocket</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7604</span>– <span class="NLM_lpage">7617</span>, <span class="refDoi"> DOI: 10.1021/jm9005115</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9005115" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7604-7617&author=K.+Hidakaauthor=T.+Kimuraauthor=H.+M.+Abdel-Rahmanauthor=J.-T.+Nguyenauthor=K.+F.+McDanielauthor=W.+E.+Kohlbrennerauthor=A.+Mollaauthor=M.+Adachiauthor=T.+Tamadaauthor=R.+Kurokiauthor=N.+Katsukiauthor=Y.+Tanakaauthor=H.+Matsumotoauthor=J.+Wangauthor=Y.+Hayashiauthor=D.+J.+Kempfauthor=Y.+Kiso&title=Small-sized+human+immunodeficiency+virus+type-1+protease+inhibitors+containing+allophenylnorstatine+to+explore+the+S2%E2%80%B2+pocket&doi=10.1021%2Fjm9005115"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm9005115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9005115%26sid%3Dliteratum%253Aachs%26aulast%3DHidaka%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DAbdel-Rahman%26aufirst%3DH.%2BM.%26aulast%3DNguyen%26aufirst%3DJ.-T.%26aulast%3DMcDaniel%26aufirst%3DK.%2BF.%26aulast%3DKohlbrenner%26aufirst%3DW.%2BE.%26aulast%3DMolla%26aufirst%3DA.%26aulast%3DAdachi%26aufirst%3DM.%26aulast%3DTamada%26aufirst%3DT.%26aulast%3DKuroki%26aufirst%3DR.%26aulast%3DKatsuki%26aufirst%3DN.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DMatsumoto%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DKempf%26aufirst%3DD.%2BJ.%26aulast%3DKiso%26aufirst%3DY.%26atitle%3DSmall-sized%2520human%2520immunodeficiency%2520virus%2520type-1%2520protease%2520inhibitors%2520containing%2520allophenylnorstatine%2520to%2520explore%2520the%2520S2%25E2%2580%25B2%2520pocket%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7604%26epage%3D7617%26doi%3D10.1021%2Fjm9005115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nojima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terashima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaku, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shintani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, H.</span></span> <span> </span><span class="NLM_article-title">Structure–activity relationships of novel HIV-1 protease inhibitors containing the 3-amino-2-chlorobenzoylallophenylnorstatine structure</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1299</span>– <span class="NLM_lpage">1308</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2007.10.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1016%2Fj.bmc.2007.10.062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=1299-1308&author=T.+Mimotoauthor=S.+Nojimaauthor=K.+Terashimaauthor=H.+Takakuauthor=M.+Shintaniauthor=H.+Hayashi&title=Structure%E2%80%93activity+relationships+of+novel+HIV-1+protease+inhibitors+containing+the+3-amino-2-chlorobenzoylallophenylnorstatine+structure&doi=10.1016%2Fj.bmc.2007.10.062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.10.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.10.062%26sid%3Dliteratum%253Aachs%26aulast%3DMimoto%26aufirst%3DT.%26aulast%3DNojima%26aufirst%3DS.%26aulast%3DTerashima%26aufirst%3DK.%26aulast%3DTakaku%26aufirst%3DH.%26aulast%3DShintani%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DH.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520novel%2520HIV-1%2520protease%2520inhibitors%2520containing%2520the%25203-amino-2-chlorobenzoylallophenylnorstatine%2520structure%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D1299%26epage%3D1308%26doi%3D10.1016%2Fj.bmc.2007.10.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takaku, H.</span>; <span class="NLM_string-name">Nojima, S.</span>; <span class="NLM_string-name">Mimoto, T.</span>; <span class="NLM_string-name">Terashima, K.</span></span> <span> </span><span class="NLM_article-title">Nobel Tripeptide Compounds and Anti-AIDS Drugs</span>. PCT Int. Appl. <span class="NLM_patent">WO 98/29118</span>, <span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=H.+Takaku&author=S.+Nojima&author=T.+Mimoto&author=K.+Terashima&title=Nobel+Tripeptide+Compounds+and+Anti-AIDS+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTakaku%26aufirst%3DH.%26atitle%3DNobel%2520Tripeptide%2520Compounds%2520and%2520Anti-AIDS%2520Drugs%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J. W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duong, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munson, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wai, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darke, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zugay, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emini, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleif, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huff, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, P. S.</span></span> <span> </span><span class="NLM_article-title">Potent HIV protease inhibitors: The development of tetrahydrofuranylglycines as novel P2-Ligands and pyrazine amides as P3-Ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">2300</span>– <span class="NLM_lpage">2310</span>, <span class="refDoi"> DOI: 10.1021/jm00068a006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00068a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADyaK3sXmtVegtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=2300-2310&author=A.+K.+Ghoshauthor=J.+W.+J.+Thompsonauthor=M.+K.+Hollowayauthor=S.+P.+McKeeauthor=T.+T.+Duongauthor=H.+Y.+Leeauthor=P.+M.+Munsonauthor=A.+M.+Smithauthor=J.+M.+Waiauthor=P.+L.+Darkeauthor=J.+A.+Zugayauthor=E.+A.+Eminiauthor=W.+A.+Schleifauthor=J.+R.+Huffauthor=P.+S.+Anderson&title=Potent+HIV+protease+inhibitors%3A+The+development+of+tetrahydrofuranylglycines+as+novel+P2-Ligands+and+pyrazine+amides+as+P3-Ligands&doi=10.1021%2Fjm00068a006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Potent HIV protease inhibitors: the development of tetrahydrofuranylglycines as novel P2-ligands and pyrazine amides as P3-ligands</span></div><div class="casAuthors">Ghosh, Arun K.; Thompson, Wayne J.; Holloway, M. Katharine; McKee, Sean P.; Duong, Tien T.; Lee, Hee Yoon; Munson, Peter M.; Smith, Anthony M.; Wai, Jenny M.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2300-10</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A series of protease inhibitors bearing constrained unnatural amino acids at the P2-position and novel heterocycles at the P3-position of compd. I (R = R1; Ro 31-8959) were synthesized, and their in vitro enzyme inhibitory and antiviral activities were evaluated.  Replacement of P2-asparagine of compd. I (R = R1) with (2S,3'R)-tetrahydrofuranylglycine resulted in improvement in enzyme inhibitory as well as antiviral potencies (compd. I; R = R2).  Interestingly, incorporation of (2S,3'S)-tetrahydrofuranylglycine at the P2-position proved to be less effective.  The resulting compd. I (R = R3) was 100-fold less potent than the 2S,3R-isomer (compd. I; R = R2).  This stereochem. preference indicated a hydrogen-bonding interaction between the tetrahydrofuranyl oxygen and the residues of the S2-region of the enzyme active site.  Furthermore, replacement of P3-quinolinoyl ligand of I (R = R1) with various novel heterocycles resulted in potent inhibitors of HIV proteases.  Of particular interest, compd. I (R = R4) with (2S,3'R)-tetrahydrofuranylglycine at P2 and pyrazine deriv. at P3 is one of the most potent inhibitors of HIV-1 (IC50 value 0.07 nM) and HIV-2 (IC50 value 0.18 nM) proteases.  Another important result in this series is the identification of compd. I (R = R5) in which the P2-P3-amide carbonyl has been removed.  The resulting compd. I (R = R5) has exhibited improvement in antiviral potency while retaining the enzyme inhibitory potency similar to compd. I (R = R1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3S-nIFldFzLVg90H21EOLACvtfcHk0lh2EtJURO08og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmtVegtbs%253D&md5=63f60b2efd113d4f2f51d869b4a4970b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm00068a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00068a006%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DThompson%26aufirst%3DJ.%2BW.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DMcKee%26aufirst%3DS.%2BP.%26aulast%3DDuong%26aufirst%3DT.%2BT.%26aulast%3DLee%26aufirst%3DH.%2BY.%26aulast%3DMunson%26aufirst%3DP.%2BM.%26aulast%3DSmith%26aufirst%3DA.%2BM.%26aulast%3DWai%26aufirst%3DJ.%2BM.%26aulast%3DDarke%26aufirst%3DP.%2BL.%26aulast%3DZugay%26aufirst%3DJ.%2BA.%26aulast%3DEmini%26aufirst%3DE.%2BA.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26aulast%3DAnderson%26aufirst%3DP.%2BS.%26atitle%3DPotent%2520HIV%2520protease%2520inhibitors%253A%2520The%2520development%2520of%2520tetrahydrofuranylglycines%2520as%2520novel%2520P2-Ligands%2520and%2520pyrazine%2520amides%2520as%2520P3-Ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D2300%26epage%3D2310%26doi%3D10.1021%2Fjm00068a006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murcko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navia, M. A.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of HIV-1 protease in complex with VX-478, a potent and orally bioavailable inhibitor of the enzyme</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">1181</span>– <span class="NLM_lpage">1182</span>, <span class="refDoi"> DOI: 10.1021/ja00108a056</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00108a056" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADyaK2MXjtVyqtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1995&pages=1181-1182&author=E.+E.+Kimauthor=C.+T.+Bakerauthor=M.+D.+Dwyerauthor=M.+A.+Murckoauthor=B.+G.+Raoauthor=R.+D.+Tungauthor=M.+A.+Navia&title=Crystal+structure+of+HIV-1+protease+in+complex+with+VX-478%2C+a+potent+and+orally+bioavailable+inhibitor+of+the+enzyme&doi=10.1021%2Fja00108a056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of HIV-1 protease in complex with VX-478, a potent and orally bioavailable inhibitor of the enzyme</span></div><div class="casAuthors">Kim, E. E.; Baker, C. T.; Dwyer, M. D.; Murcko, M. A.; Rao, B. G.; Tung, R. D.; Navia, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1181-2</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">VX-478 [3(S)-N-(3-tetrahydrofuranyloxycarbonyl)amino-1-(N,N-isobutyl-4-aminobenzenesulfonyl)amino-2-(S)-hydroxy-4-phenylbutane; C25H35N3O6S] is a potent, low-mol.-wt., orally bioavailable HIV-1 aspartic protease (retropepsin) inhibitor that is currently an advanced preclin. development candidate as a therapeutic agent against AIDS.  The crystal structure of the retropepsin-inhibitor complex, refined at 1.9 Å resoln. (R-value = 0.196), shows strong H-bonding of VX-478 to both the flap water and the catalytic Asp residues of the enzyme.  VX-478 emerged from a focused program of structure-based drug design that sought to reduce inhibitor size, an empirical goal established from an anal. of the mol. wt. distribution of all marketed oral and systemic drugs, while maintaining subnanomolar in vitro inhibitory potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNakjyopslwrVg90H21EOLACvtfcHk0lh2EtJURO08og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjtVyqtbo%253D&md5=7f32ba2d24ded71137a2d80f24b93ede</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fja00108a056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00108a056%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DE.%2BE.%26aulast%3DBaker%26aufirst%3DC.%2BT.%26aulast%3DDwyer%26aufirst%3DM.%2BD.%26aulast%3DMurcko%26aufirst%3DM.%2BA.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DNavia%26aufirst%3DM.%2BA.%26atitle%3DCrystal%2520structure%2520of%2520HIV-1%2520protease%2520in%2520complex%2520with%2520VX-478%252C%2520a%2520potent%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520the%2520enzyme%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1995%26volume%3D117%26spage%3D1181%26epage%3D1182%26doi%3D10.1021%2Fja00108a056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span> <span> </span><span class="NLM_article-title">Enhancing protein backbone binding—A fruitful concept for combating drug-resistant HIV</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1778</span>– <span class="NLM_lpage">1802</span>, <span class="refDoi"> DOI: 10.1002/anie.201102762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1002%2Fanie.201102762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVOru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=1778-1802&author=A.+K.+Ghoshauthor=D.+D.+Andersonauthor=I.+T.+Weberauthor=H.+Mitsuya&title=Enhancing+protein+backbone+binding%E2%80%94A+fruitful+concept+for+combating+drug-resistant+HIV&doi=10.1002%2Fanie.201102762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancing Protein Backbone Binding-A Fruitful Concept for Combating Drug-Resistant HIV</span></div><div class="casAuthors">Ghosh, Arun K.; Anderson, David D.; Weber, Irene T.; Mitsuya, Hiroaki</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1778-1802</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The evolution of drug resistance is one of the most fundamental problems in medicine.  In HIV/AIDS, the rapid emergence of drug-resistant HIV-1 variants is a major obstacle to current treatments.  HIV-1 protease inhibitors are essential components of present antiretroviral therapies.  However, with these protease inhibitors, resistance occurs through viral mutations that alter inhibitor binding, resulting in a loss of efficacy.  This loss of potency has raised serious questions with regard to effective long-term antiretroviral therapy for HIV/AIDS.  In this context, our research has focused on designing inhibitors that form extensive hydrogen-bonding interactions with the enzyme's backbone in the active site.  In doing so, we limit the protease's ability to acquire drug resistance as the geometry of the catalytic site must be conserved to maintain functionality.  In this Review, we examine the underlying principles of enzyme structure that support our backbone-binding concept as an effective means to combat drug resistance and highlight their application in our recent work on antiviral HIV-1 protease inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7UjK1GY9jV7Vg90H21EOLACvtfcHk0lj12kE__KzD6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVOru7k%253D&md5=0751c1ccc5d043f76fe53f7470e7b47e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fanie.201102762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201102762%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DAnderson%26aufirst%3DD.%2BD.%26aulast%3DWeber%26aufirst%3DI.%2BT.%26aulast%3DMitsuya%26aufirst%3DH.%26atitle%3DEnhancing%2520protein%2520backbone%2520binding%25E2%2580%2594A%2520fruitful%2520concept%2520for%2520combating%2520drug-resistant%2520HIV%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D1778%26epage%3D1802%26doi%3D10.1002%2Fanie.201102762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munson, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwering, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darke, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zugay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emini, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleif, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huff, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, P. S.</span></span> <span> </span><span class="NLM_article-title">3′-Tetrahydrofuranylglycine as a novel, unnatural amino acid surrogate for asparagine in the design of inhibitors of the HIV protease</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">801</span>– <span class="NLM_lpage">803</span>, <span class="refDoi"> DOI: 10.1021/ja00055a069</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00055a069" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADyaK3sXht1Gjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=1993&pages=801-803&author=W.+J.+Thompsonauthor=A.+K.+Ghoshauthor=M.+K.+Hollowayauthor=H.+Y.+Leeauthor=P.+M.+Munsonauthor=J.+E.+Schweringauthor=J.+Waiauthor=P.+L.+Darkeauthor=J.+Zugayauthor=E.+A.+Eminiauthor=W.+A.+Schleifauthor=J.+R.+Huffauthor=P.+S.+Anderson&title=3%E2%80%B2-Tetrahydrofuranylglycine+as+a+novel%2C+unnatural+amino+acid+surrogate+for+asparagine+in+the+design+of+inhibitors+of+the+HIV+protease&doi=10.1021%2Fja00055a069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">3'-Tetrahydrofuranylglycine as a novel, unnatural amino acid surrogate for asparagine in the design of inhibitors of the HIV protease</span></div><div class="casAuthors">Thompson, Wayne J.; Ghosh, Arun K.; Holloway, M. Katharine; Lee, Hee Yoon; Munson, Peter M.; Schwering, John E.; Wai, Jenny; Darke, Paul L.; Zugay, Joan; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">801-3</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The stereoselective synthesis of the novel amino acids (3'R)- and (3'S)-tetrahydrofuranylglycine are reported.  When incorporated into hydroxyethylamine transition state isostere I [R = (R)- and (S)-tetrahydrofuryl], substantial improvements in the inhibitory activities against HIV-1 and HIV-2 protease were obsd. relative to asparagine analog I (R = CH2CONH2) (Ro 31-8959).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpERQ0X4xRhbVg90H21EOLACvtfcHk0lj12kE__KzD6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXht1Gjsbs%253D&md5=ea089d154011286bb01975430f67e6ef</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fja00055a069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00055a069%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DW.%2BJ.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DLee%26aufirst%3DH.%2BY.%26aulast%3DMunson%26aufirst%3DP.%2BM.%26aulast%3DSchwering%26aufirst%3DJ.%2BE.%26aulast%3DWai%26aufirst%3DJ.%26aulast%3DDarke%26aufirst%3DP.%2BL.%26aulast%3DZugay%26aufirst%3DJ.%26aulast%3DEmini%26aufirst%3DE.%2BA.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26aulast%3DAnderson%26aufirst%3DP.%2BS.%26atitle%3D3%25E2%2580%25B2-Tetrahydrofuranylglycine%2520as%2520a%2520novel%252C%2520unnatural%2520amino%2520acid%2520surrogate%2520for%2520asparagine%2520in%2520the%2520design%2520of%2520inhibitors%2520of%2520the%2520HIV%2520protease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1993%26volume%3D115%26spage%3D801%26epage%3D803%26doi%3D10.1021%2Fja00055a069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nezami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hidaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freire, E.</span></span> <span> </span><span class="NLM_article-title">High affinity inhibition of a family of <i>Plasmodium falciparum</i> proteases by a designed adaptive inhibitor</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">8459</span>– <span class="NLM_lpage">8464</span>, <span class="refDoi"> DOI: 10.1021/bi034131z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi034131z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=8459-8464&author=A.+Nezamiauthor=T.+Kimuraauthor=K.+Hidakaauthor=A.+Kisoauthor=J.+Liuauthor=Y.+Kisoauthor=D.+E.+Goldbergauthor=E.+Freire&title=High+affinity+inhibition+of+a+family+of+Plasmodium+falciparum+proteases+by+a+designed+adaptive+inhibitor&doi=10.1021%2Fbi034131z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fbi034131z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi034131z%26sid%3Dliteratum%253Aachs%26aulast%3DNezami%26aufirst%3DA.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DHidaka%26aufirst%3DK.%26aulast%3DKiso%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DKiso%26aufirst%3DY.%26aulast%3DGoldberg%26aufirst%3DD.%2BE.%26aulast%3DFreire%26aufirst%3DE.%26atitle%3DHigh%2520affinity%2520inhibition%2520of%2520a%2520family%2520of%2520Plasmodium%2520falciparum%2520proteases%2520by%2520a%2520designed%2520adaptive%2520inhibitor%26jtitle%3DBiochemistry%26date%3D2003%26volume%3D42%26spage%3D8459%26epage%3D8464%26doi%3D10.1021%2Fbi034131z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyama, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hidaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kameoka, M.</span></span> <span> </span><span class="NLM_article-title">Evaluation of novel protease inhibitors against darunavir-resistant variants of HIV type 1</span>. <i>FEBS Open Bio</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1002/2211-5463.12160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1002%2F2211-5463.12160" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=88-95&author=M.+Inoueauthor=D.+Oyamaauthor=K.+Hidakaauthor=M.+Kameoka&title=Evaluation+of+novel+protease+inhibitors+against+darunavir-resistant+variants+of+HIV+type+1&doi=10.1002%2F2211-5463.12160"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2F2211-5463.12160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F2211-5463.12160%26sid%3Dliteratum%253Aachs%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DOyama%26aufirst%3DD.%26aulast%3DHidaka%26aufirst%3DK.%26aulast%3DKameoka%26aufirst%3DM.%26atitle%3DEvaluation%2520of%2520novel%2520protease%2520inhibitors%2520against%2520darunavir-resistant%2520variants%2520of%2520HIV%2520type%25201%26jtitle%3DFEBS%2520Open%2520Bio%26date%3D2017%26volume%3D7%26spage%3D88%26epage%3D95%26doi%3D10.1002%2F2211-5463.12160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dekhtyar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGoey, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flosi, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grampovnik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempf, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molla, A.</span></span> <span> </span><span class="NLM_article-title">Characterization of a novel human immunodeficiency virus type 1 protease inhibitor, A-790742</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1337</span>– <span class="NLM_lpage">1344</span>, <span class="refDoi"> DOI: 10.1128/AAC.01132-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1128%2FAAC.01132-07" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=1337-1344&author=T.+Dekhtyarauthor=T.+I.+Ngauthor=L.+Luauthor=S.+Masseauthor=D.+A.+DeGoeyauthor=W.+J.+Flosiauthor=D.+J.+Grampovnikauthor=L.+L.+Kleinauthor=D.+J.+Kempfauthor=A.+Molla&title=Characterization+of+a+novel+human+immunodeficiency+virus+type+1+protease+inhibitor%2C+A-790742&doi=10.1128%2FAAC.01132-07"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1128%2FAAC.01132-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01132-07%26sid%3Dliteratum%253Aachs%26aulast%3DDekhtyar%26aufirst%3DT.%26aulast%3DNg%26aufirst%3DT.%2BI.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DMasse%26aufirst%3DS.%26aulast%3DDeGoey%26aufirst%3DD.%2BA.%26aulast%3DFlosi%26aufirst%3DW.%2BJ.%26aulast%3DGrampovnik%26aufirst%3DD.%2BJ.%26aulast%3DKlein%26aufirst%3DL.%2BL.%26aulast%3DKempf%26aufirst%3DD.%2BJ.%26aulast%3DMolla%26aufirst%3DA.%26atitle%3DCharacterization%2520of%2520a%2520novel%2520human%2520immunodeficiency%2520virus%2520type%25201%2520protease%2520inhibitor%252C%2520A-790742%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D1337%26epage%3D1344%26doi%3D10.1128%2FAAC.01132-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fouchier, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malim, M. H.</span></span> <span> </span><span class="NLM_article-title">HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">4531</span>– <span class="NLM_lpage">4539</span>, <span class="refDoi"> DOI: 10.1093/emboj/16.15.4531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1093%2Femboj%2F16.15.4531" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=4531-4539&author=R.+A.+Fouchierauthor=B.+E.+Meyerauthor=J.+H.+Simonauthor=U.+Fischerauthor=M.+H.+Malim&title=HIV-1+infection+of+non-dividing+cells%3A+evidence+that+the+amino-terminal+basic+region+of+the+viral+matrix+protein+is+important+for+Gag+processing+but+not+for+post-entry+nuclear+import&doi=10.1093%2Femboj%2F16.15.4531"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F16.15.4531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F16.15.4531%26sid%3Dliteratum%253Aachs%26aulast%3DFouchier%26aufirst%3DR.%2BA.%26aulast%3DMeyer%26aufirst%3DB.%2BE.%26aulast%3DSimon%26aufirst%3DJ.%2BH.%26aulast%3DFischer%26aufirst%3DU.%26aulast%3DMalim%26aufirst%3DM.%2BH.%26atitle%3DHIV-1%2520infection%2520of%2520non-dividing%2520cells%253A%2520evidence%2520that%2520the%2520amino-terminal%2520basic%2520region%2520of%2520the%2520viral%2520matrix%2520protein%2520is%2520important%2520for%2520Gag%2520processing%2520but%2520not%2520for%2520post-entry%2520nuclear%2520import%26jtitle%3DEMBO%2520J.%26date%3D1997%26volume%3D16%26spage%3D4531%26epage%3D4539%26doi%3D10.1093%2Femboj%2F16.15.4531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Otwinowski, Z.</span>; <span class="NLM_string-name">Minor, W.</span></span> <span> </span><span class="NLM_article-title">Processing of X-Ray Diffraction Data Collected in Oscillation Mode</span>. In  <i>Methods in Enzymology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, C. W.,  Jr</span>, <span class="NLM_string-name">Sweet, R. M.</span></span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">1997</span>; Vol.  <span class="NLM_volume">276</span>, pp  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">326</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=307-326&author=Z.+Otwinowski&author=W.+Minorauthor=C.+W.+Carter&author=R.+M.+Sweet&title=Methods+in+Enzymology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26atitle%3DProcessing%2520of%2520X-Ray%2520Diffraction%2520Data%2520Collected%2520in%2520Oscillation%2520Mode%26btitle%3DMethods%2520in%2520Enzymology%26aulast%3DCarter%26aufirst%3DC.%2BW.%26pub%3DAcademic%2520Press%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span>; <span class="NLM_string-name">Schneider, T. R.</span></span> <span> </span><span class="NLM_article-title">SHELXL: High-resolution refinement</span>. In  <i>Methods in Enzymology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, C. W.,  Jr</span>, <span class="NLM_string-name">Sweet, R. M.</span></span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">1997</span>; Vol.  <span class="NLM_volume">277</span>, pp  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">343</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=319-343&author=G.+M.+Sheldrick&author=T.+R.+Schneiderauthor=C.+W.+Carter&author=R.+M.+Sweet&title=Methods+in+Enzymology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DSHELXL%253A%2520High-resolution%2520refinement%26btitle%3DMethods%2520in%2520Enzymology%26aulast%3DCarter%26aufirst%3DC.%2BW.%26pub%3DAcademic%2520Press%26date%3D1997%26volume%3D277%26spage%3D319%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E. J.</span></span> <span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1107/S0907444996012255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=15299926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method&doi=10.1107%2FS0907444996012255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0ljSQIxAaS6dkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26spage%3D240%26epage%3D255%26doi%3D10.1107%2FS0907444996012255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustyakimov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urzhumtsev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span> <span> </span><span class="NLM_article-title">Towards automated crystallographic structure refinement with <i>phenix.refine</i></span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">352</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1107/S0907444912001308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1107%2FS0907444912001308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=22505256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1Ggu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=352-367&author=P.+V.+Afonineauthor=R.+W.+Grosse-Kunstleveauthor=N.+Echolsauthor=J.+J.+Headdauthor=N.+W.+Moriartyauthor=M.+Mustyakimovauthor=T.+C.+Terwilligerauthor=A.+Urzhumtsevauthor=P.+H.+Zwartauthor=P.+D.+Adams&title=Towards+automated+crystallographic+structure+refinement+with+phenix.refine&doi=10.1107%2FS0907444912001308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Towards automated crystallographic structure refinement with phenix.refine</span></div><div class="casAuthors">Afonine, Pavel V.; Grosse-Kunstleve, Ralf W.; Echols, Nathaniel; Headd, Jeffrey J.; Moriarty, Nigel W.; Mustyakimov, Marat; Terwilliger, Thomas C.; Urzhumtsev, Alexandre; Zwart, Peter H.; Adams, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">352-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phenix.refine is a program within the PHENIX package that supports crystallog. structure refinement against exptl. data with a wide range of upper resoln. limits using a large repertoire of model parameterizations.  It has several automation features and is also highly flexible.  Several hundred parameters enable extensive customizations for complex use cases.  Multiple user-defined refinement strategies can be applied to specific parts of the model in a single refinement run.  An intuitive graphical user interface is available to guide novice users and to assist advanced users in managing refinement projects.  X-ray or neutron diffraction data can be used sep. or jointly in refinement. phenix.refine is tightly integrated into the PHENIX suite, where it serves as a crit. component in automated model building, final structure refinement, structure validation and deposition to the wwPDB.  This paper presents an overview of the major phenix.refine features, with extensive literature refs. for readers interested in more detailed discussions of the methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnhn9QwIEkTbVg90H21EOLACvtfcHk0ljWjLAOR6czgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1Ggu7c%253D&md5=1cc7da2cea396f1a75646ea709140cf1</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1107%2FS0907444912001308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444912001308%26sid%3Dliteratum%253Aachs%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DMustyakimov%26aufirst%3DM.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DUrzhumtsev%26aufirst%3DA.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26atitle%3DTowards%2520automated%2520crystallographic%2520structure%2520refinement%2520with%2520phenix.refine%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2012%26volume%3D68%26spage%3D352%26epage%3D367%26doi%3D10.1107%2FS0907444912001308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 7 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jingzhe Cao, <span class="NLM_string-name hlFld-ContribAuthor">Todd K. Hyster</span>. </span><span class="cited-content_cbyCitation_article-title">Pyridoxal-Catalyzed Racemization of α-Aminoketones Enables the Stereodivergent Synthesis of 1,2-Amino Alcohols Using Ketoreductases. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2020,</strong> <em>10 </em>
                                    (11)
                                     , 6171-6175. <a href="https://doi.org/10.1021/acscatal.0c01502" title="DOI URL">https://doi.org/10.1021/acscatal.0c01502</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.0c01502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.0c01502%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DPyridoxal-Catalyzed%252BRacemization%252Bof%252B%2525CE%2525B1-Aminoketones%252BEnables%252Bthe%252BStereodivergent%252BSynthesis%252Bof%252B1%25252C2-Amino%252BAlcohols%252BUsing%252BKetoreductases%26aulast%3DCao%26aufirst%3DJingzhe%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D01042020%26date%3D07052020%26date%3D15052020%26date%3D11052020%26volume%3D10%26issue%3D11%26spage%3D6171%26epage%3D6175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Aswathy
N. Muttathukattil, Sriraksha Srinivasan, Antarip Halder, <span class="NLM_string-name hlFld-ContribAuthor">Govardhan Reddy</span>. </span><span class="cited-content_cbyCitation_article-title">Role of Guanidinium-Carboxylate Ion Interaction in Enzyme Inhibition with Implications for Drug Design. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry B</span><span> <strong>2019,</strong> <em>123 </em>
                                    (44)
                                     , 9302-9311. <a href="https://doi.org/10.1021/acs.jpcb.9b06130" title="DOI URL">https://doi.org/10.1021/acs.jpcb.9b06130</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jpcb.9b06130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jpcb.9b06130%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520B%26atitle%3DRole%252Bof%252BGuanidinium-Carboxylate%252BIon%252BInteraction%252Bin%252BEnzyme%252BInhibition%252Bwith%252BImplications%252Bfor%252BDrug%252BDesign%26aulast%3DMuttathukattil%26aufirst%3DAswathy%2BN.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D27062019%26date%3D18092019%26date%3D24102019%26date%3D09102019%26volume%3D123%26issue%3D44%26spage%3D9302%26epage%3D9311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrzej S.  Skwarecki</span>, <span class="hlFld-ContribAuthor ">Michał G.  Nowak</span>, <span class="hlFld-ContribAuthor ">Maria J.  Milewska</span>. </span><span class="cited-content_cbyCitation_article-title">Amino Acid and Peptide‐Based Antiviral Agents. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>145 </em><a href="https://doi.org/10.1002/cmdc.202100397" title="DOI URL">https://doi.org/10.1002/cmdc.202100397</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100397%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DAmino%252BAcid%252Band%252BPeptide%2525E2%252580%252590Based%252BAntiviral%252BAgents%26aulast%3DSkwarecki%26aufirst%3DAndrzej%2BS.%26date%3D2021%26date%3D2021%26volume%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saira  Hussain</span>, <span class="hlFld-ContribAuthor ">Ata ur  Rehman</span>, <span class="hlFld-ContribAuthor ">David J.  Luckett</span>, <span class="hlFld-ContribAuthor ">Syed Muhammad Saqlan  Naqvi</span>, <span class="hlFld-ContribAuthor ">Christopher L.  Blanchard</span>. </span><span class="cited-content_cbyCitation_article-title">Protease Inhibitors Purified from the Canola Meal Extracts of Two Genetically Diverse Genotypes Exhibit Antidiabetic and Antihypertension Properties. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (7)
                                     , 2078. <a href="https://doi.org/10.3390/molecules26072078" title="DOI URL">https://doi.org/10.3390/molecules26072078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26072078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26072078%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DProtease%252BInhibitors%252BPurified%252Bfrom%252Bthe%252BCanola%252BMeal%252BExtracts%252Bof%252BTwo%252BGenetically%252BDiverse%252BGenotypes%252BExhibit%252BAntidiabetic%252Band%252BAntihypertension%252BProperties%26aulast%3DHussain%26aufirst%3DSaira%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D7%26spage%3D2078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José-Manuel  Gally</span>, <span class="hlFld-ContribAuthor ">Stéphane  Bourg</span>, <span class="hlFld-ContribAuthor ">Jade  Fogha</span>, <span class="hlFld-ContribAuthor ">Quoc-Tuan  Do</span>, <span class="hlFld-ContribAuthor ">Samia  Aci-Sèche</span>, <span class="hlFld-ContribAuthor ">Pascal  Bonnet</span>. </span><span class="cited-content_cbyCitation_article-title">VSPrep: A KNIME Workflow for the Preparation of Molecular Databases for Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2020,</strong> <em>27 </em>
                                    (38)
                                     , 6480-6494. <a href="https://doi.org/10.2174/0929867326666190614160451" title="DOI URL">https://doi.org/10.2174/0929867326666190614160451</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867326666190614160451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867326666190614160451%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DVSPrep%25253A%252BA%252BKNIME%252BWorkflow%252Bfor%252Bthe%252BPreparation%252Bof%252BMolecular%252BDatabases%252Bfor%252BVirtual%252BScreening%26aulast%3DGally%26aufirst%3DJos%25C3%25A9-Manuel%26date%3D2020%26volume%3D27%26issue%3D38%26spage%3D6480%26epage%3D6494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nusrat  Sahiba</span>, <span class="hlFld-ContribAuthor ">Ayushi  Sethiya</span>, <span class="hlFld-ContribAuthor ">Jay  Soni</span>, <span class="hlFld-ContribAuthor ">Dinesh K.  Agarwal</span>, <span class="hlFld-ContribAuthor ">Shikha  Agarwal</span>. </span><span class="cited-content_cbyCitation_article-title">Saturated Five-Membered Thiazolidines and Their Derivatives: From Synthesis to Biological Applications. </span><span class="cited-content_cbyCitation_journal-name">Topics in Current Chemistry</span><span> <strong>2020,</strong> <em>378 </em>
                                    (2)
                                     <a href="https://doi.org/10.1007/s41061-020-0298-4" title="DOI URL">https://doi.org/10.1007/s41061-020-0298-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s41061-020-0298-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs41061-020-0298-4%26sid%3Dliteratum%253Aachs%26jtitle%3DTopics%2520in%2520Current%2520Chemistry%26atitle%3DSaturated%252BFive-Membered%252BThiazolidines%252Band%252BTheir%252BDerivatives%25253A%252BFrom%252BSynthesis%252Bto%252BBiological%252BApplications%26aulast%3DSahiba%26aufirst%3DNusrat%26date%3D2020%26date%3D2020%26volume%3D378%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">János András  Mótyán</span>, <span class="hlFld-ContribAuthor ">Márió  Miczi</span>, <span class="hlFld-ContribAuthor ">József  Tőzsér</span>. </span><span class="cited-content_cbyCitation_article-title">Dimer Interface Organization is a Main Determinant of Intermonomeric Interactions and Correlates with Evolutionary Relationships of Retroviral and Retroviral-Like Ddi1 and Ddi2 Proteases. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (4)
                                     , 1352. <a href="https://doi.org/10.3390/ijms21041352" title="DOI URL">https://doi.org/10.3390/ijms21041352</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21041352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21041352%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDimer%252BInterface%252BOrganization%252Bis%252Ba%252BMain%252BDeterminant%252Bof%252BIntermonomeric%252BInteractions%252Band%252BCorrelates%252Bwith%252BEvolutionary%252BRelationships%252Bof%252BRetroviral%252Band%252BRetroviral-Like%252BDdi1%252Band%252BDdi2%252BProteases%26aulast%3DM%25C3%25B3ty%25C3%25A1n%26aufirst%3DJ%25C3%25A1nos%2BAndr%25C3%25A1s%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D4%26spage%3D1352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01709&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Allophenylnorstatine-containing HIV protease inhibitors <b>1</b> and <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01709&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Incorporation of Thfg at the P<sub>2</sub> residue and the corresponding binding subsites.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01709&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01709&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, −10 °C, 2 h; (b) NaH, CH<sub>2</sub>(CO<sub>2</sub>Et)<sub>2</sub>, DMF, reflux, 20 h; (c) 1 M NaOH aq., 40 °C, 72 h then H<sub>3</sub>O<sup>+</sup>; (d) Cu<sub>2</sub>O, CH<sub>3</sub>CN, 80 °C, 12 h; (e) Me<sub>3</sub>COCl, Et<sub>3</sub>N, THF, −78 °C then <i>N</i>-lithio-(<i>S</i>)-(−)-4-benzyloxazolidine, 2 h; (f) KN(TMS)<sub>2</sub>, THF, −78 °C, 30 min then trisyl azide, −78 °C, 2 min then AcOH, 35 °C, 1 h; (g) SnCl<sub>2</sub>, EtOH, 0 °C, 3.5 h; (h) (Boc)<sub>2</sub>O, NaHCO<sub>3</sub> aq., dioxane, rt, 19 h; (i) LiOH, THF–H<sub>2</sub>O, rt, 2.5 h.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01709&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 4 M-HCl/dioxane, anisole, rt, 15–60 min; (b) <b>9</b>, EDC·HCl, HOBt, Et<sub>3</sub>N, DMF, rt, 14 h; (c) 2-quinolinecarboxylic acid or 2-quinoxalinecarboxylic acid, BOP, Et<sub>3</sub>N, DMF, rt, 14–19 h, then RP-HPLC purification; (d) <b>12</b>, EDC·HCl, HOBt, Et<sub>3</sub>N, DMF, rt, 13 h, then RP-HPLC purification; (e) 5% Pd(OH)<sub>2</sub>, EtOH-THF, rt, 10 h; (f) 7-isoquinolinyloxyacetic acid, BOP, HOBt, Et<sub>3</sub>N, DMF, rt, 14 h, then RP-HPLC purification.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01709&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 4 N HCl/dioxane, anisole, rt, 15–30 min; (b) <b>9</b>, EDC·HCl, HOBt, Et<sub>3</sub>N, DMF, rt, 21 h; (d) carboxylic acid derivatives, BOP, Et<sub>3</sub>N, DMF, rt, 12–40 h, then RP-HPLC purification.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0008.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01709&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 4 N HCl/dioxane, anisole, rt, 15–60 min for <b>a</b>, <b>b</b>, <b>c</b>, <b>f</b> or 2–5 min for <b>d</b>, <b>e</b>; (b) <b>9</b>, EDC·HCl, HOBt, Et<sub>3</sub>N, DMF, rt, 13–21 h; (d) (3-dimethylamino)phenoxyacetic acid, BOP, Et<sub>3</sub>N, DMF, rt, 13–23 h, then RP-HPLC purification.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0009.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01709&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 4 N HCl/dioxane, anisole, rt, 30 min; (b) Boc-Val-OH or Boc-Asn-OH, EDC·HCl, HOBt, Et<sub>3</sub>N, DMF, rt, 14–15 h; (d) benzofuran-2-carboxylic acid or 7-methoxybenzofuran-2-carboxylic acid, BOP, Et<sub>3</sub>N, DMF, rt, 14–15 h, and prep. HPLC.</p></p></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure for <b>21f</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01709&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/medium/jm-2017-01709a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray crystal structures of <b>21f</b> bound to wild-type (PDB ID, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5YOK">5YOK</a>) and lopinavir-resistant (PDB ID, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5YOJ">5YOJ</a>) proteases. (a) Hydrogen bond interactions in the active sites of wild-type HIV-1 protease. (b) Superimposition of cocrystals complexed with WTm5 (green) and A17m5 (red). Side chains of the mutated residues in the S2/S2′ pockets were presented with molecular surfaces. Figures were generated using <i>PyMOL</i> (Schrödinger LLC, OR, SA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01709/20180622/images/large/jm-2017-01709a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01709&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i56">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10223" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10223" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 36 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span>US Department
of Health and Human Services panel on antiretroviral guidelines for
adults and adolescents. Guidelines for the use of antiretroviral agents
in HIV-1-infected adults and adolescents. <a href="https://aidsinfo.nih.gov/guidelines" class="extLink">https://aidsinfo.nih.gov/guidelines</a> (accessed on Dec 27, <span class="NLM_year">2016</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=US+Department%0Aof+Health+and+Human+Services+panel+on+antiretroviral+guidelines+for%0Aadults+and+adolescents.+Guidelines+for+the+use+of+antiretroviral+agents%0Ain+HIV-1-infected+adults+and+adolescents.+https%3A%2F%2Faidsinfo.nih.gov%2Fguidelines+%28accessed+on+Dec+27%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armour, D.</span></span> <span> </span><span class="NLM_article-title">The discovery of the CCR5 receptor antagonist, UK-427,857, a new agent for the treatment of HIV infection and AIDS</span>. <i>Prog. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">271</span>, <span class="refDoi"> DOI: 10.1016/S0079-6468(05)43007-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1016%2FS0079-6468%2805%2943007-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=15850827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADC%252BD2MXps1Citbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2005&pages=239-271&author=A.+Woodauthor=D.+Armour&title=The+discovery+of+the+CCR5+receptor+antagonist%2C+UK-427%2C857%2C+a+new+agent+for+the+treatment+of+HIV+infection+and+AIDS&doi=10.1016%2FS0079-6468%2805%2943007-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of the CCR5 receptor antagonist, UK-427,857, a new agent for the treatment of HIV infection and AIDS</span></div><div class="casAuthors">Wood, Anthony; Armour, Duncan</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">239-271</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The drug discovery program that led to the identification of UK-427,857, a prototype CCR5 antagonist with excellent potency against lab-adapted and primary HIV-1 isolates, as a clin. candidate for the treatment of HIV is described.  In particular, strategies for minimizing cardiac toxicity while maintaining ADME properties commensurate with low dose are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIJQwMygW-grVg90H21EOLACvtfcHk0lhC9Jiai4Dbyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXps1Citbg%253D&md5=8c4bb50b02b7e6d8cfa13d844e39017c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2805%2943007-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252805%252943007-6%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DA.%26aulast%3DArmour%26aufirst%3DD.%26atitle%3DThe%2520discovery%2520of%2520the%2520CCR5%2520receptor%2520antagonist%252C%2520UK-427%252C857%252C%2520a%2520new%2520agent%2520for%2520the%2520treatment%2520of%2520HIV%2520infection%2520and%2520AIDS%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D43%26spage%3D239%26epage%3D271%26doi%3D10.1016%2FS0079-6468%2805%2943007-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johns, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasuji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weatherhead, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taishi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temelkoff, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taoda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanimoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshinaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garvey, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, T.</span></span> <span> </span><span class="NLM_article-title">Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5901</span>– <span class="NLM_lpage">5916</span>, <span class="refDoi"> DOI: 10.1021/jm400645w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400645w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVWhurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5901-5916&author=B.+A.+Johnsauthor=T.+Kawasujiauthor=J.+G.+Weatherheadauthor=T.+Taishiauthor=D.+P.+Temelkoffauthor=H.+Yoshidaauthor=T.+Akiyamaauthor=Y.+Taodaauthor=H.+Muraiauthor=R.+Kiyamaauthor=M.+Fujiauthor=N.+Tanimotoauthor=J.+Jeffreyauthor=S.+A.+Fosterauthor=T.+Yoshinagaauthor=T.+Sekiauthor=M.+Kobayashiauthor=A.+Satoauthor=M.+N.+Johnsonauthor=E.+P.+Garveyauthor=T.+Fujiwara&title=Carbamoyl+pyridone+HIV-1+integrase+inhibitors+3.+A+diastereomeric+approach+to+chiral+nonracemic+tricyclic+ring+systems+and+the+discovery+of+dolutegravir+%28S%2FGSK1349572%29+and+%28S%2FGSK1265744%29&doi=10.1021%2Fjm400645w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Carbamoyl Pyridone HIV-1 Integrase Inhibitors 3. A Diastereomeric Approach to Chiral Nonracemic Tricyclic Ring Systems and the Discovery of Dolutegravir (S/GSK1349572) and (S/GSK1265744)</span></div><div class="casAuthors">Johns, Brian A.; Kawasuji, Takashi; Weatherhead, Jason G.; Taishi, Teruhiko; Temelkoff, David P.; Yoshida, Hiroshi; Akiyama, Toshiyuki; Taoda, Yoshiyuki; Murai, Hitoshi; Kiyama, Ryuichi; Fuji, Masahiro; Tanimoto, Norihiko; Jeffrey, Jerry; Foster, Scott A.; Yoshinaga, Tomokazu; Seki, Takahiro; Kobayashi, Masanori; Sato, Akihiko; Johnson, Matthew N.; Garvey, Edward P.; Fujiwara, Tamio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5901-5916</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report herein the discovery of the human immunodeficiency virus type-1 (HIV-1) integrase inhibitors dolutegravir (S/GSK1349572) (3, III) and S/GSK1265744 (4, IV).  These drugs stem from a series of carbamoyl pyridone analogs designed using a two-metal chelation model of the integrase catalytic active site.  Structure-activity studies evolved a tricyclic series of carbamoyl pyridines that demonstrated properties indicative of once-daily dosing and superior potency against resistant viral strains.  An inherent hemiaminal ring fusion stereocenter within the tricyclic carbamoyl pyridone scaffold led to a crit. substrate controlled diastereoselective synthetic strategy whereby chiral information from small readily available amino alcs. was employed to control relative and abs. stereochem. of the final drug candidates.  Modest to extremely high levels of stereochem. control were obsd. depending on ring size and position of the stereocenter.  This approach resulted in the discovery of 3 and 4, which are currently in clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1G_fuC1lAtLVg90H21EOLACvtfcHk0lgrRfGx-t_wDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVWhurfK&md5=c44c9e62870c2177b07cdd08d22ea600</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm400645w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400645w%26sid%3Dliteratum%253Aachs%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DWeatherhead%26aufirst%3DJ.%2BG.%26aulast%3DTaishi%26aufirst%3DT.%26aulast%3DTemelkoff%26aufirst%3DD.%2BP.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DTaoda%26aufirst%3DY.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DTanimoto%26aufirst%3DN.%26aulast%3DJeffrey%26aufirst%3DJ.%26aulast%3DFoster%26aufirst%3DS.%2BA.%26aulast%3DYoshinaga%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DM.%2BN.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DCarbamoyl%2520pyridone%2520HIV-1%2520integrase%2520inhibitors%25203.%2520A%2520diastereomeric%2520approach%2520to%2520chiral%2520nonracemic%2520tricyclic%2520ring%2520systems%2520and%2520the%2520discovery%2520of%2520dolutegravir%2520%2528S%252FGSK1349572%2529%2520and%2520%2528S%252FGSK1265744%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5901%26epage%3D5916%26doi%3D10.1021%2Fjm400645w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deeks, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewin, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Havlir, D. V.</span></span> <span> </span><span class="NLM_article-title">The end of AIDS: HIV infection as a chronic disease</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>382</i></span>,  <span class="NLM_fpage">1525</span>– <span class="NLM_lpage">1533</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(13)61809-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1016%2FS0140-6736%2813%2961809-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2013&pages=1525-1533&author=S.+G.+Deeksauthor=S.+R.+Lewinauthor=D.+V.+Havlir&title=The+end+of+AIDS%3A+HIV+infection+as+a+chronic+disease&doi=10.1016%2FS0140-6736%2813%2961809-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2813%2961809-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252813%252961809-7%26sid%3Dliteratum%253Aachs%26aulast%3DDeeks%26aufirst%3DS.%2BG.%26aulast%3DLewin%26aufirst%3DS.%2BR.%26aulast%3DHavlir%26aufirst%3DD.%2BV.%26atitle%3DThe%2520end%2520of%2520AIDS%253A%2520HIV%2520infection%2520as%2520a%2520chronic%2520disease%26jtitle%3DLancet%26date%3D2013%26volume%3D382%26spage%3D1525%26epage%3D1533%26doi%3D10.1016%2FS0140-6736%2813%2961809-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hill, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozniak, A. L.</span></span> <span> </span><span class="NLM_article-title">How can we achieve universal access to low-cost treatment for HIV?</span>. <i>J. Virus Erad.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=27781100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A280%3ADC%252BC2srps1Kisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=193-197&author=A.+M.+Hillauthor=A.+L.+Pozniak&title=How+can+we+achieve+universal+access+to+low-cost+treatment+for+HIV%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">How can we achieve universal access to low-cost treatment for HIV?</span></div><div class="casAuthors">Hill Andrew M; Pozniak Anton L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of virus eradication</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">193-197</span>
        ISSN:<span class="NLM_cas:issn">2055-6640</span>.
    </div><div class="casAbstract">Mass production of low-cost antiretrovirals (ARVs) has already allowed over 17 million individuals to access treatment for HIV infection, mainly in low-income countries.  It is possible to manufacture combination ARVs for $110 per person-year, using tenofovir (TDF), lamivudine (3TC) and efavirenz (EFV).  New combinations of ARVs costing as little as $60 per person-year will be available in the near future.  Pre-exposure prophylaxis using TDF in combination with either 3TC or emtricitabine (FTC) could also be provided for less than $90 per person-year.  Voluntary licensing allows people in the poorest countries to access new ARVs at prices close to manufacturing costs.  Patents on several key ARVs will expire by 2018 and should allow worldwide access to high-quality, low-cost triple combination therapy, such as TDF/3TC/EFV.  Several protease inhibitors will also become available as generics by 2018.  However, ongoing patent restrictions will lead to sustained high prices for the most recently developed ARVs in most middle- and high-income countries.  These include the nucleotide tenofovir alafenamide, the integrase strand inhibitor dolutegravir and several single combination tablet regimens.  We suggest that as patents for ARVs expire, health authorities first need to rapidly import and introduce generic versions of drugs such as abacavir, 3TC, EFV and TDF.  Once these low prices have been established for these generics, cost-effectiveness of patented ARVs needs to be re-evaluated.  It may no longer be justified to pay high prices for these drugs.  A strategy of low-cost generic ARVs for most people, with higher-cost patented alternatives used as switch options, could allow for an increased number of people to receive ARVs in the context of fixed health budgets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ6gwms_bc8qLYtC3U5jeOifW6udTcc2eYABUIL_ZnLerntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srps1Kisg%253D%253D&md5=cef75b0db592fa7cc85fac3d6b91d297</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DA.%2BM.%26aulast%3DPozniak%26aufirst%3DA.%2BL.%26atitle%3DHow%2520can%2520we%2520achieve%2520universal%2520access%2520to%2520low-cost%2520treatment%2520for%2520HIV%253F%26jtitle%3DJ.%2520Virus%2520Erad.%26date%3D2016%26volume%3D2%26spage%3D193%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clemente, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coman, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiaville, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janka, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeung, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nukoolkarn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govindasamy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agbandje-McKenna, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leelamanit, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodenow, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, B. M.</span></span> <span> </span><span class="NLM_article-title">Analysis of HIV-1 CRF_01 A/E protease inhibitor resistance: structural determinants for maintaining sensitivity and developing resistance to atazanavir</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">5468</span>– <span class="NLM_lpage">5477</span>, <span class="refDoi"> DOI: 10.1021/bi051886s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi051886s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=5468-5477&author=J.+C.+Clementeauthor=R.+M.+Comanauthor=M.+M.+Thiavilleauthor=L.+K.+Jankaauthor=J.+A.+Jeungauthor=S.+Nukoolkarnauthor=L.+Govindasamyauthor=M.+Agbandje-McKennaauthor=R.+McKennaauthor=W.+Leelamanitauthor=M.+M.+Goodenowauthor=B.+M.+Dunn&title=Analysis+of+HIV-1+CRF_01+A%2FE+protease+inhibitor+resistance%3A+structural+determinants+for+maintaining+sensitivity+and+developing+resistance+to+atazanavir&doi=10.1021%2Fbi051886s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fbi051886s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi051886s%26sid%3Dliteratum%253Aachs%26aulast%3DClemente%26aufirst%3DJ.%2BC.%26aulast%3DComan%26aufirst%3DR.%2BM.%26aulast%3DThiaville%26aufirst%3DM.%2BM.%26aulast%3DJanka%26aufirst%3DL.%2BK.%26aulast%3DJeung%26aufirst%3DJ.%2BA.%26aulast%3DNukoolkarn%26aufirst%3DS.%26aulast%3DGovindasamy%26aufirst%3DL.%26aulast%3DAgbandje-McKenna%26aufirst%3DM.%26aulast%3DMcKenna%26aufirst%3DR.%26aulast%3DLeelamanit%26aufirst%3DW.%26aulast%3DGoodenow%26aufirst%3DM.%2BM.%26aulast%3DDunn%26aufirst%3DB.%2BM.%26atitle%3DAnalysis%2520of%2520HIV-1%2520CRF_01%2520A%252FE%2520protease%2520inhibitor%2520resistance%253A%2520structural%2520determinants%2520for%2520maintaining%2520sensitivity%2520and%2520developing%2520resistance%2520to%2520atazanavir%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D5468%26epage%3D5477%26doi%3D10.1021%2Fbi051886s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coman, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilliland, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sochet, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodenow, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, B. M.</span></span> <span> </span><span class="NLM_article-title">The contribution of naturally occurring polymorphisms in altering the biochemical and structural characteristics of HIV-1 subtype C protease</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">731</span>– <span class="NLM_lpage">743</span>, <span class="refDoi"> DOI: 10.1021/bi7018332</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi7018332" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=731-743&author=R.+M.+Comanauthor=A.+H.+Robbinsauthor=M.+A.+Fernandezauthor=C.+T.+Gillilandauthor=A.+A.+Sochetauthor=M.+M.+Goodenowauthor=R.+McKennaauthor=B.+M.+Dunn&title=The+contribution+of+naturally+occurring+polymorphisms+in+altering+the+biochemical+and+structural+characteristics+of+HIV-1+subtype+C+protease&doi=10.1021%2Fbi7018332"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fbi7018332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi7018332%26sid%3Dliteratum%253Aachs%26aulast%3DComan%26aufirst%3DR.%2BM.%26aulast%3DRobbins%26aufirst%3DA.%2BH.%26aulast%3DFernandez%26aufirst%3DM.%2BA.%26aulast%3DGilliland%26aufirst%3DC.%2BT.%26aulast%3DSochet%26aufirst%3DA.%2BA.%26aulast%3DGoodenow%26aufirst%3DM.%2BM.%26aulast%3DMcKenna%26aufirst%3DR.%26aulast%3DDunn%26aufirst%3DB.%2BM.%26atitle%3DThe%2520contribution%2520of%2520naturally%2520occurring%2520polymorphisms%2520in%2520altering%2520the%2520biochemical%2520and%2520structural%2520characteristics%2520of%2520HIV-1%2520subtype%2520C%2520protease%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D731%26epage%3D743%26doi%3D10.1021%2Fbi7018332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osswald, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glauninger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agniswamy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span> <span> </span><span class="NLM_article-title">Probing lipophilic adamantyl group as the P1-ligand for HIV-1 protease inhibitors: design, synthesis, protein X-ray structural studies, and biological evaluation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6826</span>– <span class="NLM_lpage">6837</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00639</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00639" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFWgsL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6826-6837&author=A.+K.+Ghoshauthor=H.+L.+Osswaldauthor=K.+Glauningerauthor=J.+Agniswamyauthor=Y.-F.+Wangauthor=H.+Hayashiauthor=M.+Aokiauthor=I.+T.+Weberauthor=H.+Mitsuya&title=Probing+lipophilic+adamantyl+group+as+the+P1-ligand+for+HIV-1+protease+inhibitors%3A+design%2C+synthesis%2C+protein+X-ray+structural+studies%2C+and+biological+evaluation&doi=10.1021%2Facs.jmedchem.6b00639"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Probing Lipophilic Adamantyl Group as the P1-Ligand for HIV-1 Protease Inhibitors: Design, Synthesis, Protein X-ray Structural Studies, and Biological Evaluation</span></div><div class="casAuthors">Ghosh, Arun K.; Osswald, Heather L.; Glauninger, Kristof; Agniswamy, Johnson; Wang, Yuan-Fang; Hayashi, Hironori; Aoki, Manabu; Weber, Irene T.; Mitsuya, Hiroaki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6826-6837</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of potent HIV-1 protease inhibitors with a lipophilic adamantyl P1 ligand have been designed, synthesized, and evaluated.  We have developed an enantioselective synthesis of adamantane-derived hydroxyethylamine isosteres utilizing Sharpless asym. epoxidn. as the key step.  Various inhibitors incorporating P1-adamantylmethyl in combination with P2 ligands such as 3-(R)-THF, 3-(S)-THF, bis-THF, and THF-THP were examd.  The S1' pocket was also probed with Ph and phenylmethyl ligands.  Inhibitor 15d, with an iso-Bu P1' ligand and a bis-THF P2 ligand, proved to be the most potent of the series.  The cLogP value of inhibitor 15d is improved compared to inhibitor 2 with a phenylmethyl P1-ligand.  X-ray structural studies of 15d, 15h, and 15i with HIV-1 protease complexes revealed mol. insight into the inhibitor-protein interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn14NWamaSc7Vg90H21EOLACvtfcHk0liNum5uujVyTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFWgsL7F&md5=133ec054d4a0d142c827cfd34fd3edaa</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00639%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DOsswald%26aufirst%3DH.%2BL.%26aulast%3DGlauninger%26aufirst%3DK.%26aulast%3DAgniswamy%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.-F.%26aulast%3DHayashi%26aufirst%3DH.%26aulast%3DAoki%26aufirst%3DM.%26aulast%3DWeber%26aufirst%3DI.%2BT.%26aulast%3DMitsuya%26aufirst%3DH.%26atitle%3DProbing%2520lipophilic%2520adamantyl%2520group%2520as%2520the%2520P1-ligand%2520for%2520HIV-1%2520protease%2520inhibitors%253A%2520design%252C%2520synthesis%252C%2520protein%2520X-ray%2520structural%2520studies%252C%2520and%2520biological%2520evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6826%26epage%3D6837%26doi%3D10.1021%2Facs.jmedchem.6b00639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kempf, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Real, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernstein, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Japour, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rode, R. A.</span></span> <span> </span><span class="NLM_article-title">Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">7462</span>– <span class="NLM_lpage">7469</span>, <span class="refDoi"> DOI: 10.1128/JVI.75.16.7462-7469.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1128%2FJVI.75.16.7462-7469.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=11462018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsFKkurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2001&pages=7462-7469&author=D.+J.+Kempfauthor=J.+D.+Isaacsonauthor=M.+S.+Kingauthor=S.+C.+Brunauthor=Y.+Xuauthor=K.+Realauthor=B.+M.+Bernsteinauthor=A.+J.+Japourauthor=E.+Sunauthor=R.+A.+Rode&title=Identification+of+genotypic+changes+in+human+immunodeficiency+virus+protease+that+correlate+with+reduced+susceptibility+to+the+protease+inhibitor+lopinavir+among+viral+isolates+from+protease+inhibitor-experienced+patients&doi=10.1128%2FJVI.75.16.7462-7469.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients</span></div><div class="casAuthors">Kempf, Dale J.; Isaacson, Jeffrey D.; King, Martin S.; Brun, Scott C.; Xu, Yi; Real, Kathryn; Bernstein, Barry M.; Japour, Anthony J.; Sun, Eugene; Rode, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7462-7469</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The assocn. of genotypic changes in human immunodeficiency virus (HIV) protease with reduced in vitro susceptibility to the new protease inhibitor lopinavir (previously ABT-378) was explored using a panel of viral isolates from subjects failing therapy with other protease inhibitors.  Two statistical tests showed that specific mutations at 11 amino acid positions in protease (L10F/I/R/V, K20M/R, L24I, M46I/L, F53L, I54L/T/V, L63P, A71I/L/T/V, V82A/F/T, I84V, and L90M) were assocd. with reduced susceptibility.  Mutations at positions 82, 54, 10, 63, 71, and 84 were most closely assocd. with relatively modest (4- and 10-fold) changes in phenotype, while the K20M/R and F53L mutations, in conjunction with multiple other mutations, were assocd. with >20- and >40-fold-reduced susceptibility, resp.  The median 50% inhibitory concns. (IC50) of lopinavir against isolates with 0 to 3, 4 or 5, 6 or 7, and 8 to 10 of the above 11 mutations were 0.8-, 2.7-, 13.5-, and 44.0-fold higher, resp., than the IC50 against wild-type HIV.  On av., the IC50 of lopinavir increased by 1.74-fold per mutation in isolates contg. three or more mutations.  Each of the 16 viruses that displayed a >20-fold change in susceptibility contained mutations at residues 10, 54, 63, and 82 and/or 84, along with a median of three mutations at residues 20, 24, 46, 53, 71, and 90.  The no. of protease mutations from the 11 identified in these analyses (the lopinavir mutation score) may be useful for the interpretation of HIV genotypic resistance testing with respect of lopinavir-ritonavir (Kaletra) regimens and may provide insight into the genetic barrier to resistance to lopinavir-ritonavir in both antiretroviral therapy-naive and protease inhibitor-experienced patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqymRxgMBzAbbVg90H21EOLACvtfcHk0liNum5uujVyTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsFKkurk%253D&md5=03c037022055c0f5868fd0f48f410539</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1128%2FJVI.75.16.7462-7469.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.75.16.7462-7469.2001%26sid%3Dliteratum%253Aachs%26aulast%3DKempf%26aufirst%3DD.%2BJ.%26aulast%3DIsaacson%26aufirst%3DJ.%2BD.%26aulast%3DKing%26aufirst%3DM.%2BS.%26aulast%3DBrun%26aufirst%3DS.%2BC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DReal%26aufirst%3DK.%26aulast%3DBernstein%26aufirst%3DB.%2BM.%26aulast%3DJapour%26aufirst%3DA.%2BJ.%26aulast%3DSun%26aufirst%3DE.%26aulast%3DRode%26aufirst%3DR.%2BA.%26atitle%3DIdentification%2520of%2520genotypic%2520changes%2520in%2520human%2520immunodeficiency%2520virus%2520protease%2520that%2520correlate%2520with%2520reduced%2520susceptibility%2520to%2520the%2520protease%2520inhibitor%2520lopinavir%2520among%2520viral%2520isolates%2520from%2520protease%2520inhibitor-experienced%2520patients%26jtitle%3DJ.%2520Virol.%26date%3D2001%26volume%3D75%26spage%3D7462%26epage%3D7469%26doi%3D10.1128%2FJVI.75.16.7462-7469.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Surleraux, D. L. N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verschueren, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pille, G. M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de
Kock, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonckers, T. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peeters, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Meyer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azijn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauwels, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bethune, M.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabu-Jeyabalan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiffer, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigerinck, P. B. T. P.</span></span> <span> </span><span class="NLM_article-title">Discovery and selection of TMC114, a next generation HIV-1 protease inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1813</span>– <span class="NLM_lpage">1822</span>, <span class="refDoi"> DOI: 10.1021/jm049560p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049560p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotVOlu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1813-1822&author=D.+L.+N.+G.+Surlerauxauthor=A.+Tahriauthor=W.+G.+Verschuerenauthor=G.+M.+E.+Pilleauthor=H.+A.+de%0AKockauthor=T.+H.+M.+Jonckersauthor=A.+Peetersauthor=S.+De+Meyerauthor=H.+Azijnauthor=R.+Pauwelsauthor=M.-P.+de+Bethuneauthor=N.+M.+Kingauthor=M.+Prabu-Jeyabalanauthor=C.+A.+Schifferauthor=P.+B.+T.+P.+Wigerinck&title=Discovery+and+selection+of+TMC114%2C+a+next+generation+HIV-1+protease+inhibitor&doi=10.1021%2Fjm049560p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Selection of TMC114, a Next Generation HIV-1 Protease Inhibitor</span></div><div class="casAuthors">Surleraux, Dominique L. N. G.; Tahri, Abdellah; Verschueren, Wim G.; Pille, Geert M. E.; de Kock, Herman A.; Jonckers, Tim H. M.; Peeters, Anik; De Meyer, Sandra; Azijn, Hilde; Pauwels, Rudi; de Bethune, Marie-Pierre; King, Nancy M.; Prabu-Jeyabalan, Moses; Schiffer, Celia A.; Wigerinck, Piet B. T. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1813-1822</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The screening of known HIV-1 protease inhibitors against a panel of multidrug-resistant viruses revealed the potent activity of TMC126 on drug-resistant mutants.  In comparison to amprenavir, the improved affinity of TMC126 is largely the result of one extra hydrogen bond to the backbone of the protein in the P2 pocket.  Modification of the substitution pattern on the phenylsulfonamide P2' substituent of TMC126 created an interesting SAR, with the close analog TMC114 being found to have a similar antiviral activity against the mutant and the wild-type viruses.  X-ray and thermodn. studies on both wild-type and mutant enzymes showed an extremely high enthalpy driven affinity of TMC114 for HIV-1 protease.  In vitro selection of mutants resistant to TMC114 starting from wild-type virus proved to be extremely difficult; this was not the case for other close analogs.  Therefore, the extra H-bond to the backbone in the P2 pocket cannot be the only explanation for the interesting antiviral profile of TMC114.  Absorption studies in animals indicated that TMC114 has pharmacokinetic properties comparable to currently approved HIV-1 protease inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdYfZu3Lc6mbVg90H21EOLACvtfcHk0lhg4b5YdCqmwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotVOlu7Y%253D&md5=35809ccdec57ebb6afa7af1b80362f74</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm049560p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049560p%26sid%3Dliteratum%253Aachs%26aulast%3DSurleraux%26aufirst%3DD.%2BL.%2BN.%2BG.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DVerschueren%26aufirst%3DW.%2BG.%26aulast%3DPille%26aufirst%3DG.%2BM.%2BE.%26aulast%3Dde%2BKock%26aufirst%3DH.%2BA.%26aulast%3DJonckers%26aufirst%3DT.%2BH.%2BM.%26aulast%3DPeeters%26aufirst%3DA.%26aulast%3DDe%2BMeyer%26aufirst%3DS.%26aulast%3DAzijn%26aufirst%3DH.%26aulast%3DPauwels%26aufirst%3DR.%26aulast%3Dde%2BBethune%26aufirst%3DM.-P.%26aulast%3DKing%26aufirst%3DN.%2BM.%26aulast%3DPrabu-Jeyabalan%26aufirst%3DM.%26aulast%3DSchiffer%26aufirst%3DC.%2BA.%26aulast%3DWigerinck%26aufirst%3DP.%2BB.%2BT.%2BP.%26atitle%3DDiscovery%2520and%2520selection%2520of%2520TMC114%252C%2520a%2520next%2520generation%2520HIV-1%2520protease%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1813%26epage%3D1822%26doi%3D10.1021%2Fjm049560p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekhtyar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempf, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molla, A.</span></span> <span> </span><span class="NLM_article-title">Characterization of resistant HIV variants generated by in vitro passage with lopinavir/ritonavir</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">173</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.1016/S0166-3542(03)00107-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1016%2FS0166-3542%2803%2900107-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2003&pages=173-180&author=H.+Moauthor=L.+Luauthor=T.+Dekhtyarauthor=K.+D.+Stewartauthor=E.+Sunauthor=D.+J.+Kempfauthor=A.+Molla&title=Characterization+of+resistant+HIV+variants+generated+by+in+vitro+passage+with+lopinavir%2Fritonavir&doi=10.1016%2FS0166-3542%2803%2900107-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0166-3542%2803%2900107-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-3542%252803%252900107-4%26sid%3Dliteratum%253Aachs%26aulast%3DMo%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DDekhtyar%26aufirst%3DT.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DSun%26aufirst%3DE.%26aulast%3DKempf%26aufirst%3DD.%2BJ.%26aulast%3DMolla%26aufirst%3DA.%26atitle%3DCharacterization%2520of%2520resistant%2520HIV%2520variants%2520generated%2520by%2520in%2520vitro%2520passage%2520with%2520lopinavir%252Fritonavir%26jtitle%3DAntiviral%2520Res.%26date%3D2003%26volume%3D59%26spage%3D173%26epage%3D180%26doi%3D10.1016%2FS0166-3542%2803%2900107-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danish, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki-Ogata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shafer, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span> <span> </span><span class="NLM_article-title">Loss of protease dimerization inhibition activity of darunavir is associated with the acquisition of resistance to darunavir by HIV-1</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">10079</span>– <span class="NLM_lpage">10089</span>, <span class="refDoi"> DOI: 10.1128/JVI.05121-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1128%2FJVI.05121-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=21813613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlWiur3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2011&pages=10079-10089&author=Y.+Kohauthor=M.+Aokiauthor=M.+L.+Danishauthor=H.+Aoki-Ogataauthor=M.+Amanoauthor=D.+Dasauthor=R.+W.+Shaferauthor=A.+K.+Ghoshauthor=H.+Mitsuya&title=Loss+of+protease+dimerization+inhibition+activity+of+darunavir+is+associated+with+the+acquisition+of+resistance+to+darunavir+by+HIV-1&doi=10.1128%2FJVI.05121-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of protease dimerization inhibition activity of darunavir is associated with the acquisition of resistance to darunavir by HIV-1</span></div><div class="casAuthors">Koh, Yasuhiro; Aoki, Manabu; Danish, Matthew L.; Aoki-Ogata, Hiromi; Amano, Masayuki; Das, Debananda; Shafer, Robert W.; Ghosh, Arun K.; Mitsuya, Hiroaki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">10079-10089</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Dimerization of HIV protease is essential for the acquisition of protease's proteolytic activity.  We previously identified a group of HIV protease dimerization inhibitors, including darunavir (DRV).  In the present work, we examine whether loss of DRV's protease dimerization inhibition activity is assocd. with HIV development of DRV resistance.  Single amino acid substitutions, including I3A, L5A, R8A/Q, L24A, T26A, D29N, R87K, T96A, L97A, and F99A, disrupted protease dimerization, as examd. using an intermol. fluorescence resonance energy transfer (FRET)-based HIV expression assay.  All recombinant HIVNL4-3-based clones with such a protease dimerization-disrupting substitution failed to replicate.  A highly DRV-resistant in vitro-selected HIV variant and clin. HIV strains isolated from AIDS patients failing to respond to DRV-contg. antiviral regimens typically had the V32I, L33F, I54M, and I84V substitutions in common in protease.  None of up to 3 of the 4 substitutions affected DRV's protease dimerization inhibition, which was significantly compromised by the four combined substitutions.  Recombinant infectious clones contg. up to 3 of the 4 substitutions remained sensitive to DRV, while a clonal HIV variant with all 4 substitutions proved highly resistant to DRV with a 205-fold 50% effective concn. (EC50) difference compared to HIVNL4-3.  The present data suggest that the loss of DRV activity to inhibit protease dimerization represents a novel mechanism contributing to HIV resistance to DRV.  The finding that 4 substitutions in PR are required for significant loss of DRV's protease dimerization inhibition should at least partially explain the reason DRV has a high genetic barrier against HIV's acquisition of DRV resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogoboda3XZ0rVg90H21EOLACvtfcHk0lhg4b5YdCqmwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlWiur3M&md5=1deea3ce630cf9a04cbbbe3ee253195d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1128%2FJVI.05121-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.05121-11%26sid%3Dliteratum%253Aachs%26aulast%3DKoh%26aufirst%3DY.%26aulast%3DAoki%26aufirst%3DM.%26aulast%3DDanish%26aufirst%3DM.%2BL.%26aulast%3DAoki-Ogata%26aufirst%3DH.%26aulast%3DAmano%26aufirst%3DM.%26aulast%3DDas%26aufirst%3DD.%26aulast%3DShafer%26aufirst%3DR.%2BW.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DMitsuya%26aufirst%3DH.%26atitle%3DLoss%2520of%2520protease%2520dimerization%2520inhibition%2520activity%2520of%2520darunavir%2520is%2520associated%2520with%2520the%2520acquisition%2520of%2520resistance%2520to%2520darunavir%2520by%2520HIV-1%26jtitle%3DJ.%2520Virol.%26date%3D2011%26volume%3D85%26spage%3D10079%26epage%3D10089%26doi%3D10.1128%2FJVI.05121-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisanuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shintani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakikawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akaji, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, Y.</span></span> <span> </span><span class="NLM_article-title">Rational design and synthesis of a novel class of active site-targeted HIV protease inhibitors containing a hydroxymethylcarbonyl isostere. Use of phenylnorstatine or allophenylnorstatine as a transition-state mimic</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">2465</span>– <span class="NLM_lpage">2467</span>, <span class="refDoi"> DOI: 10.1248/cpb.39.2465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1248%2Fcpb.39.2465" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1991&pages=2465-2467&author=T.+Mimotoauthor=J.+Imaiauthor=S.+Tanakaauthor=N.+Hattoriauthor=O.+Takahashiauthor=S.+Kisanukiauthor=Y.+Naganoauthor=M.+Shintaniauthor=H.+Hayashiauthor=K.+Sakikawaauthor=K.+Akajiauthor=Y.+Kiso&title=Rational+design+and+synthesis+of+a+novel+class+of+active+site-targeted+HIV+protease+inhibitors+containing+a+hydroxymethylcarbonyl+isostere.+Use+of+phenylnorstatine+or+allophenylnorstatine+as+a+transition-state+mimic&doi=10.1248%2Fcpb.39.2465"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1248%2Fcpb.39.2465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.39.2465%26sid%3Dliteratum%253Aachs%26aulast%3DMimoto%26aufirst%3DT.%26aulast%3DImai%26aufirst%3DJ.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DHattori%26aufirst%3DN.%26aulast%3DTakahashi%26aufirst%3DO.%26aulast%3DKisanuki%26aufirst%3DS.%26aulast%3DNagano%26aufirst%3DY.%26aulast%3DShintani%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DH.%26aulast%3DSakikawa%26aufirst%3DK.%26aulast%3DAkaji%26aufirst%3DK.%26aulast%3DKiso%26aufirst%3DY.%26atitle%3DRational%2520design%2520and%2520synthesis%2520of%2520a%2520novel%2520class%2520of%2520active%2520site-targeted%2520HIV%2520protease%2520inhibitors%2520containing%2520a%2520hydroxymethylcarbonyl%2520isostere.%2520Use%2520of%2520phenylnorstatine%2520or%2520allophenylnorstatine%2520as%2520a%2520transition-state%2520mimic%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1991%26volume%3D39%26spage%3D2465%26epage%3D2467%26doi%3D10.1248%2Fcpb.39.2465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisanuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akaji, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, Y.</span></span> <span> </span><span class="NLM_article-title">KNI-102, a novel tripeptide HIV protease inhibitor containing allophenylnorstatine as a transition-state mimic</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">3088</span>– <span class="NLM_lpage">3090</span>, <span class="refDoi"> DOI: 10.1248/cpb.39.3088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1248%2Fcpb.39.3088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1799953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADyaK38XhsVegsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1991&pages=3088-3090&author=T.+Mimotoauthor=J.+Imaiauthor=S.+Tanakaauthor=N.+Hattoriauthor=S.+Kisanukiauthor=K.+Akajiauthor=Y.+Kiso&title=KNI-102%2C+a+novel+tripeptide+HIV+protease+inhibitor+containing+allophenylnorstatine+as+a+transition-state+mimic&doi=10.1248%2Fcpb.39.3088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">KNI-102, a novel tripeptide HIV protease inhibitor containing allophenylnorstatine as a transition-state mimic</span></div><div class="casAuthors">Mimoto, Tsutomu; Imai, Junya; Tanaka, Shigeki; Hattori, Naoko; Kisanuki, Sumitsugu; Akaji, Kenichi; Kiso, Yoshiaki</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3088-90</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    </div><div class="casAbstract">HIV-1 protease inhibitors contg. allophenylnorstatine[Apns; (2S,3S)-3-amino-2-hydroxy-4-phenylbutyric acid]-Pro (syn diastereomer) as a transition-state mimic were established to be potent and highly selective.  Z-Asn-Apns-Pro-NHBut (KNI-102) is the only tripeptide exhibiting substantial anti-HIV activity and may be of min. size for potent, selective inhibition of HIV protease.  Ready availability due to its simple chem. structure and stability should make it valuable for studies of the development of metabolically stable anti-AIDS drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3IUEjcsc-gLVg90H21EOLACvtfcHk0lhS5DOm93b7Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsVegsbw%253D&md5=3e32a98a7b2bfe77f33897b23349f1df</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1248%2Fcpb.39.3088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.39.3088%26sid%3Dliteratum%253Aachs%26aulast%3DMimoto%26aufirst%3DT.%26aulast%3DImai%26aufirst%3DJ.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DHattori%26aufirst%3DN.%26aulast%3DKisanuki%26aufirst%3DS.%26aulast%3DAkaji%26aufirst%3DK.%26aulast%3DKiso%26aufirst%3DY.%26atitle%3DKNI-102%252C%2520a%2520novel%2520tripeptide%2520HIV%2520protease%2520inhibitor%2520containing%2520allophenylnorstatine%2520as%2520a%2520transition-state%2520mimic%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1991%26volume%3D39%26spage%3D3088%26epage%3D3090%26doi%3D10.1248%2Fcpb.39.3088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akaji, K.</span></span> <span> </span><span class="NLM_article-title">Small dipeptide-based HIV protease inhibitors containing the hydroxymethylcarbonyl isostere as an ideal transition-state mimic</span>. <i>Biopolymers</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1097-0282(1999)51:1<59::AID-BIP7>3.0.CO;2-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1002%2F%28SICI%291097-0282%281999%2951%3A1%3C59%3A%3AAID-BIP7%3E3.0.CO%3B2-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1999&pages=59-68&author=Y.+Kisoauthor=H.+Matsumotoauthor=S.+Mizumotoauthor=T.+Kimuraauthor=Y.+Fujiwaraauthor=K.+Akaji&title=Small+dipeptide-based+HIV+protease+inhibitors+containing+the+hydroxymethylcarbonyl+isostere+as+an+ideal+transition-state+mimic&doi=10.1002%2F%28SICI%291097-0282%281999%2951%3A1%3C59%3A%3AAID-BIP7%3E3.0.CO%3B2-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0282%281999%2951%3A1%3C59%3A%3AAID-BIP7%3E3.0.CO%3B2-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0282%25281999%252951%253A1%253C59%253A%253AAID-BIP7%253E3.0.CO%253B2-3%26sid%3Dliteratum%253Aachs%26aulast%3DKiso%26aufirst%3DY.%26aulast%3DMatsumoto%26aufirst%3DH.%26aulast%3DMizumoto%26aufirst%3DS.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DFujiwara%26aufirst%3DY.%26aulast%3DAkaji%26aufirst%3DK.%26atitle%3DSmall%2520dipeptide-based%2520HIV%2520protease%2520inhibitors%2520containing%2520the%2520hydroxymethylcarbonyl%2520isostere%2520as%2520an%2520ideal%2520transition-state%2520mimic%26jtitle%3DBiopolymers%26date%3D1999%26volume%3D51%26spage%3D59%26epage%3D68%26doi%3D10.1002%2F%28SICI%291097-0282%281999%2951%3A1%3C59%3A%3AAID-BIP7%3E3.0.CO%3B2-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohhara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honjo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okazaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hidaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroki, R.</span></span> <span> </span><span class="NLM_article-title">Structure of HIV-1 protease in complex with potent inhibitor KNI-272 determined by high resolution X-ray and neutron crystallography</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">4641</span>– <span class="NLM_lpage">4646</span>, <span class="refDoi"> DOI: 10.1073/pnas.0809400106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1073%2Fpnas.0809400106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=4641-4646&author=M.+Adachiauthor=T.+Ohharaauthor=K.+Kuriharaauthor=T.+Tamadaauthor=E.+Honjoauthor=N.+Okazakiauthor=S.+Araiauthor=Y.+Shoyamaauthor=K.+Kimuraauthor=H.+Matsumuraauthor=S.+Sugiyamaauthor=H.+Adachiauthor=K.+Takanoauthor=Y.+Moriauthor=K.+Hidakaauthor=T.+Kimuraauthor=Y.+Hayashiauthor=Y.+Kisoauthor=R.+Kuroki&title=Structure+of+HIV-1+protease+in+complex+with+potent+inhibitor+KNI-272+determined+by+high+resolution+X-ray+and+neutron+crystallography&doi=10.1073%2Fpnas.0809400106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0809400106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0809400106%26sid%3Dliteratum%253Aachs%26aulast%3DAdachi%26aufirst%3DM.%26aulast%3DOhhara%26aufirst%3DT.%26aulast%3DKurihara%26aufirst%3DK.%26aulast%3DTamada%26aufirst%3DT.%26aulast%3DHonjo%26aufirst%3DE.%26aulast%3DOkazaki%26aufirst%3DN.%26aulast%3DArai%26aufirst%3DS.%26aulast%3DShoyama%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DK.%26aulast%3DMatsumura%26aufirst%3DH.%26aulast%3DSugiyama%26aufirst%3DS.%26aulast%3DAdachi%26aufirst%3DH.%26aulast%3DTakano%26aufirst%3DK.%26aulast%3DMori%26aufirst%3DY.%26aulast%3DHidaka%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DKiso%26aufirst%3DY.%26aulast%3DKuroki%26aufirst%3DR.%26atitle%3DStructure%2520of%2520HIV-1%2520protease%2520in%2520complex%2520with%2520potent%2520inhibitor%2520KNI-272%2520determined%2520by%2520high%2520resolution%2520X-ray%2520and%2520neutron%2520crystallography%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D4641%26epage%3D4646%26doi%3D10.1073%2Fpnas.0809400106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulnik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Topol, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, J. W.</span></span> <span> </span><span class="NLM_article-title">Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophenylnorstatine</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.1016/S0969-2126(01)00192-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1016%2FS0969-2126%2801%2900192-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=8590019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADyaK2MXmvVyrs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1995&pages=581-590&author=E.+T.+Baldwinauthor=T.+N.+Bhatauthor=S.+Gulnikauthor=B.+Liuauthor=I.+A.+Topolauthor=Y.+Kisoauthor=T.+Mimotoauthor=H.+Mitsuyaauthor=J.+W.+Erickson&title=Structure+of+HIV-1+protease+with+KNI-272%2C+a+tight-binding+transition-state+analog+containing+allophenylnorstatine&doi=10.1016%2FS0969-2126%2801%2900192-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophenylnorstatine</span></div><div class="casAuthors">Baldwin, Eric T.; Bhat, T. Narayana; Gulnik, Sergel; Liu, Beishan; Topol, Igor A.; Kiso, Yoshiaki; Mimoto, Tsutomu; Mitsuya, Hiroaki; Erickson, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">581-90</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">HIV-1 protease (HIV PR), an aspartic protease, cleaves Phe-Pro bonds in the Gag and Gag-Pol viral polyproteins.  Substrate-based peptide mimics constitute a major class of inhibitors of HIV PR presently being developed for AIDS treatment.  One such compd., KNI-272, which incorporates allophenylnorstatine (Apns)-thioproline (Thp) in place of Phe-Pro, has potent antiviral activity and is undergoing clin. trials.  The structure of the enzyme-inhibitor complex should lead to an understanding of the structural basis for its tight binding properties and provide a framework for interpreting the emerging resistance to this drug.  The three-dimensional crystal structure of KNI-272 bound to HIV PR has been detd. to 2.0 Å resoln. and used to analyze structure-activity data and drug resistance for the Arg8→Gln and Ile84→Val mutations in HIV PR.  The conformationally constrained Apns-Thp linkage is favorably recognized in its low energy trans conformation, which results in a sym. mode of binding to the active-site aspartic acids and also explains the unusual preference of HIV PR for the S, or syn, hydroxyl group of the Apns residue.  The inhibitor recognizes the enzyme via hydrogen bonds to three bridging water mols., including one that is coordinated directly to the catalytic Asp125 residue.  The structure of the HIV PR/KNI-272 complex illustrates the importance of limiting the conformational degrees of freedom and of using protein-bound water mols. for binding potent inhibitors.  The binding mode of HIV PR inhibitors can be predicted from the stereochem. relation between adjacent hydroxyl-bearing and side chain bearing carbon atoms of the P1 substituent.  The structure also provides a framework for designing analogs targeted to drug-resistant mutant enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJR45zXxpXZbVg90H21EOLACvtfcHk0lgjr87SRpP9ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvVyrs74%253D&md5=4a8f8d322cdb9c1bef21ce589df93f92</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2801%2900192-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252801%252900192-7%26sid%3Dliteratum%253Aachs%26aulast%3DBaldwin%26aufirst%3DE.%2BT.%26aulast%3DBhat%26aufirst%3DT.%2BN.%26aulast%3DGulnik%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DTopol%26aufirst%3DI.%2BA.%26aulast%3DKiso%26aufirst%3DY.%26aulast%3DMimoto%26aufirst%3DT.%26aulast%3DMitsuya%26aufirst%3DH.%26aulast%3DErickson%26aufirst%3DJ.%2BW.%26atitle%3DStructure%2520of%2520HIV-1%2520protease%2520with%2520KNI-272%252C%2520a%2520tight-binding%2520transition-state%2520analog%2520containing%2520allophenylnorstatine%26jtitle%3DStructure%26date%3D1995%26volume%3D3%26spage%3D581%26epage%3D590%26doi%3D10.1016%2FS0969-2126%2801%2900192-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedberg, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wingfield, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufman, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torchia, D. A.</span></span> <span> </span><span class="NLM_article-title">Solution NMR evidence that the HIV-1 protease catalytic aspartyl groups have different ionization states in the complex formed with the asymmetric drug KNI-272</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">9945</span>– <span class="NLM_lpage">9950</span>, <span class="refDoi"> DOI: 10.1021/bi961268z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi961268z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADyaK28XksVCht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1996&pages=9945-9950&author=Y.-X.+Wangauthor=D.+I.+Freedbergauthor=T.+Yamazakiauthor=P.+T.+Wingfieldauthor=S.+J.+Stahlauthor=J.+D.+Kaufmanauthor=Y.+Kisoauthor=D.+A.+Torchia&title=Solution+NMR+evidence+that+the+HIV-1+protease+catalytic+aspartyl+groups+have+different+ionization+states+in+the+complex+formed+with+the+asymmetric+drug+KNI-272&doi=10.1021%2Fbi961268z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Solution NMR Evidence That the HIV-1 Protease Catalytic Aspartyl Groups Have Different Ionization States in the Complex Formed with the Asymmetric Drug KNI-272</span></div><div class="casAuthors">Wang, Yun-Xing; Freedberg, Daron I.; Yamazaki, Toshimasa; Wingfield, Paul T.; Stahl, Stephen J.; Kaufman, Joshua D.; Kiso, Yoshiaki; Torchia, Dennis A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">9945-9950</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In order to improve the design of HIV-1 protease inhibitors, it is essential to understand how they interact with active site residues, particularly the catalytic Asp25 and Asp125 residues.  KNI-272 is a promising, potent HIV-1 protease inhibitor (Ki ≈ 5 pM), currently undergoing phase 1 clin. trials.  Because KNI-272 is asym., the complex it forms with the homodimeric HIV-1 protease also lacks symmetry, and the two protease monomers can have distinct NMR spectra.  Monomer specific signal assignments were obtained for amino acid residues in the drug binding site as well as for six of the eight Asp residues in the protease/KNI-272 complex.  Using these assignments, the ionization states of the Asp carboxyl groups were detd. from measurements of (a) the pD dependence of the chem. shifts of the Asp carboxyl carbons and (b) the H/D isotope effect upon the Asp carboxyl carbon chem. shifts.  The results of these measurements indicate that the carboxyl of Asp25 is protonated while that of Asp125 is not protonated.  These findings provide not only the first exptl. evidence regarding the distinct protonation states of Asp25/125 in HIV-1 protease/drug complexes, but also shed light on interactions responsible for inhibitor binding that should form the basis for improved drug designs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr3SuB8Bk727Vg90H21EOLACvtfcHk0lgjr87SRpP9ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XksVCht7o%253D&md5=a99ca03ebff3a485f71b411f744b3f0d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fbi961268z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi961268z%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.-X.%26aulast%3DFreedberg%26aufirst%3DD.%2BI.%26aulast%3DYamazaki%26aufirst%3DT.%26aulast%3DWingfield%26aufirst%3DP.%2BT.%26aulast%3DStahl%26aufirst%3DS.%2BJ.%26aulast%3DKaufman%26aufirst%3DJ.%2BD.%26aulast%3DKiso%26aufirst%3DY.%26aulast%3DTorchia%26aufirst%3DD.%2BA.%26atitle%3DSolution%2520NMR%2520evidence%2520that%2520the%2520HIV-1%2520protease%2520catalytic%2520aspartyl%2520groups%2520have%2520different%2520ionization%2520states%2520in%2520the%2520complex%2520formed%2520with%2520the%2520asymmetric%2520drug%2520KNI-272%26jtitle%3DBiochemistry%26date%3D1996%26volume%3D35%26spage%3D9945%26epage%3D9950%26doi%3D10.1021%2Fbi961268z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaku, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisanuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukazawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terashima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nojima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enomoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakikawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shintani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, Y.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship of orally potent tripeptide-based HIV protease inhibitors containing hydroxymethylcarbonyl isostere</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1310</span>– <span class="NLM_lpage">1326</span>, <span class="refDoi"> DOI: 10.1248/cpb.48.1310</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1248%2Fcpb.48.1310" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2000&pages=1310-1326&author=T.+Mimotoauthor=N.+Hattoriauthor=H.+Takakuauthor=S.+Kisanukiauthor=T.+Fukazawaauthor=K.+Terashimaauthor=R.+Katoauthor=S.+Nojimaauthor=S.+Misawaauthor=T.+Uenoauthor=J.+Imaiauthor=H.+Enomotoauthor=S.+Tanakaauthor=H.+Sakikawaauthor=M.+Shintaniauthor=H.+Hayashiauthor=Y.+Kiso&title=Structure-activity+relationship+of+orally+potent+tripeptide-based+HIV+protease+inhibitors+containing+hydroxymethylcarbonyl+isostere&doi=10.1248%2Fcpb.48.1310"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1248%2Fcpb.48.1310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.48.1310%26sid%3Dliteratum%253Aachs%26aulast%3DMimoto%26aufirst%3DT.%26aulast%3DHattori%26aufirst%3DN.%26aulast%3DTakaku%26aufirst%3DH.%26aulast%3DKisanuki%26aufirst%3DS.%26aulast%3DFukazawa%26aufirst%3DT.%26aulast%3DTerashima%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DR.%26aulast%3DNojima%26aufirst%3DS.%26aulast%3DMisawa%26aufirst%3DS.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DImai%26aufirst%3DJ.%26aulast%3DEnomoto%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DSakikawa%26aufirst%3DH.%26aulast%3DShintani%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DH.%26aulast%3DKiso%26aufirst%3DY.%26atitle%3DStructure-activity%2520relationship%2520of%2520orally%2520potent%2520tripeptide-based%2520HIV%2520protease%2520inhibitors%2520containing%2520hydroxymethylcarbonyl%2520isostere%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2000%26volume%3D48%26spage%3D1310%26epage%3D1326%26doi%3D10.1248%2Fcpb.48.1310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaku, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nojima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terashima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukazawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shintani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, H.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship of small-sized HIV protease inhibitors containing allophenylnorstatine</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1789</span>– <span class="NLM_lpage">1802</span>, <span class="refDoi"> DOI: 10.1021/jm980637h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm980637h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1789-1802&author=T.+Mimotoauthor=R.+Katoauthor=H.+Takakuauthor=S.+Nojimaauthor=K.+Terashimaauthor=S.+Misawaauthor=T.+Fukazawaauthor=T.+Uenoauthor=H.+Satoauthor=M.+Shintaniauthor=Y.+Kisoauthor=H.+Hayashi&title=Structure-activity+relationship+of+small-sized+HIV+protease+inhibitors+containing+allophenylnorstatine&doi=10.1021%2Fjm980637h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm980637h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980637h%26sid%3Dliteratum%253Aachs%26aulast%3DMimoto%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DR.%26aulast%3DTakaku%26aufirst%3DH.%26aulast%3DNojima%26aufirst%3DS.%26aulast%3DTerashima%26aufirst%3DK.%26aulast%3DMisawa%26aufirst%3DS.%26aulast%3DFukazawa%26aufirst%3DT.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DShintani%26aufirst%3DM.%26aulast%3DKiso%26aufirst%3DY.%26aulast%3DHayashi%26aufirst%3DH.%26atitle%3DStructure-activity%2520relationship%2520of%2520small-sized%2520HIV%2520protease%2520inhibitors%2520containing%2520allophenylnorstatine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1789%26epage%3D1802%26doi%3D10.1021%2Fjm980637h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yusa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kavlick, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maroun, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shintani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falloon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masur, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span> <span> </span><span class="NLM_article-title">JE-2147: A dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">8675</span>– <span class="NLM_lpage">8680</span>, <span class="refDoi"> DOI: 10.1073/pnas.96.15.8675</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1073%2Fpnas.96.15.8675" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=8675-8680&author=K.+Yoshimuraauthor=R.+Katoauthor=K.+Yusaauthor=M.+F.+Kavlickauthor=V.+Marounauthor=A.+Nguyenauthor=T.+Mimotoauthor=T.+Uenoauthor=M.+Shintaniauthor=J.+Falloonauthor=H.+Masurauthor=H.+Hayashiauthor=J.+Ericksonauthor=H.+Mitsuya&title=JE-2147%3A+A+dipeptide+protease+inhibitor+%28PI%29+that+potently+inhibits+multi-PI-resistant+HIV-1&doi=10.1073%2Fpnas.96.15.8675"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.15.8675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.15.8675%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimura%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DR.%26aulast%3DYusa%26aufirst%3DK.%26aulast%3DKavlick%26aufirst%3DM.%2BF.%26aulast%3DMaroun%26aufirst%3DV.%26aulast%3DNguyen%26aufirst%3DA.%26aulast%3DMimoto%26aufirst%3DT.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DShintani%26aufirst%3DM.%26aulast%3DFalloon%26aufirst%3DJ.%26aulast%3DMasur%26aufirst%3DH.%26aulast%3DHayashi%26aufirst%3DH.%26aulast%3DErickson%26aufirst%3DJ.%26aulast%3DMitsuya%26aufirst%3DH.%26atitle%3DJE-2147%253A%2520A%2520dipeptide%2520protease%2520inhibitor%2520%2528PI%2529%2520that%2520potently%2520inhibits%2520multi-PI-resistant%2520HIV-1%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D8675%26epage%3D8680%26doi%3D10.1073%2Fpnas.96.15.8675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hidaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Rahman, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, J.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDaniel, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlbrenner, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempf, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, Y.</span></span> <span> </span><span class="NLM_article-title">Small-sized human immunodeficiency virus type-1 protease inhibitors containing allophenylnorstatine to explore the S<sub>2</sub>′ pocket</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7604</span>– <span class="NLM_lpage">7617</span>, <span class="refDoi"> DOI: 10.1021/jm9005115</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9005115" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7604-7617&author=K.+Hidakaauthor=T.+Kimuraauthor=H.+M.+Abdel-Rahmanauthor=J.-T.+Nguyenauthor=K.+F.+McDanielauthor=W.+E.+Kohlbrennerauthor=A.+Mollaauthor=M.+Adachiauthor=T.+Tamadaauthor=R.+Kurokiauthor=N.+Katsukiauthor=Y.+Tanakaauthor=H.+Matsumotoauthor=J.+Wangauthor=Y.+Hayashiauthor=D.+J.+Kempfauthor=Y.+Kiso&title=Small-sized+human+immunodeficiency+virus+type-1+protease+inhibitors+containing+allophenylnorstatine+to+explore+the+S2%E2%80%B2+pocket&doi=10.1021%2Fjm9005115"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm9005115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9005115%26sid%3Dliteratum%253Aachs%26aulast%3DHidaka%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DAbdel-Rahman%26aufirst%3DH.%2BM.%26aulast%3DNguyen%26aufirst%3DJ.-T.%26aulast%3DMcDaniel%26aufirst%3DK.%2BF.%26aulast%3DKohlbrenner%26aufirst%3DW.%2BE.%26aulast%3DMolla%26aufirst%3DA.%26aulast%3DAdachi%26aufirst%3DM.%26aulast%3DTamada%26aufirst%3DT.%26aulast%3DKuroki%26aufirst%3DR.%26aulast%3DKatsuki%26aufirst%3DN.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DMatsumoto%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DKempf%26aufirst%3DD.%2BJ.%26aulast%3DKiso%26aufirst%3DY.%26atitle%3DSmall-sized%2520human%2520immunodeficiency%2520virus%2520type-1%2520protease%2520inhibitors%2520containing%2520allophenylnorstatine%2520to%2520explore%2520the%2520S2%25E2%2580%25B2%2520pocket%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7604%26epage%3D7617%26doi%3D10.1021%2Fjm9005115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nojima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terashima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaku, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shintani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, H.</span></span> <span> </span><span class="NLM_article-title">Structure–activity relationships of novel HIV-1 protease inhibitors containing the 3-amino-2-chlorobenzoylallophenylnorstatine structure</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1299</span>– <span class="NLM_lpage">1308</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2007.10.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1016%2Fj.bmc.2007.10.062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=1299-1308&author=T.+Mimotoauthor=S.+Nojimaauthor=K.+Terashimaauthor=H.+Takakuauthor=M.+Shintaniauthor=H.+Hayashi&title=Structure%E2%80%93activity+relationships+of+novel+HIV-1+protease+inhibitors+containing+the+3-amino-2-chlorobenzoylallophenylnorstatine+structure&doi=10.1016%2Fj.bmc.2007.10.062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.10.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.10.062%26sid%3Dliteratum%253Aachs%26aulast%3DMimoto%26aufirst%3DT.%26aulast%3DNojima%26aufirst%3DS.%26aulast%3DTerashima%26aufirst%3DK.%26aulast%3DTakaku%26aufirst%3DH.%26aulast%3DShintani%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DH.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520novel%2520HIV-1%2520protease%2520inhibitors%2520containing%2520the%25203-amino-2-chlorobenzoylallophenylnorstatine%2520structure%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D1299%26epage%3D1308%26doi%3D10.1016%2Fj.bmc.2007.10.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takaku, H.</span>; <span class="NLM_string-name">Nojima, S.</span>; <span class="NLM_string-name">Mimoto, T.</span>; <span class="NLM_string-name">Terashima, K.</span></span> <span> </span><span class="NLM_article-title">Nobel Tripeptide Compounds and Anti-AIDS Drugs</span>. PCT Int. Appl. <span class="NLM_patent">WO 98/29118</span>, <span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=H.+Takaku&author=S.+Nojima&author=T.+Mimoto&author=K.+Terashima&title=Nobel+Tripeptide+Compounds+and+Anti-AIDS+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTakaku%26aufirst%3DH.%26atitle%3DNobel%2520Tripeptide%2520Compounds%2520and%2520Anti-AIDS%2520Drugs%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J. W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duong, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munson, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wai, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darke, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zugay, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emini, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleif, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huff, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, P. S.</span></span> <span> </span><span class="NLM_article-title">Potent HIV protease inhibitors: The development of tetrahydrofuranylglycines as novel P2-Ligands and pyrazine amides as P3-Ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">2300</span>– <span class="NLM_lpage">2310</span>, <span class="refDoi"> DOI: 10.1021/jm00068a006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00068a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADyaK3sXmtVegtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=2300-2310&author=A.+K.+Ghoshauthor=J.+W.+J.+Thompsonauthor=M.+K.+Hollowayauthor=S.+P.+McKeeauthor=T.+T.+Duongauthor=H.+Y.+Leeauthor=P.+M.+Munsonauthor=A.+M.+Smithauthor=J.+M.+Waiauthor=P.+L.+Darkeauthor=J.+A.+Zugayauthor=E.+A.+Eminiauthor=W.+A.+Schleifauthor=J.+R.+Huffauthor=P.+S.+Anderson&title=Potent+HIV+protease+inhibitors%3A+The+development+of+tetrahydrofuranylglycines+as+novel+P2-Ligands+and+pyrazine+amides+as+P3-Ligands&doi=10.1021%2Fjm00068a006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Potent HIV protease inhibitors: the development of tetrahydrofuranylglycines as novel P2-ligands and pyrazine amides as P3-ligands</span></div><div class="casAuthors">Ghosh, Arun K.; Thompson, Wayne J.; Holloway, M. Katharine; McKee, Sean P.; Duong, Tien T.; Lee, Hee Yoon; Munson, Peter M.; Smith, Anthony M.; Wai, Jenny M.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2300-10</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A series of protease inhibitors bearing constrained unnatural amino acids at the P2-position and novel heterocycles at the P3-position of compd. I (R = R1; Ro 31-8959) were synthesized, and their in vitro enzyme inhibitory and antiviral activities were evaluated.  Replacement of P2-asparagine of compd. I (R = R1) with (2S,3'R)-tetrahydrofuranylglycine resulted in improvement in enzyme inhibitory as well as antiviral potencies (compd. I; R = R2).  Interestingly, incorporation of (2S,3'S)-tetrahydrofuranylglycine at the P2-position proved to be less effective.  The resulting compd. I (R = R3) was 100-fold less potent than the 2S,3R-isomer (compd. I; R = R2).  This stereochem. preference indicated a hydrogen-bonding interaction between the tetrahydrofuranyl oxygen and the residues of the S2-region of the enzyme active site.  Furthermore, replacement of P3-quinolinoyl ligand of I (R = R1) with various novel heterocycles resulted in potent inhibitors of HIV proteases.  Of particular interest, compd. I (R = R4) with (2S,3'R)-tetrahydrofuranylglycine at P2 and pyrazine deriv. at P3 is one of the most potent inhibitors of HIV-1 (IC50 value 0.07 nM) and HIV-2 (IC50 value 0.18 nM) proteases.  Another important result in this series is the identification of compd. I (R = R5) in which the P2-P3-amide carbonyl has been removed.  The resulting compd. I (R = R5) has exhibited improvement in antiviral potency while retaining the enzyme inhibitory potency similar to compd. I (R = R1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3S-nIFldFzLVg90H21EOLACvtfcHk0lgpeb9T-QBcWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmtVegtbs%253D&md5=63f60b2efd113d4f2f51d869b4a4970b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm00068a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00068a006%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DThompson%26aufirst%3DJ.%2BW.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DMcKee%26aufirst%3DS.%2BP.%26aulast%3DDuong%26aufirst%3DT.%2BT.%26aulast%3DLee%26aufirst%3DH.%2BY.%26aulast%3DMunson%26aufirst%3DP.%2BM.%26aulast%3DSmith%26aufirst%3DA.%2BM.%26aulast%3DWai%26aufirst%3DJ.%2BM.%26aulast%3DDarke%26aufirst%3DP.%2BL.%26aulast%3DZugay%26aufirst%3DJ.%2BA.%26aulast%3DEmini%26aufirst%3DE.%2BA.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26aulast%3DAnderson%26aufirst%3DP.%2BS.%26atitle%3DPotent%2520HIV%2520protease%2520inhibitors%253A%2520The%2520development%2520of%2520tetrahydrofuranylglycines%2520as%2520novel%2520P2-Ligands%2520and%2520pyrazine%2520amides%2520as%2520P3-Ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D2300%26epage%3D2310%26doi%3D10.1021%2Fjm00068a006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murcko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navia, M. A.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of HIV-1 protease in complex with VX-478, a potent and orally bioavailable inhibitor of the enzyme</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">1181</span>– <span class="NLM_lpage">1182</span>, <span class="refDoi"> DOI: 10.1021/ja00108a056</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00108a056" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADyaK2MXjtVyqtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1995&pages=1181-1182&author=E.+E.+Kimauthor=C.+T.+Bakerauthor=M.+D.+Dwyerauthor=M.+A.+Murckoauthor=B.+G.+Raoauthor=R.+D.+Tungauthor=M.+A.+Navia&title=Crystal+structure+of+HIV-1+protease+in+complex+with+VX-478%2C+a+potent+and+orally+bioavailable+inhibitor+of+the+enzyme&doi=10.1021%2Fja00108a056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of HIV-1 protease in complex with VX-478, a potent and orally bioavailable inhibitor of the enzyme</span></div><div class="casAuthors">Kim, E. E.; Baker, C. T.; Dwyer, M. D.; Murcko, M. A.; Rao, B. G.; Tung, R. D.; Navia, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1181-2</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">VX-478 [3(S)-N-(3-tetrahydrofuranyloxycarbonyl)amino-1-(N,N-isobutyl-4-aminobenzenesulfonyl)amino-2-(S)-hydroxy-4-phenylbutane; C25H35N3O6S] is a potent, low-mol.-wt., orally bioavailable HIV-1 aspartic protease (retropepsin) inhibitor that is currently an advanced preclin. development candidate as a therapeutic agent against AIDS.  The crystal structure of the retropepsin-inhibitor complex, refined at 1.9 Å resoln. (R-value = 0.196), shows strong H-bonding of VX-478 to both the flap water and the catalytic Asp residues of the enzyme.  VX-478 emerged from a focused program of structure-based drug design that sought to reduce inhibitor size, an empirical goal established from an anal. of the mol. wt. distribution of all marketed oral and systemic drugs, while maintaining subnanomolar in vitro inhibitory potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNakjyopslwrVg90H21EOLACvtfcHk0lhIBXg9g_fjvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjtVyqtbo%253D&md5=7f32ba2d24ded71137a2d80f24b93ede</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fja00108a056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00108a056%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DE.%2BE.%26aulast%3DBaker%26aufirst%3DC.%2BT.%26aulast%3DDwyer%26aufirst%3DM.%2BD.%26aulast%3DMurcko%26aufirst%3DM.%2BA.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DNavia%26aufirst%3DM.%2BA.%26atitle%3DCrystal%2520structure%2520of%2520HIV-1%2520protease%2520in%2520complex%2520with%2520VX-478%252C%2520a%2520potent%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520the%2520enzyme%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1995%26volume%3D117%26spage%3D1181%26epage%3D1182%26doi%3D10.1021%2Fja00108a056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span> <span> </span><span class="NLM_article-title">Enhancing protein backbone binding—A fruitful concept for combating drug-resistant HIV</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1778</span>– <span class="NLM_lpage">1802</span>, <span class="refDoi"> DOI: 10.1002/anie.201102762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1002%2Fanie.201102762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVOru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=1778-1802&author=A.+K.+Ghoshauthor=D.+D.+Andersonauthor=I.+T.+Weberauthor=H.+Mitsuya&title=Enhancing+protein+backbone+binding%E2%80%94A+fruitful+concept+for+combating+drug-resistant+HIV&doi=10.1002%2Fanie.201102762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancing Protein Backbone Binding-A Fruitful Concept for Combating Drug-Resistant HIV</span></div><div class="casAuthors">Ghosh, Arun K.; Anderson, David D.; Weber, Irene T.; Mitsuya, Hiroaki</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1778-1802</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The evolution of drug resistance is one of the most fundamental problems in medicine.  In HIV/AIDS, the rapid emergence of drug-resistant HIV-1 variants is a major obstacle to current treatments.  HIV-1 protease inhibitors are essential components of present antiretroviral therapies.  However, with these protease inhibitors, resistance occurs through viral mutations that alter inhibitor binding, resulting in a loss of efficacy.  This loss of potency has raised serious questions with regard to effective long-term antiretroviral therapy for HIV/AIDS.  In this context, our research has focused on designing inhibitors that form extensive hydrogen-bonding interactions with the enzyme's backbone in the active site.  In doing so, we limit the protease's ability to acquire drug resistance as the geometry of the catalytic site must be conserved to maintain functionality.  In this Review, we examine the underlying principles of enzyme structure that support our backbone-binding concept as an effective means to combat drug resistance and highlight their application in our recent work on antiviral HIV-1 protease inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7UjK1GY9jV7Vg90H21EOLACvtfcHk0lhIBXg9g_fjvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVOru7k%253D&md5=0751c1ccc5d043f76fe53f7470e7b47e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fanie.201102762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201102762%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DAnderson%26aufirst%3DD.%2BD.%26aulast%3DWeber%26aufirst%3DI.%2BT.%26aulast%3DMitsuya%26aufirst%3DH.%26atitle%3DEnhancing%2520protein%2520backbone%2520binding%25E2%2580%2594A%2520fruitful%2520concept%2520for%2520combating%2520drug-resistant%2520HIV%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D1778%26epage%3D1802%26doi%3D10.1002%2Fanie.201102762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munson, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwering, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darke, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zugay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emini, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleif, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huff, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, P. S.</span></span> <span> </span><span class="NLM_article-title">3′-Tetrahydrofuranylglycine as a novel, unnatural amino acid surrogate for asparagine in the design of inhibitors of the HIV protease</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">801</span>– <span class="NLM_lpage">803</span>, <span class="refDoi"> DOI: 10.1021/ja00055a069</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00055a069" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADyaK3sXht1Gjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=1993&pages=801-803&author=W.+J.+Thompsonauthor=A.+K.+Ghoshauthor=M.+K.+Hollowayauthor=H.+Y.+Leeauthor=P.+M.+Munsonauthor=J.+E.+Schweringauthor=J.+Waiauthor=P.+L.+Darkeauthor=J.+Zugayauthor=E.+A.+Eminiauthor=W.+A.+Schleifauthor=J.+R.+Huffauthor=P.+S.+Anderson&title=3%E2%80%B2-Tetrahydrofuranylglycine+as+a+novel%2C+unnatural+amino+acid+surrogate+for+asparagine+in+the+design+of+inhibitors+of+the+HIV+protease&doi=10.1021%2Fja00055a069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">3'-Tetrahydrofuranylglycine as a novel, unnatural amino acid surrogate for asparagine in the design of inhibitors of the HIV protease</span></div><div class="casAuthors">Thompson, Wayne J.; Ghosh, Arun K.; Holloway, M. Katharine; Lee, Hee Yoon; Munson, Peter M.; Schwering, John E.; Wai, Jenny; Darke, Paul L.; Zugay, Joan; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">801-3</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The stereoselective synthesis of the novel amino acids (3'R)- and (3'S)-tetrahydrofuranylglycine are reported.  When incorporated into hydroxyethylamine transition state isostere I [R = (R)- and (S)-tetrahydrofuryl], substantial improvements in the inhibitory activities against HIV-1 and HIV-2 protease were obsd. relative to asparagine analog I (R = CH2CONH2) (Ro 31-8959).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpERQ0X4xRhbVg90H21EOLACvtfcHk0lhIBXg9g_fjvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXht1Gjsbs%253D&md5=ea089d154011286bb01975430f67e6ef</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fja00055a069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00055a069%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DW.%2BJ.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DLee%26aufirst%3DH.%2BY.%26aulast%3DMunson%26aufirst%3DP.%2BM.%26aulast%3DSchwering%26aufirst%3DJ.%2BE.%26aulast%3DWai%26aufirst%3DJ.%26aulast%3DDarke%26aufirst%3DP.%2BL.%26aulast%3DZugay%26aufirst%3DJ.%26aulast%3DEmini%26aufirst%3DE.%2BA.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26aulast%3DAnderson%26aufirst%3DP.%2BS.%26atitle%3D3%25E2%2580%25B2-Tetrahydrofuranylglycine%2520as%2520a%2520novel%252C%2520unnatural%2520amino%2520acid%2520surrogate%2520for%2520asparagine%2520in%2520the%2520design%2520of%2520inhibitors%2520of%2520the%2520HIV%2520protease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1993%26volume%3D115%26spage%3D801%26epage%3D803%26doi%3D10.1021%2Fja00055a069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nezami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hidaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freire, E.</span></span> <span> </span><span class="NLM_article-title">High affinity inhibition of a family of <i>Plasmodium falciparum</i> proteases by a designed adaptive inhibitor</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">8459</span>– <span class="NLM_lpage">8464</span>, <span class="refDoi"> DOI: 10.1021/bi034131z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi034131z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=8459-8464&author=A.+Nezamiauthor=T.+Kimuraauthor=K.+Hidakaauthor=A.+Kisoauthor=J.+Liuauthor=Y.+Kisoauthor=D.+E.+Goldbergauthor=E.+Freire&title=High+affinity+inhibition+of+a+family+of+Plasmodium+falciparum+proteases+by+a+designed+adaptive+inhibitor&doi=10.1021%2Fbi034131z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fbi034131z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi034131z%26sid%3Dliteratum%253Aachs%26aulast%3DNezami%26aufirst%3DA.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DHidaka%26aufirst%3DK.%26aulast%3DKiso%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DKiso%26aufirst%3DY.%26aulast%3DGoldberg%26aufirst%3DD.%2BE.%26aulast%3DFreire%26aufirst%3DE.%26atitle%3DHigh%2520affinity%2520inhibition%2520of%2520a%2520family%2520of%2520Plasmodium%2520falciparum%2520proteases%2520by%2520a%2520designed%2520adaptive%2520inhibitor%26jtitle%3DBiochemistry%26date%3D2003%26volume%3D42%26spage%3D8459%26epage%3D8464%26doi%3D10.1021%2Fbi034131z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyama, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hidaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kameoka, M.</span></span> <span> </span><span class="NLM_article-title">Evaluation of novel protease inhibitors against darunavir-resistant variants of HIV type 1</span>. <i>FEBS Open Bio</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1002/2211-5463.12160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1002%2F2211-5463.12160" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=88-95&author=M.+Inoueauthor=D.+Oyamaauthor=K.+Hidakaauthor=M.+Kameoka&title=Evaluation+of+novel+protease+inhibitors+against+darunavir-resistant+variants+of+HIV+type+1&doi=10.1002%2F2211-5463.12160"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2F2211-5463.12160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F2211-5463.12160%26sid%3Dliteratum%253Aachs%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DOyama%26aufirst%3DD.%26aulast%3DHidaka%26aufirst%3DK.%26aulast%3DKameoka%26aufirst%3DM.%26atitle%3DEvaluation%2520of%2520novel%2520protease%2520inhibitors%2520against%2520darunavir-resistant%2520variants%2520of%2520HIV%2520type%25201%26jtitle%3DFEBS%2520Open%2520Bio%26date%3D2017%26volume%3D7%26spage%3D88%26epage%3D95%26doi%3D10.1002%2F2211-5463.12160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dekhtyar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGoey, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flosi, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grampovnik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempf, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molla, A.</span></span> <span> </span><span class="NLM_article-title">Characterization of a novel human immunodeficiency virus type 1 protease inhibitor, A-790742</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1337</span>– <span class="NLM_lpage">1344</span>, <span class="refDoi"> DOI: 10.1128/AAC.01132-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1128%2FAAC.01132-07" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=1337-1344&author=T.+Dekhtyarauthor=T.+I.+Ngauthor=L.+Luauthor=S.+Masseauthor=D.+A.+DeGoeyauthor=W.+J.+Flosiauthor=D.+J.+Grampovnikauthor=L.+L.+Kleinauthor=D.+J.+Kempfauthor=A.+Molla&title=Characterization+of+a+novel+human+immunodeficiency+virus+type+1+protease+inhibitor%2C+A-790742&doi=10.1128%2FAAC.01132-07"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1128%2FAAC.01132-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01132-07%26sid%3Dliteratum%253Aachs%26aulast%3DDekhtyar%26aufirst%3DT.%26aulast%3DNg%26aufirst%3DT.%2BI.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DMasse%26aufirst%3DS.%26aulast%3DDeGoey%26aufirst%3DD.%2BA.%26aulast%3DFlosi%26aufirst%3DW.%2BJ.%26aulast%3DGrampovnik%26aufirst%3DD.%2BJ.%26aulast%3DKlein%26aufirst%3DL.%2BL.%26aulast%3DKempf%26aufirst%3DD.%2BJ.%26aulast%3DMolla%26aufirst%3DA.%26atitle%3DCharacterization%2520of%2520a%2520novel%2520human%2520immunodeficiency%2520virus%2520type%25201%2520protease%2520inhibitor%252C%2520A-790742%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D1337%26epage%3D1344%26doi%3D10.1128%2FAAC.01132-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fouchier, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malim, M. H.</span></span> <span> </span><span class="NLM_article-title">HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">4531</span>– <span class="NLM_lpage">4539</span>, <span class="refDoi"> DOI: 10.1093/emboj/16.15.4531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1093%2Femboj%2F16.15.4531" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=4531-4539&author=R.+A.+Fouchierauthor=B.+E.+Meyerauthor=J.+H.+Simonauthor=U.+Fischerauthor=M.+H.+Malim&title=HIV-1+infection+of+non-dividing+cells%3A+evidence+that+the+amino-terminal+basic+region+of+the+viral+matrix+protein+is+important+for+Gag+processing+but+not+for+post-entry+nuclear+import&doi=10.1093%2Femboj%2F16.15.4531"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F16.15.4531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F16.15.4531%26sid%3Dliteratum%253Aachs%26aulast%3DFouchier%26aufirst%3DR.%2BA.%26aulast%3DMeyer%26aufirst%3DB.%2BE.%26aulast%3DSimon%26aufirst%3DJ.%2BH.%26aulast%3DFischer%26aufirst%3DU.%26aulast%3DMalim%26aufirst%3DM.%2BH.%26atitle%3DHIV-1%2520infection%2520of%2520non-dividing%2520cells%253A%2520evidence%2520that%2520the%2520amino-terminal%2520basic%2520region%2520of%2520the%2520viral%2520matrix%2520protein%2520is%2520important%2520for%2520Gag%2520processing%2520but%2520not%2520for%2520post-entry%2520nuclear%2520import%26jtitle%3DEMBO%2520J.%26date%3D1997%26volume%3D16%26spage%3D4531%26epage%3D4539%26doi%3D10.1093%2Femboj%2F16.15.4531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Otwinowski, Z.</span>; <span class="NLM_string-name">Minor, W.</span></span> <span> </span><span class="NLM_article-title">Processing of X-Ray Diffraction Data Collected in Oscillation Mode</span>. In  <i>Methods in Enzymology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, C. W.,  Jr</span>, <span class="NLM_string-name">Sweet, R. M.</span></span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">1997</span>; Vol.  <span class="NLM_volume">276</span>, pp  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">326</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=307-326&author=Z.+Otwinowski&author=W.+Minorauthor=C.+W.+Carter&author=R.+M.+Sweet&title=Methods+in+Enzymology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26atitle%3DProcessing%2520of%2520X-Ray%2520Diffraction%2520Data%2520Collected%2520in%2520Oscillation%2520Mode%26btitle%3DMethods%2520in%2520Enzymology%26aulast%3DCarter%26aufirst%3DC.%2BW.%26pub%3DAcademic%2520Press%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span>; <span class="NLM_string-name">Schneider, T. R.</span></span> <span> </span><span class="NLM_article-title">SHELXL: High-resolution refinement</span>. In  <i>Methods in Enzymology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, C. W.,  Jr</span>, <span class="NLM_string-name">Sweet, R. M.</span></span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">1997</span>; Vol.  <span class="NLM_volume">277</span>, pp  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">343</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=319-343&author=G.+M.+Sheldrick&author=T.+R.+Schneiderauthor=C.+W.+Carter&author=R.+M.+Sweet&title=Methods+in+Enzymology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DSHELXL%253A%2520High-resolution%2520refinement%26btitle%3DMethods%2520in%2520Enzymology%26aulast%3DCarter%26aufirst%3DC.%2BW.%26pub%3DAcademic%2520Press%26date%3D1997%26volume%3D277%26spage%3D319%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E. J.</span></span> <span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1107/S0907444996012255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=15299926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method&doi=10.1107%2FS0907444996012255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0lgBGx2OT6PqjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26spage%3D240%26epage%3D255%26doi%3D10.1107%2FS0907444996012255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustyakimov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urzhumtsev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span> <span> </span><span class="NLM_article-title">Towards automated crystallographic structure refinement with <i>phenix.refine</i></span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">352</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1107/S0907444912001308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=10.1107%2FS0907444912001308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=22505256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1Ggu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=352-367&author=P.+V.+Afonineauthor=R.+W.+Grosse-Kunstleveauthor=N.+Echolsauthor=J.+J.+Headdauthor=N.+W.+Moriartyauthor=M.+Mustyakimovauthor=T.+C.+Terwilligerauthor=A.+Urzhumtsevauthor=P.+H.+Zwartauthor=P.+D.+Adams&title=Towards+automated+crystallographic+structure+refinement+with+phenix.refine&doi=10.1107%2FS0907444912001308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Towards automated crystallographic structure refinement with phenix.refine</span></div><div class="casAuthors">Afonine, Pavel V.; Grosse-Kunstleve, Ralf W.; Echols, Nathaniel; Headd, Jeffrey J.; Moriarty, Nigel W.; Mustyakimov, Marat; Terwilliger, Thomas C.; Urzhumtsev, Alexandre; Zwart, Peter H.; Adams, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">352-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phenix.refine is a program within the PHENIX package that supports crystallog. structure refinement against exptl. data with a wide range of upper resoln. limits using a large repertoire of model parameterizations.  It has several automation features and is also highly flexible.  Several hundred parameters enable extensive customizations for complex use cases.  Multiple user-defined refinement strategies can be applied to specific parts of the model in a single refinement run.  An intuitive graphical user interface is available to guide novice users and to assist advanced users in managing refinement projects.  X-ray or neutron diffraction data can be used sep. or jointly in refinement. phenix.refine is tightly integrated into the PHENIX suite, where it serves as a crit. component in automated model building, final structure refinement, structure validation and deposition to the wwPDB.  This paper presents an overview of the major phenix.refine features, with extensive literature refs. for readers interested in more detailed discussions of the methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnhn9QwIEkTbVg90H21EOLACvtfcHk0lgBGx2OT6PqjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1Ggu7c%253D&md5=1cc7da2cea396f1a75646ea709140cf1</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1107%2FS0907444912001308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444912001308%26sid%3Dliteratum%253Aachs%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DMustyakimov%26aufirst%3DM.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DUrzhumtsev%26aufirst%3DA.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26atitle%3DTowards%2520automated%2520crystallographic%2520structure%2520refinement%2520with%2520phenix.refine%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2012%26volume%3D68%26spage%3D352%26epage%3D367%26doi%3D10.1107%2FS0907444912001308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5YOK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5YOK','PDB','5YOK'); return false;">PDB: 5YOK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5YOJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5YOJ','PDB','5YOJ'); return false;">PDB: 5YOJ</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i51"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01709">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_72852"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01709">10.1021/acs.jmedchem.7b01709</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">HPLC analysis of target compounds; X-ray diffraction data collection and refinement statistics; Supplementary figure (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01709/suppl_file/jm7b01709_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01709/suppl_file/jm7b01709_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01709/suppl_file/jm7b01709_si_001.pdf">jm7b01709_si_001.pdf (262.35 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01709/suppl_file/jm7b01709_si_002.csv">jm7b01709_si_002.csv (3.06 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The atomic coordinates for the crystal structures of WTm5 and A17m5 proteases with compound <b>21f</b> can be assessed using PDB ID codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5YOK">5YOK</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5YOJ">5YOJ</a>, respectively.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01709&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-12%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01709%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01709" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67999f8a3afc3c10","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
